April Wang Armstrong

Photo of April Wang Armstrong
Title(s)Professor, Medicine
SchoolMedicine
ORCID ORCID Icon0000-0003-0064-8707 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. April Armstrong is Professor and Chief of Dermatology at University of California Los Angeles (UCLA). She oversees and leads the dermatology division, including managing clinical operations and promoting research and education. She also serves as Co-Director for Network Resources at the UCLA Clinical and Translational Research Institute. Prior to being the Chief of Dermatology at UCLA, Dr. Armstrong served as Associate Dean for Clinical Research at the University of Southern California (USC) for 8 years, where she led initiatives to improve research infrastructure and streamline processes to provide an efficient environment for research. She also held two prominent leadership positions at USC, serving as Vice Chair in the Department of Dermatology and Director of Clinical Research Support at the Southern California Clinical and Translational Research Institute. Prior to being at USC, Dr. Armstrong served as Vice Chair and Director of Clinical Trials and Outcomes Units at the University of California Davis and later at the University of Colorado.
    Dr. Armstrong is an internationally renowned dermatologist and clinical researcher in inflammatory skin diseases including psoriasis and atopic dermatitis. She is a federally funded investigator whose research focuses on (1) evaluating novel systemic and topical therapies for inflammatory skin diseases, (2) identifying treatment goals and comorbidities associated with skin diseases, and (3) increasing patient access using innovative, technology-enabled healthcare delivery methods. Dr. Armstrong has conducted over 150 clinical trials and published over 400 articles in scientific journals. Her research has been supported by the NIH, AHRQ, PCORI, Dermatology Foundation, and the National Psoriasis Foundation.

    Dr. Armstrong is also a passionate educator, having mentored numerous medical students, residents, and postdoctoral research fellows. She has received institutional and national teaching awards for her educational efforts.

    Dr. Armstrong has a long history of service to the medical profession on a national and international level. She serves as a board member of the American Academy of Dermatology, immediate Past Chair of the Medical Board at the National Psoriasis Foundation, Co-President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), councilor for the International Eczema Council and International Psoriasis Council, and a board member for the International Dermatology Outcome Measures and the California Society of Dermatology and Dermatological Surgery (CalDerm). She is also an editorial board member of JAMA Dermatology and had also served on the editorial boards of JAAD and other journals. Dr. Armstrong is past President of the American DermatoEpidemiology Network and Sacramento Valley Dermatology Society.

    Dr. Armstrong obtained her medical degree from Harvard Medical School and completed dermatology residency at the Harvard Combined Dermatology Residency Program. She also obtained a Master of Public Health degree from Harvard School of Public Health.

    Collapse Biography 
    Collapse education and training
    Lewis and Clark College, Portland, OregonB.A.06/1998Biochemistry and Communication
    Harvard Medical School, Boston, MassachusettsM.D.06/2004Medicine
    Harvard-Massachusetts General Hospital, Boston, MassachusettsInternship06/2005Internal Medicine
    Harvard Combined Dermatology Residency Program, Boston, MassachusettsResidency06/2008Dermatology
    Harvard School of Public Health, Boston, MassachusettsClinical Effectiveness Program08/2007Clinical Effectiveness Program
    Harvard School of Public Health, Boston, MassachusettsM.P.H08/2010Master of Public Health
    Collapse awards and honors
    Harvard Medical School 2004  - 2004Richard C. Cabot Prize for Excellence in Medical Education
    American Telemedicine Association2006  - 2006Innovative Research Award in Teledermatology
    21st World Congress of Dermatology2007  - 2007Outstanding Research Award
    Mass General Hospital, Harvard Medical School2008  - 2008First Place in Dermatology Clinical Research
    California HealthCare Foundation2009  - 2009Outstanding Award for Research in Telehealth
    Women’s Dermatologic Society2009  - 2009Academic Research Award
    Agency for Healthcare Research and Quality (AHRQ) 2009  - 2009K08 Mentored Career Development Award
    University of California Davis2010  - 2010Faculty Mentorship Award for NIH T32 Program
    University of California Davis2010  - 2010Outstanding Faculty Award for Mentoring Students in Research
    American Academy of Dermatology2011  - 2011President’s Citation for Volunteerism in Telemedicine
    University of California Davis2011  - 2011Outstanding Faculty Award for Mentoring Students in Research
    University of California Davis2012  - 2012Outstanding Faculty Award for Mentoring Students in Research
    University of California Davis2013  - 2013Faculty Mentorship Award for NIH T32 Program
    University of California Davis2013  - 2013Outstanding Faculty Award for Mentoring Students in Research
    International League of Dermatological Societies2014  - 2014Young Dermatologist International Achievement Award
    American Academy of Dermatology2015  - 2015President’s Citation for Scholarly Contributions in Psoriasis
    American Academy of Dermatology2015  - 2015President’s Citation for Scholarly Contributions in Psoriasis
    American Dermatological Association2016  - 2016Induction into the American Dermatological Association
    American Skin Association 2018  - 2018American Skin Association Research Achievement Award
    National Psoriasis Foundation 2022  - 2022Women Who Lead Award

    Collapse Research 
    Collapse research activities and funding
    Team-Based Connected Health to Improve Access and Outcomes in Atopic Dermatitis
    NIH/NIAMS 7R01AR073486-06Feb 21, 2024 - Jan 31, 2025
    Role: Principal Investigator
    Description: The goal of TCH is to enable effective management of chronic skin diseases via high-quality and efficient online care between providers and patients.
    Assessment of Treatment Satisfaction in Psoriasis
    NIH/NIAMS 1R01AR081226-01A1May 1, 2023 - Feb 28, 2027
    Role: Principal Investigator
    Description: The overarching goal of this study is to validate a patient-reported, dermatology-specific treatment satisfaction instrument (DermSat).
    Assessment of Treatment Satisfaction in Psoriasis
    NIH R01AR081226May 1, 2023 - Feb 28, 2027
    Role: Principal Investigator
    Team-Based Connected Health to Improve Access and Outcomes in Atopic Dermatitis
    NIH R01AR073486Feb 5, 2019 - Jan 31, 2025
    Role: Principal Investigator
    Patient-Centered Online Care Model for Follow-Up Management of Atopic Dermatitis
    NIH K08HS018341Sep 30, 2009 - Jul 31, 2014
    Role: Principal Investigator
    Patient-Centered Online Care Model for Follow-Up Management of Atopic Dermatitis
    AHRQ 5K08HS018341-05Sep 30, 2009 - Oct 31, 2013
    Role: Principal Investigator
    Description: The long-term research goal is to improve patient access to specialist care. The immediate research goals are to design and evaluate technology-enabled models of delivering specialist care to patients with chronic dermatologic diseases.
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse webpage

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial. JAMA Dermatol. 2026 07 01; 162(7):709-719. Lebwohl M, Blauvelt A, Kartman CE, Leatherwood C, Gordon KB, Sattar N, Puig L, Merola JF, Siu K, Wang R, Sun L, Leung A, Somani N, Rueda MJ, Cardoso A, Genovese MC, Armstrong AW, Strober B. PMID: 42139049; PMCID: PMC13179568.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    2. Patient Preferences for Treatment Attributes in Moderate to Severe Chronic Hand Eczema: A Discrete Choice Experiment. Dermatol Ther (Heidelb). 2026 Jun 12. Armstrong AW, Bin Sawad A, Hazra NC, Balu S, Maslin D, Libchaber B, Huang R, Gauthier-Loiselle M, Guerin A. PMID: 42286397.
      View in: PubMed   Mentions:
    3. Efficacy and Safety of Nemolizumab at Week 48: Results from the Maintenance Phase of Two Global Phase 3 Pivotal Studies (ARCADIA 1&2) in Patients with Moderate-to-Severe Atopic Dermatitis. Acta Derm Venereol. 2026 Jun 10; 106. Wollenberg A, Silverberg JI, Legat FJ, Tauber M, Laquer VT, Armstrong AW, Pink AE, Naldi L, Pulka G, Zdybski J, Tsianakas A, Diaz J, Svarca I, Beecker J, Balakirski G, Pauser S, Ulianov L, Ryzhkova A, Machu JL, Piketty C. PMID: 42272192.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    4. International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus Statement. JAMA Dermatol. 2026 06 01; 162(6):631-639. Merola JF, Childs BA, Bartley BR, Bissonnette R, Bieber T, Guttman-Yassky E, Paller AS, Simpson EL, Armstrong AW, Irvine AD. PMID: 41984444.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. The 2nd Brazilian GRAPPA International Meeting on Psoriasis and Psoriatic Arthritis - 2° Encontro Internacional do GRAPPA sobre Psoríase e Artrite Psoriásica. J Rheumatol. 2026 Jun 01. Goldenstein-Schainberg C, Grynszpan RL, Ribeiro AL, Azevedo VF, Armstrong AW, Mease PJ. PMID: 41985924.
      View in: PubMed   Mentions:    Fields:    
    6. Global Healthcare Study on Psoriasis (GHSP): cohort profile and first findings. BMJ Open. 2026 May 19; 16(5):e112891. Maul JT, Fröhlich F, Nielsen ML, Maul LV, Torres T, Thyssen JP, Armstrong A, Oon HH, Ji M, Kang X, Valenzuela F, Romiti R, Carvalho AVE, Novoa F, Sousa M, Luz M, Guevara BEK, Doss N, Gisondi P, Chularojanamontri L, Kündig TM, Egeberg A, Thomsen SF, Didaskalu JA. PMID: 42156142; PMCID: PMC13202043.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial. Dermatol Ther (Heidelb). 2026 Jun; 16(6):3215-3234. Elbuluk N, Armstrong AW, Vender R, Bhutani T, Green L, Ferris LK, Laquer V, Moore A, Weisman J, Zhang W, Winkelman W, Gooderham MJ. PMID: 42143206.
      View in: PubMed   Mentions:
    8. Systemic Pharmacological Treatments for Chronic Plaque Psoriasis. JAMA Dermatol. 2026 May 01; 162(5):525-526. Armstrong AW, Nong Y, Merola JF. PMID: 41879788.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Chronic Urticaria Is Independently Associated with Atherosclerotic Cardiovascular Disease: A National Cohort Study of the MarketScan Databases. Am J Clin Dermatol. 2026 Jul; 27(4):851-854. Cortes JA, Nong Y, Smart K, Aflatooni S, Palma G, Johnsen N, Ure A, Armstrong AW. PMID: 42045752.
      View in: PubMed   Mentions:    Fields:    
    10. Treatment Patterns and Economic Burden in Moderate to Severe Chronic Hand Eczema in the USA: A Real-World Retrospective Claims Analysis. Dermatol Ther (Heidelb). 2026 Jun; 16(6):3013-3026. Armstrong AW, Burne R, Bin Sawad A, Lemyre A, Gauthier-Loiselle M, Guerin A, Vinson T, Milovac B, Balu S. PMID: 42029887.
      View in: PubMed   Mentions:
    11. Treatment Patterns in Pediatric Hidradenitis Suppurativa: Time to Treatment Initiation, Initial Treatment, and Time to Switching. Pediatr Dermatol. 2026 Apr 14. Aflatooni S, Ure A, Smart K, Cortes JA, Palma G, Johnsen N, Nong Y, Armstrong AW. PMID: 41978948.
      View in: PubMed   Mentions:    Fields:    
    12. Envudeucitinib, a Potent, Next-Generation, Allosteric Inhibitor of TYK2: A Narrative Review. Dermatol Ther (Heidelb). 2026 Jun; 16(6):2661-2673. Armstrong AW, Krueger JG, Strober BE, Stein Gold LF, Desai SR, Muscianisi E, Klyachkin Y, Ucpinar S, Tilley MK, Blauvelt A. PMID: 41934538.
      View in: PubMed   Mentions:
    13. Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension. JAMA Dermatol. 2026 Apr 01; 162(4):359-367. Augustin M, Feldman SR, Warren RB, Armstrong A, Vender R, López-Ferrer A, Dawe WH, Lambert J, Szilagyi B, Hoepken B, Warham R, Gottlieb AB. PMID: 41706476; PMCID: PMC12917748.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    14. Delays in Medical Care Among Skin of Color Melanoma Patients: A Population-Based Study. J Drugs Dermatol. 2026 Apr 01; 25(4):391-393. Khan S, Jeong C, Zagona-Prizio C, Mehta MD, Maynard N, Reddy R, Yee D, Armstrong AW. PMID: 41931684.
      View in: PubMed   Mentions:    Fields:    
    15. Metformin is associated with 90-day decreased risk of death and AKI after shoulder arthroplasty in diabetic patients. J Orthop. 2026 Jun; 76:187-190. Haj Shehadeh T, Chaudhry J, Sandeep R, Updegrove G, Armstrong A, Lanham N. PMID: 41971041; PMCID: PMC13062505.
      View in: PubMed   Mentions:
    16. Concordance Between Patient- and Physician-Reported Improvement With Dupilumab in Atopic Dermatitis. J Dermatol. 2026 Apr; 53(4):708-711. Conde G, Carmenate Y, Bello G, Armstrong AW. PMID: 41823146.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Lebrikizumab off-therapy remission sustained up to 38 weeks in atopic dermatitis. J Dermatolog Treat. 2026 Dec; 37(1):2636417. Silverberg JI, Bieber T, Eyerich K, Armstrong AW, Nickoloff BJ, Natalie CR, Gallo G, Okragly A, Wolf E, Xu C, Moser BA, Rueda MJ, Elmaraghy H, Uluckan O, Gudjonsson JE. PMID: 41814992.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    18. GLP-1RAs and cardiovascular risk reduction in psoriasis: A retrospective cohort study. J Eur Acad Dermatol Venereol. 2026 Mar 05. Ma EJ, Roberts AM, Jeong CY, Chou P, Katz A, Nong Y, Johnsen N, Yan M, Ochoa MT, Armstrong AW. PMID: 41785915.
      View in: PubMed   Mentions:    Fields:    
    19. Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence. J Drugs Dermatol. 2026 Mar 01; 25(3):211-220. Lebwohl MG, Krueger JG, Koo JY, Han G, Armstrong AW, Strober BE, Kircik LH. PMID: 41779761.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Advanced Topical Nonsteroidal Therapies for Atopic Dermatitis: Consensus Statements from an Expert Panel. J Drugs Dermatol. 2026 Mar 01; 25(3):221-227. Armstrong AW, Nong Y, Bunick CG, Chovatiya R, Hebert AA, Kircik L, Yu J, Lebwohl MG. PMID: 41811426.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Expert Consensus on Advanced Topical Nonsteroidal Therapies for Chronic Hand Eczema. J Drugs Dermatol. 2026 Mar 01; 25(3):228-233. Armstrong AW, Nong Y, Bunick CG, Chovatiya R, Hebert AA, Kircik L, Yu J, Lebwohl MG. PMID: 41779760.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Systemic Corticosteroid Exposure in Patients with Atopic Dermatitis: A US Population-Based Study. Dermatol Ther (Heidelb). 2026 Mar; 16(3):1723-1737. Bunick CG, Vleugels RA, Lebwohl M, Armstrong AW, Grada A, Yue EX, Saranadasa M, Wegrzyn L, D'Andrea E. PMID: 41723777; PMCID: PMC13013726.
      View in: PubMed   Mentions:
    23. Onset and depth of response with abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis, including prominent head-and-neck dermatitis: A post hoc analysis of the head-to-head phase 3 JADE DARE study. J Am Acad Dermatol. 2026 Jun; 94(6):1857-1861. Armstrong AW, Gooderham MJ, Eyerich K, Reich K, Blauvelt A, Hong HC, Edwards RA, Bonfanti G, Clibborn C, Biswas P, Chan G, Feeney C, Güler E. PMID: 41724439.
      View in: PubMed   Mentions:    Fields:    
    24. The 487-gene expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: Results from a prospective trial. J Am Acad Dermatol. 2026 Jun; 94(6):1714-1722. Silverberg JI, Eichenfield LF, Armstrong AW, Bagel J, Lockshin B, Boh E, Koo J, Farberg AS, Goldberg MS, Quick AP, Lebwohl MG. PMID: 41707702.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    25. Expert Recommendations for the Diagnosis and Management of Chronic Hand Eczema in the United States. Am J Clin Dermatol. 2026 Mar; 27(2):227-245. Silverberg JI, Cohen D, Guttman-Yassky E, Eichenfield LF, Simpson EL, Armstrong A, Yu J, Stein-Gold L, Ehst BD, Begolka WS, Bunick CG, Chovatiya R. PMID: 41655167; PMCID: PMC13032955.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Effects of GLP-1 Receptor Agonists on Major Cardiovascular Events Among Patients with Atopic Dermatitis: A Population-Based Study. Dermatitis. 2026 Feb 06; 17103568251410211. Katz A, Nong Y, Ma EJ, Roberts AM, Chou PP, Jeong CY, Yan MJ, Johnsen N, Armstrong AW. PMID: 41649183.
      View in: PubMed   Mentions:    Fields:    
    27. INDIVIDUAL ARTICLE: Evidence-Based Synthesis of Deucravacitinib: Long Term Efficacy, Safety, and Practical Use in Moderate-to-Severe Psoriasis. J Drugs Dermatol. 2026 Feb 01; 25(2):70210s3-70210s10. Katz A, Kircik C, Lamb A, Armstrong A. PMID: 41642152.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Quantifying Treatment Burden in Hidradenitis Suppurativa: A Cohort Study. J Cutan Med Surg. 2026 Jan 16; 12034754251411878. Jeong C, Roberts A, Hur M, Chou P, Katz A, Ma E, Yan MJ, Johnsen N, Nong Y, Armstrong AW. PMID: 41542838.
      View in: PubMed   Mentions:    Fields:    
    29. Role of real-world evidence from patient registries for psoriasis in decision-making: a systematic review. BMJ Open Qual. 2026 01 12; 15(1). Passero L, Simon TA, Zhong Y, Zhuo J, Varga S, Armstrong AW. PMID: 41526088; PMCID: PMC12815139.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. SPECTREM phase IIIb clinical trial results through week 16: guselkumab efficacy and safety for the treatment of low body surface area, moderate psoriasis with high-impact site involvement. Br J Dermatol. 2026 01 06; 194(1):25-36. Stein Gold L, Gottlieb AB, Armstrong AW, Alkousakis T, Bissonnette R, Langley RG, Krueger J, Papp K, Choi O, Rowland K, Chan D, Jeyarajah J, Park-Wyllie L, Gao LL, Gordon KB, Merola JF, Lebwohl MG, Strober B. PMID: 40875818.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    31. Flexure-Based Locking Plates Can Modulate Interfragmentary Motion in Distal Femur and Diaphyseal Fractures: A Parametric Finite Element Analysis. J Biomech Eng. 2026 Jan 01; 148(1). Huxman C, Updegrove G, Armstrong A, Wee H, Frecker MI, Butler J, Lewis GS. PMID: 41239898; PMCID: PMC12755169.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Clarifying psoriasis disease severity: A position statement from the National Psoriasis Foundation Medical Board. J Am Acad Dermatol. 2026 Apr; 94(4):1348-1349. Blauvelt A, Prussick R, Merola JF, Shahriari M, Cather J, Eakin GS, McCormick Howard L, Lebwohl MG, Armstrong AW, Duffin KC. PMID: 41478505.
      View in: PubMed   Mentions:    Fields:    
    33. Short-Term Efficacy of Lebrikizumab Versus Dupilumab in Combination with Topical Corticosteroids in Adults with Moderate-to-Severe Atopic Dermatitis: Matching-Adjusted Indirect Comparison. Dermatol Ther (Heidelb). 2026 Feb; 16(2):1025-1040. Chovatiya R, Armstrong A, Kircik L, Puig L, Kirchhof MG, Torres T, Binamer Y, Duarte G, Akmaz B, Dossenbach M, Gallo G, Yang C, Seminario-Vidal L, Ding Y, Silverberg JI. PMID: 41420795; PMCID: PMC12936302.
      View in: PubMed   Mentions: 2  
    34. Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT. Dermatol Ther (Heidelb). 2026 Jan; 16(1):585-603. Armstrong A, Papp KA, Lebwohl M, Savage LJ, Yamanaka K, Vlase DE, Warham R, Lambert J, López Pinto JM, Wixted K, Thaçi D. PMID: 41359217; PMCID: PMC12873024.
      View in: PubMed   Mentions:
    35. Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis. Dermatol Ther (Heidelb). 2026 Jan; 16(1):637-646. Armstrong AW, Warren RB, Sofen H, Spelman L, Linaberry M, Becker B, Jou YM, Daamen C, Kimball AB. PMID: 41350512; PMCID: PMC12873009.
      View in: PubMed   Mentions:
    36. Association between out-of-pocket costs and treatment patterns in psoriasis and psoriatic arthritis: A claims-based cohort study. JAAD Int. 2026 Feb; 24:332-334. Roberts AM, Jeong C, Chou P, Ma EJ, Katz A, Yan MJ, Johnsen N, Nong Y, Armstrong AW. PMID: 41561196; PMCID: PMC12814830.
      View in: PubMed   Mentions:
    37. Laboratory monitoring in patients with moderate to severe plaque psoriasis. J Dermatolog Treat. 2025 Dec; 36(1):2583227. Fenkel JM, Osborne JA, Armstrong AW, Strober B, Stein Gold L, Cameron M, Lebwohl M. PMID: 41346021.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Differences in prescription patterns among various physician specialties for patients with chronic spontaneous urticaria. J Am Acad Dermatol. 2026 May; 94(5):1504-1506. Chou P, Ma E, Roberts A, Jeong C, Katz A, Yan MJ, Johnsen N, Nong Y, Yee M, Armstrong A. PMID: 41349721.
      View in: PubMed   Mentions:    Fields:    
    39. Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting. J Drugs Dermatol. 2025 Dec 01; 24(12):1215-1221. Romanelli S, Ball GD, Zhang AJ, Asare C, Hao A, Hamade H, Hren GM, Nong Y, Barbieri JS, Khattri S, Jaleel T, Liu WW, Kim B, Shinohara M, Larocca C, Butler D, Siegel D, Silverberg N, Barrio SF, Christensen R, Ehlert A, Latella J, Strand V, Armstrong AW, Perez-Chada L, Merola JF, Gottlieb AB. PMID: 41329147.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Hot Topics: Exploring Artificial Intelligence and Inflammatory Memory in the Management of Psoriatic Diseases. J Rheumatol. 2025 Dec 01; 52(Suppl 3):80-82. Shucheng H, Armstrong AW, Eidsmo L, Poddubnyy D. PMID: 40763946.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting. J Rheumatol. 2025 Dec 01; 52(Suppl 3):8-11. Romanelli S, Childs B, Strand V, Armstrong AW, Perez-Chada LM, Merola JF, Gottlieb AB. PMID: 40763947.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare Professionals. Dermatol Ther (Heidelb). 2026 Jan; 16(1):499-520. Matthews R, Armstrong AW, Augustin M, Baker C, Carrascosa JM, Kirby B, Langley R, McBride S, Reich A, Romiti R, Sampogna F, Warren RB. PMID: 41273665; PMCID: PMC12872985.
      View in: PubMed   Mentions: 1  
    43. Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors. J Am Acad Dermatol. 2026 03; 94(3):802-809. Blauvelt A, Strober BE, Eakin GS, McCormick Howard L, Langan C, van de Kerkhof PCM, Puig L, Lebwohl MG, Romiti R, Armstrong AW, Choon SE, Ramessur R, Gelfand JM, Merola JF, Winthrop KL, Torres T. PMID: 41260526.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. Matching-Adjusted Indirect Comparison of the Efficacy of Delgocitinib Cream and Dupilumab in the Treatment of Moderate to Severe Atopic Hand Eczema. Dermatol Ther (Heidelb). 2026 Jan; 16(1):423-436. Cohen D, Bewley A, Wollenberg A, Hong HC, Armstrong A, Jonsen E, Maslin D, Thoning H, von Eyben R, Chovatiya R. PMID: 41240207; PMCID: PMC12872990.
      View in: PubMed   Mentions:
    45. Effect of biologic use on the development of psoriatic arthritis: A population-based study. J Eur Acad Dermatol Venereol. 2026 May; 40(5):900-907. Miao KL, Huang MY, Guo L, Lung K, Armstrong AW. PMID: 41195984.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. The Colors Beneath: More Than a Skin Condition. J Am Acad Dermatol. 2026 Jun; 94(6):1897-1899. Yan MJ, Chou PP, Roberts AM, Jeong CY, Johnsen N, Katz A, Ma EJ, Nong Y, Armstrong AW. PMID: 41183709.
      View in: PubMed   Mentions:    Fields:    
    47. An atypical case of pemphigus herpetiformis with erythroderma. JAAD Case Rep. 2026 Jan; 67:1-4. Jeong C, Chou PP, Dong E, Shen A, McKenzie S, Lane F, Smart C, Kang Y, Kasperkiewicz M, Armstrong AW. PMID: 41362875; PMCID: PMC12681901.
      View in: PubMed   Mentions:
    48. Chronic companions: An updated national cross-sectional study of metabolic syndrome comorbidities in outpatient visits for hidradenitis suppurativa. PLoS One. 2025; 20(10):e0333010. Ma EJ, Roberts AM, Chou P, Katz A, Jeong CY, Nong Y, Ochoa MT, Armstrong AW. PMID: 41134833; PMCID: PMC12551858.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    49. Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis. Dermatol Ther (Heidelb). 2026 Jan; 16(1):277-291. Augustin M, Armstrong A, Issa NT, Petersen AS, von Eyben R, Festini T, Torres T. PMID: 41131441; PMCID: PMC12873049.
      View in: PubMed   Mentions: 2  
    50. Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials. Am J Clin Dermatol. 2026 Jan; 27(1):149-166. Mayo T, Silverberg JI, Armstrong A, Guttman-Yassky E, Blauvelt A, Esdaile B, Kabashima K, Gooderham M, Kircik L, Schneider S, Bennike N, von Eyben R, Martel BC, Røpke MA, Katoh N, Alexis AF. PMID: 41118053.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsCTClinical Trials
    51. Surgical and patient factors associated with baseplate failures after reverse shoulder arthroplasty: a study by the ASES Complications of RSA Multicenter Research Group. J Shoulder Elbow Surg. 2026 Apr; 35(4):965-977. ASES Complications of RSA Research Group, Bowler A, Glass EA, Corban J, Diestel DR, McDonald-Stahl M, Stevens CS, Arnold RP, Sahi H, Puzzitiello R, Swanson DP, Moverman MA, Lohre R, Mahendraraj KA, Le K, Dunn WR, Cannon DJ, Carlson H, Chabot PJ, Cogan C, Colatruglio MR, Friedman LG, Gaudette JA, Green J, Grobaty L, Gutman M, Ho JC, Hones K, Kahsai E, Kakalecik J, Kirkham M, Kloby MA, Konrade EN, Knack MC, LaMonica T, Loveland A, Mathew JI, Merrill E, Mousad AD, Myhre L, Nahr A, Nyfeler J, Parsell DE, Patel M, Pazik M, Polisetty TS, Ponnuru P, Scanaliato J, Shen A, Smith KM, Sprengel KA, Thakar O, Turnbull L, Vaughan A, Wheelwright JC, Whitson A, Williams AB, Williams T, Abboud J, Armstrong A, Austin L, Brolin T, Entezari V, Garrigues GE, Grawe B, Gulotta LV, Hobgood R, Horneff JG, Iannotti J, Hsu JE, Khazzam M, King JJ, Kirsch JM, Levy JC, Murthi A, Namdari S, Nicholson GP, Otto RJ, Ricchetti ET, Tashjian RZ, Throckmorton T, Wright T, Jawa A. PMID: 41072715.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Supporting evidence and recommendations for the management of patients with systemic-eligible atopic dermatitis: A Canadian consensus document. JAAD Int. 2026 Feb; 24:31-49. Purdy K, Gooderham M, Abu-Hilal M, Armstrong A, Asiniwasis R, Dhadwal G, Jack C, Lansang P, Lovegrove F, Ringuet J, Spring S. PMID: 41244860; PMCID: PMC12615338.
      View in: PubMed   Mentions:
    53. IL-17C as a Driver of Inflammation in Psoriasis. Adv Ther. 2025 Nov; 42(11):5451-5467. Han G, Armstrong A, Krueger JG, Jacobson A. PMID: 40986185.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    54. Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic Failure. Dermatol Ther (Heidelb). 2025 Nov; 15(11):3253-3266. Green L, Armstrong A, Han G, Jacobson A. PMID: 40971026; PMCID: PMC12549485.
      View in: PubMed   Mentions:
    55. Optimal Itch Response in Adults Treated with Dupilumab for Moderate-to-Severe Atopic Dermatitis. Dermatol Ther (Heidelb). 2025 Nov; 15(11):3437-3446. Ständer S, Yosipovitch G, Kim BS, Steinhoff M, Armstrong A, Legat FJ, Kabashima K, Nakahara T, Igarashi A, Praestgaard AH, Nguyen TV, Bastian M. PMID: 40971025; PMCID: PMC12549453.
      View in: PubMed   Mentions:
    56. Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials. Lancet. 2025 Sep 27; 406(10510):1363-1374. Gold LS, Armstrong AW, Bissonnette R, Magnolo N, Vender RB, Sebastian M, Galimberti ML, Tsianakas A, Arnone M, Wallace P, Simon M, Riera-Monroig J, Gerdes S, Waibel J, Gonzalez-Cantero A, Schwarz B, Tada Y, Cecchini M, Ehst B, Kircik L, Kephart L, Reyes-Servin O, Edem BE, Campbell JH, Shen YK, Cresswell K, Li S, DeKlotz CMC, Nunes F, Papp KA. PMID: 40976249.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    57. Variation in depression risk by race and ethnicity in vitiligo. JAAD Int. 2025 Dec; 23:20-23. Yan MJ, Chou PP, Roberts AM, Jeong CY, Johnsen N, Katz A, Ma EJ, Nong Y, Armstrong AW. PMID: 41019934; PMCID: PMC12465040.
      View in: PubMed   Mentions:
    58. Systemic Corticosteroid Use in Atopic Dermatitis: A Position Paper to Inform Safer Clinical Practice and Policy. J Invest Dermatol. 2025 Dec; 145(12):2947-2949. Burshtein J, Bunick CG, Vleugels RA, Armstrong AW, Golant AK, Schlesinger T, Strober BE, Song EJ, Gold LS, Lebwohl M. PMID: 40914897.
      View in: PubMed   Mentions: 3     Fields:    
    59. Patient Experiences with Psoriatic Disease in the USA: Results from the Psoriasis and Beyond Global Study. Drugs Real World Outcomes. 2025 Dec; 12(4):525-539. Armstrong AW, Mburu S, Gondo GC, Kornyeyeva E, Frade S, Ogdie A. PMID: 40879928; PMCID: PMC12634971.
      View in: PubMed   Mentions:
    60. Efficacy and safety of tildrakizumab in patients with early- vs. late-onset psoriasis. Br J Dermatol. 2025 08 18; 193(3):442-450. Armstrong AW, Blauvelt A, Lebwohl M, Asahina A, Gogineni R, Griffiths CEM. PMID: 40365708.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    61. Benefits of Earlier Apremilast Initiation in Patients with Psoriasis and Limited Skin Involvement: Results from a Real-World Retrospective Study. Dermatol Ther (Heidelb). 2025 Oct; 15(10):2911-2923. Armstrong A, Strober B, Gisondi P, Orroth KK, Cordey M, Kent ST, Deignan C, Jardon S, Hernandez RK, Brookhart MA, Stein Gold L. PMID: 40767996; PMCID: PMC12454763.
      View in: PubMed   Mentions: 1  
    62. Metformin does not decrease the incidence of shoulder arthroplasty in patients with glenohumeral joint osteoarthritis. JSES Rev Rep Tech. 2025 Nov; 5(4):621-624. Haj Shehadeh T, Chaudhry J, Abdeen A, Updegrove G, Armstrong A, Lanham N. PMID: 41179472; PMCID: PMC12573443.
      View in: PubMed   Mentions: 1  
    63. Defining On-Treatment Remission in Plaque Psoriasis: A Consensus Statement From the National Psoriasis Foundation. JAMA Dermatol. 2025 Aug 01; 161(8):863-869. Armstrong AW, Gondo GC, Merola JF, Roberts AM, Pérez-Chada LM, Balak DMW, Eakin GS, Read C, Le ST, Gutierrez Y, Bhutani T, Blauvelt A, Duffin KC, Fakharzadeh S, Feldman SR, Gelfand JM, Gladman DD, Glick B, Green LJ, Han G, Hawkes JE, Hwang ST, Johnsen N, Kalb RE, Kircik L, Langley RG, Lebwohl MG, Lewitt GM, Maverakis E, Prussick R, Reddy SM, Rosen CF, Scher JU, Siegel EL, Wallace EB, Weinberg JM, Yamauchi PS, Yosipovitch G, Liao W, Remission Workgroup of the National Psoriasis Foundation. PMID: 40531503.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    64. Brodalumab: Seven-Year US Pharmacovigilance Report. Dermatol Ther (Heidelb). 2025 Oct; 15(10):3025-3035. Lebwohl MG, Koo JY, Armstrong AW, Strober BE, Yoon SH, Rawnsley NN, Goehring EL, Jacobson AA. PMID: 40730908; PMCID: PMC12454691.
      View in: PubMed   Mentions:
    65. Efficacy and safety of ME3183, an oral phosphodiesterase 4 inhibitor, in patients with plaque psoriasis. J Eur Acad Dermatol Venereol. 2026 Apr; 40(4):610-616. Papp KA, Armstrong AW, Koresawa T, Otake K, Hirata M, Kano A. PMID: 40715001; PMCID: PMC13014432.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    66. GLP-1RAs and cardiovascular risk reduction in hidradenitis suppurativa: A real-world cohort study. J Eur Acad Dermatol Venereol. 2026 Feb; 40(2):e140-e142. Chou PP, Jeong C, Ma E, Roberts AM, Katz A, Nong Y, Yan MJ, Johnsen N, Armstrong AW. PMID: 40693677.
      View in: PubMed   Mentions:    Fields:    
    67. Tapinarof Cream for Adults and Children with Atopic Dermatitis-Efficacy by Race and Fitzpatrick Skin Type in Two Phase 3 Randomized Clinical Trials. Dermatol Ther (Heidelb). 2025 Sep; 15(9):2667-2682. Alexis AF, Kircik L, Chovatiya R, Rice ZP, Soong W, Bhutani T, Brown PM, Piscitelli SC, Rubenstein DS, Tallman AM, Armstrong AW. PMID: 40696240; PMCID: PMC12354664.
      View in: PubMed   Mentions: 1  
    68. Real-World Skin Clearance and Quality of Life with risankizumab in Patients with Psoriasis with Moderate Skin Involvement and Those Eligible for Systemic Therapy Per International Psoriasis Council Classification. Dermatol Ther (Heidelb). 2025 Sep; 15(9):2409-2421. Strober B, Patel M, Kaldas MI, St John G, Photowala H, Sima AP, Eckmann T, Beeghly A, Armstrong A. PMID: 40593269; PMCID: PMC12354662.
      View in: PubMed   Mentions: 5  
    69. Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic Keratosis. J Drugs Dermatol. 2025 Jul 01; 24(7):19913s13-19913s18. Roberts AM, Kircik L, Lebwohl M, Armstrong AW. PMID: 40627585.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    70. Tirbanibulin 1% Ointment: Clinical Trial and Real-World Evidence on Efficacy, Tolerability, Safety, and Patient-Reported Outcomes. J Drugs Dermatol. 2025 Jul 01; 24(7):19912s5-19912s12. Jeong C, Kircik L, Lebwohl M, Armstrong AW. PMID: 40627586.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    71. The Epidemiology of Atopic Dermatitis among Adults and Adolescents with Alopecia Areata in the United States. J Invest Dermatol. 2026 Feb; 146(2):365-373.e3. Bunick CG, Armstrong AW, Grada A, Soliman AM, Li C, Bristow CC, Khan IA, Lipiszko D, Silverberg JI, Issa NT, Mostaghimi A. PMID: 40581103.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    72. Psoriasis. Nat Rev Dis Primers. 2025 Jun 26; 11(1):45. Armstrong AW, Blauvelt A, Callis Duffin K, Huang YH, Savage LJ, Guo L, Merola JF. PMID: 40571687.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    73. Do female patients see their physicians differently? A population-based study evaluating perception of physician communication by patients with hidradenitis suppurativa. J Dermatol. 2025 Aug; 52(8):1263-1273. Harvey LF, Kingston P, Kikuchi R, Manasyan A, Sadrolashrafi K, Hao A, Tolson H, Yee D, Armstrong AW. PMID: 40536223.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    74. Patient-Reported Outcomes by Baseline Body Surface Area Involvement Among Individuals Initiating Biologic Therapy: Results from the CorEvitas Psoriasis Registry. Dermatol Ther (Heidelb). 2025 Aug; 15(8):2117-2130. Armstrong AW, Feldman SR, Fitzgerald T, Alkousakis T, Sima A, Li A, Kang HJ, Main SI, Khattri S, Stein Gold L. PMID: 40498388; PMCID: PMC12256371.
      View in: PubMed   Mentions:
    75. Rapid Onset of Itch Relief With Tapinarof in Two Phase 3 Trials in Atopic Dermatitis. J Drugs Dermatol. 2025 Jun 01; 24(6):600-607. Simpson EL, Silverberg JI, Bissonnette R, Stein Gold L, Armstrong A, Hebert AA, Serrao RT, Jakus JR, Brown PM, Rubenstein DS, Piscitelli SC, Tallman AM, Eichenfield LF. PMID: 40465504.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    76. Deucravacitinib in Patients with Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis: Improvements in Joint Pain and the Impact of Musculoskeletal Symptoms. Dermatol Ther (Heidelb). 2025 Aug; 15(8):2281-2293. Merola JF, Mease PJ, Armstrong AW, Strand V, Lehman T, Varga S, Choi JC, Becker B, Zhong Y, Colombo MJ, Thaçi D, Bili A, Gottlieb AB. PMID: 40445270; PMCID: PMC12256370.
      View in: PubMed   Mentions: 1  
    77. Comparing antibiotic prescribing patterns for hidradenitis suppurativa between the emergency department and ambulatory care setting. PLoS One. 2025; 20(5):e0310651. Tolson H, Yamamoto RK, Kikuchi R, Sadrolashrafi K, Hao A, Guo L, Bilimoria S, Yee D, Armstrong AW. PMID: 40388367; PMCID: PMC12088064.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    78. Efficacy and safety of ruxolitinib cream in children aged 2 to 11 years with atopic dermatitis: Results from TRuE-AD3, a phase 3, randomized double-blind study. J Am Acad Dermatol. 2025 09; 93(3):689-698. Eichenfield LF, Stein Gold LF, Simpson EL, Zaenglein AL, Armstrong AW, Tollefson MM, Soong W, Wine Lee L, Devani AR, Forman SB, Siri DD, Kallender H, Angel B, Li Q, Chen X, Paller AS. PMID: 40378883.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    79. Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes. Dermatol Ther (Heidelb). 2025 Jul; 15(7):1787-1796. Strober BE, Bukhalo M, Armstrong AW, Pariser D, Kircik L, Johnson B, Montgomery P, Dickerson TJ. PMID: 40349264; PMCID: PMC12126387.
      View in: PubMed   Mentions: 1  
    80. The Impact of Geographic Dermatologist Density on Melanoma Mortality J Drugs Dermatol. 2025 05 01; 24(5):e36-e37. Burshtein J, Zakria D, Shah M, Rosenberg A, DeBusk L, Armstrong A, Rigel D. PMID: 40327564.
      View in: PubMed   Mentions:    Fields:    
    81. Emergency versus Outpatient Care for Pediatric Atopic Dermatitis: A Population-Based Study of Sociodemographic Factors and Health Care Utilization. J Pediatr. 2025 08; 283:114604. Yamamoto RK, Tolson HC, Hao A, Kikuchi R, Sadrolashrafi K, Guo L, Bilimoria SN, Yee D, Armstrong AW. PMID: 40252957.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. Correction to: Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatol Ther (Heidelb). 2025 Apr; 15(4):1037-1044. Armstrong AW, Augustin M, Beaumont JL, Pham TP, Hudgens S, Gordon KB, Zhuo J, Becker B, Zhong Y, Kisa RM, Banerjee S, Papp KA. PMID: 40048065; PMCID: PMC11971066.
      View in: PubMed   Mentions:
    83. Dynamic Fracture Fixation Plates: A Systematic Review of Evolving Design Approaches. Ann Biomed Eng. 2025 Jun; 53(6):1271-1290. Huxman C, Armstrong A, Updegrove G, Lewis GS, Butler J. PMID: 40140151.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials. Dermatol Ther (Heidelb). 2025 Apr; 15(4):1025-1035. Armstrong AW, Kircik L, Stein Gold L, Strober B, De Oliveira CHMC, Vaile J, Jou YM, Daamen C, Scharnitz T, Lebwohl M. PMID: 40113724; PMCID: PMC11971090.
      View in: PubMed   Mentions: 1  
    85. Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials. J Eur Acad Dermatol Venereol. 2025 Jul; 39(7):1336-1351. Armstrong AW, Lebwohl M, Warren RB, Sofen H, Morita A, Paul C, Papp KA, Colombo MJ, Scotto J, Vaile J, Zhuo J, Vritzali E, Berger V, Schroeder G, Banerjee S, Thaçi D, Strober B. PMID: 40045918; PMCID: PMC12188513.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    86. Validation of DermSat-7 for Assessing Treatment Satisfaction in Patients With Psoriasis. JAMA Dermatol. 2025 Feb 26. Armstrong AW, Lee K, Yee D, Woodbury M, Zundell M, Zagona-Prizio C, Yousif J, Grant C, Shields A, Chou P, Callis Duffin K, Gottlieb AB, Merola JF, Perez-Chada L. PMID: 40009402; PMCID: PMC11866064.
      View in: PubMed   Mentions:    Fields:    
    87. Construct Validity of the IDEOM Musculoskeletal Questionnaire: An Instrument to Measure Musculoskeletal Symptoms in Patients with Psoriatic Disease. J Invest Dermatol. 2025 Jul; 145(7):1798-1801.e4. Perez-Chada LM, Gondo G, Grant C, Woodbury M, Kucharik AH, Armstrong AW, Eder L, Mease P, Ogdie A, Strand V, Gottlieb AB, Merola JF. PMID: 39864735.
      View in: PubMed   Mentions: 1     Fields:    
    88. Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment. Am J Clin Dermatol. 2025 Mar; 26(2):199-211. Gorelick J, Nguyen A, Schneider SKR, Martel BC, Madsen DE, Armstrong AW. PMID: 39820896; PMCID: PMC11850464.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    89. Gender differences in pain interference with daily activities and functional impairment among patients with hidradenitis suppurativa: A population-based study in the United States. J Eur Acad Dermatol Venereol. 2025 Aug; 39(8):e709-e712. Kingston P, Peterson H, Lee K, Huang MY, Yee D, Korouri E, Armstrong AW. PMID: 39775852.
      View in: PubMed   Mentions:    Fields:    
    90. Lebrikizumab is associated with improvements in patient-reported symptoms and quality-of-life measures across Eczema Area and Severity Index response categories: pooled results from phase-3 randomized ADvocate1 and ADvocate2 studies in patients with moderate-to-severe atopic dermatitis. J Dermatolog Treat. 2025 Dec; 36(1):2442720. Blauvelt A, Kircik L, Schlesinger T, Pierce E, Burge R, Behling M, Atwater AR, ElMaraghy H, Armstrong A. PMID: 39761965.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    91. Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study. Eur Respir J. 2025 Jan; 65(1). Chalmers JD, Shteinberg M, Mall MA, O'Donnell AE, Watz H, Gupta A, Frahm E, Eleftheraki A, Rauch J, Chotirmall SH, Armstrong AW, Eickholz P, Hasegawa N, Sauter W, McShane PJ. PMID: 39255990; PMCID: PMC11694546.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCellsCTClinical Trials
    92. Trending Psychiatric Comorbidities in Patients with Alopecia Areata in the United States from 2002 to 2019. J Clin Aesthet Dermatol. 2025 Jan; 18(1):18-19. Peterson H, Miao KL, Huang MY, Armstrong AW. PMID: 39830822; PMCID: PMC11741168.
      View in: PubMed   Mentions:
    93. INDIVIDUAL ARTICLE: Psoriasis and Obesity: Optimizing Pharmacologic Treatment and Lifestyle Interventions. J Drugs Dermatol. 2025 Jan 01; 24(1):491722s4-491722s14. Guo L, Kircik L, Armstrong AW. PMID: 39761151.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    94. Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials. JAMA Dermatol. 2025 Jan 01; 161(1):56-66. Armstrong AW, Lebwohl M, Warren RB, Sofen H, Imafuku S, Ohtsuki M, Spelman L, Passeron T, Papp KA, Kisa RM, Vaile J, Berger V, Vritzali E, Hoyt K, Colombo MJ, Scotto J, Banerjee S, Strober B, Thaçi D, Blauvelt A. PMID: 39602111; PMCID: PMC11736510.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    95. The association between obesity and efficacy of psoriasis therapies: An expert consensus panel. J Am Acad Dermatol. 2025 04; 92(4):807-815. Burshtein J, Armstrong A, Chow M, DeBusk L, Gottlieb AB, Gold LS, Korman NJ, Lio P, Merola J, Rosmarin D, Rosenberg A, Van Voorhees A, Lebwohl M. PMID: 39709077.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    96. Deucravacitinib in Japanese patients with plaque, generalized pustular, or erythrodermic psoriasis: Patient-reported outcomes in the POETYK PSO-4 study. J Dermatol. 2025 Feb; 52(2):353-358. Tada Y, Armstrong AW, Imafuku S, Okubo Y, Morita A, Zhong Y, Zhuo J, Becker B, Napoli A, Banerjee S, Ohtsuki M. PMID: 39641509; PMCID: PMC11807358.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    97. Evaluation of Pharmacokinetics of Lebrikizumab in Healthy Individuals After Subcutaneous Administration Using a Prefilled Syringe or Autoinjector in a Phase 1 Randomized Study. Clin Ther. 2025 Jan; 47(1):55-61. Datta-Mannan A, Moser B, Xu W, Jackson K, Witcher J, Armstrong AW, Blauvelt A, Lio PA. PMID: 39638723.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    98. International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting. J Drugs Dermatol. 2024 Dec 01; 23(12):1114-1120. Zhang AJ, Ball G, Zundell MP, Agüero R, Yee D, Shields A, Asare C, Navrazhina K, Liu W, Foolad N, Kwock J, Tejwani P, Hamade H, Jaleel T, Butler D, Silverberg N, Nattkemper L, Siegel DM, Tan J, Kim BS, Larocca C, Shinohara MM, Ehlert A, Latella J, Guttman-Yassky E, Krueger JG, Strand V, Armstrong AW, Merola JF, Perez-Chada L, Gottlieb AB. PMID: 39630678.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    99. Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial. JAMA Dermatol. 2024 Dec 01; 160(12):1320-1328. Gelfand JM, Armstrong AW, Lim HW, Feldman SR, Johnson SM, Claiborne WCC, Kalb RE, Jakus J, Mangold AR, Flowers RH, Bhutani T, Durkin JR, Bagel J, Fretzin S, Sheehan MP, Krell J, Reeder M, Kaffenberger J, Kartono F, Takeshita J, Bridges AM, Fielding E, Nehal US, Schaecher KL, Howard LM, Eakin GS, Báez S, Bishop BE, Fitzsimmons RC, Papadopoulos M, Song WB, Linn KA, Hubbard RA, Shin DB, Callis Duffin K. PMID: 39319513; PMCID: PMC11425190.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    100. The impact of insurance status on psoriasis patients' healthcare-seeking behavior: a population-based study in the United States. BMC Health Serv Res. 2024 Nov 29; 24(1):1504. Sadrolashrafi K, Hao A, Yamamoto RK, Guo L, Kikuchi R, Tolson HC, Bilimoria SN, Yee DK, Armstrong AW. PMID: 39614287; PMCID: PMC11606074.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    101. Brodalumab: Six-Year US Pharmacovigilance Report. Dermatol Ther (Heidelb). 2025 Jan; 15(1):213-222. Lebwohl MG, Koo JY, Armstrong AW, Strober BE, Yoon SH, Rawnsley NN, Goehring EL, Mangin GD, Jacobson AA. PMID: 39589679; PMCID: PMC11785849.
      View in: PubMed   Mentions: 3  
    102. Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies. Am J Clin Dermatol. 2025 Jan; 26(1):121-137. Simpson EL, Augustin M, Thaçi D, Misery L, Armstrong AW, Blauvelt A, Papp KA, Szepietowski JC, Boguniewicz M, Kwatra SG, Kallender H, Sturm D, Ren H, Kircik L. PMID: 39546129; PMCID: PMC11742460.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    103. Low success rate of closed reductions when treating dislocations after reverse shoulder arthroplasty: a study by the ASES Complications of RSA Multicenter Research Group. J Shoulder Elbow Surg. 2025 Jun; 34(6):1477-1486. ASES Complications of RSA Research Group, Puzzitiello R, Glass EA, Bowler AR, Swanson DP, Moverman M, Lohre R, Mahendraraj KA, McDonald-Stahl M, Diestel DR, Le K, Dunn WR, Cannon DJ, Friedman LGM, Gaudette JA, Green J, Grobaty L, Gutman M, Kakalecik J, Kloby MA, Konrade EN, Knack MC, Loveland A, Mathew JI, Myhre L, Nyfeler J, Parsell DE, Pazik M, Polisetty TS, Ponnuru P, Smith KM, Sprengel KA, Thakar O, Turnbull L, Vaughan A, Wheelwright JC, Abboud J, Armstrong A, Austin L, Brolin T, Entezari V, Garrigues GE, Grawe B, Gulotta LV, Hobgood R, Horneff JG, Hsu JE, Iannotti J, Khazzam M, King JJ, Kirsch JM, Levy JC, Murthi A, Namdari S, Nicholson GP, Otto RJ, Ricchetti ET, Tashjian R, Throckmorton T, Wright T, Jawa A. PMID: 39547489.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    104. Indirect comparison of deucravacitinib and other systemic treatments for moderate to severe plaque psoriasis in Asian populations: A systematic literature review and network meta-analysis. J Dermatol. 2024 Dec; 51(12):1559-1571. Tsai TF, Tada Y, Kung C, Zhong Y, Cichewicz A, Borkowska K, Westley T, Kisa RM, Huang YH, Gao XH, Jo SJ, Armstrong AW. PMID: 39526612; PMCID: PMC11624152.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    105. Chronic Obstructive Pulmonary Disease Outcomes in Patients with Psoriasis. J Invest Dermatol. 2025 May; 145(5):1196-1198.e1. Guo L, Bilimoria SN, Kikuchi R, Hao A, Sadrolashrafi K, Yamamoto RK, Tolson H, Yee D, Armstrong AW. PMID: 39522941.
      View in: PubMed   Mentions:    Fields:    
    106. Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis. Dermatol Ther (Heidelb). 2024 Nov; 14(11):3133-3147. Warren RB, Donnelly K, Kiri S, Taieb V, Slim M, Fahrbach K, Neupane B, Betts M, Armstrong A. PMID: 39485596; PMCID: PMC11557745.
      View in: PubMed   Mentions: 4  
    107. Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study. Dermatology. 2025; 241(1):10-18. Thyssen JP, Rosmarin D, Costanzo A, Warren R, Chu CY, Chovatiya R, Ladizinski B, Hu X, Liu Y, Calimlim B, Nduaka C, Vigna N, Armstrong A. PMID: 39476813; PMCID: PMC11793090.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    108. Matching-Adjusted Indirect Comparison of Risankizumab Versus Deucravacitinib in Patients with Moderate-to-Severe Plaque Psoriasis. Dermatol Ther (Heidelb). 2024 Nov; 14(11):3071-3081. Armstrong AW, Soliman AM, Gisondi P, Fang S, Patel M, Strober B. PMID: 39453596; PMCID: PMC11557788.
      View in: PubMed   Mentions: 1  
    109. Professional Behavior Assessment During Residency Training: Can We Identify Outliers? JB JS Open Access. 2024 Oct-Dec; 9(4). Van Heest A, Frick S, Harrast J, Martin D, Saniei M, Taitsman L, Armstrong A. PMID: 39440279; PMCID: PMC11495753.
      View in: PubMed   Mentions:
    110. Contact Dermatitis in the United States: A Population-Based Study on Patient Visit Characteristics and Treatment Prescription Patterns. Dermatitis. 2025 Jan-Feb; 36(1):53-61. Hao A, Yu RP, Kikuchi R, Sadrolashrafi K, Guo L, Yamamoto RK, Tolson H, Yee D, Bilimoria S, Pourali SP, Adler BL, Armstrong AW. PMID: 39403761.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    111. Patient-Identified Treatment Goals for Psoriatic Disease: Results From a US Patient Survey. J Psoriasis Psoriatic Arthritis. 2025 Jan; 10(1):11-21. Armstrong A, Levit NA, Schneider B, Seiden R, Shi L, Kaplan B, Wu JJ. PMID: 39544333; PMCID: PMC11559564.
      View in: PubMed   Mentions: 1  
    112. Global Comparison of COVID-19 Vaccination Rates among Psoriasis Patients. Life (Basel). 2024 Oct 13; 14(10). Korouri E, Jeong C, Peterson H, Valenzuela F, Romiti R, Didaskalu JA, Egeberg A, Oon HH, Maul LV, Kingston P, Lee K, Huang MY, Yee D, Artiga K, Aguero R, Maul JT, Armstrong AW. PMID: 39459597; PMCID: PMC11509075.
      View in: PubMed   Mentions: 1  
    113. Treat-to-Target Outcomes With Tapinarof Cream 1% in Phase 3 Trials for Plaque Psoriasis. Cutis. 2024 Oct; 114(4):122-127. Armstrong AW, Bissonnette R, Chovatiya R, Bhutani T, Brown PM, Tallman AM, Papp KA. PMID: 39621574.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    114. Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial. JAMA Dermatol. 2024 Oct 01; 160(10):1066-1074. Armstrong AW, Gooderham M, Lynde C, Maari C, Forman S, Green L, Laquer V, Zhang X, Franchimont N, Gangolli EA, Blau J, Zhao Y, Zhang W, Srivastava B, Heap G, Papp K. PMID: 39167366; PMCID: PMC11339701.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    115. GRAPPA Debate: Targeted Small Molecules Versus Biologics as First-Line Systemic Therapy After Conventional Therapy for Moderate-to-Severe Psoriasis. J Rheumatol. 2024 Oct 01; 51(Suppl 2):89-92. Liao W, Armstrong AW, Duffin KC. PMID: 39009402.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    116. Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual Meeting. J Rheumatol. 2024 Oct 01; 51(Suppl 2):16-18. Ball GD, Yee D, Zhang AJ, Perez-Chada LM, Strand V, Merola JF, Armstrong AW, Gottlieb AB. PMID: 39009383.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    117. Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2023 Annual Meeting. J Rheumatol. 2024 Oct 01; 51(Suppl 2):1-5. Gladman DD, FitzGerald O, Armstrong AW, Goel N, Gottlieb AB. PMID: 39009394.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    118. Insights and Innovations: A Review of the GRAPPA 2023 Trainee Symposium. J Rheumatol. 2024 Oct 01; 51(Suppl 2):33-38. Husni ME, Cheemalavagu S, Armstrong AW, Eder L. PMID: 39009400.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    119. GRAPPA 2023 Annual Meeting Report: Hot Topic Session on Measurement of Musculoskeletal Symptoms in Psoriatic Disease. J Rheumatol. 2024 Oct 01; 51(Suppl 2):51-53. Zhang AJ, Perez-Chada LM, Strand V, Armstrong AW, Gottlieb AB, Merola JF. PMID: 39009404.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    120. Mechanically compliant locking plates for diaphyseal fracture fixation: A biomechanical study. J Orthop Res. 2025 01; 43(1):217-227. Huxman C, Lewis G, Armstrong A, Updegrove G, Koroneos Z, Butler J. PMID: 39279031; PMCID: PMC11615426.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    121. Efficacy of Brodalumab in Patients with Psoriasis and Risk Factors for Treatment Failure: A Review of Post Hoc Analyses. Dermatol Ther (Heidelb). 2024 Oct; 14(10):2709-2726. Lebwohl MG, Armstrong AW, Alexis AF, Lain EL, Jacobson AA. PMID: 39264399; PMCID: PMC11480272.
      View in: PubMed   Mentions: 4  
    122. Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO). Acta Derm Venereol. 2024 Sep 05; 104:adv40556. Armstrong AW, Riedl E, Brunner PM, Piaserico S, Visser WI, Haustrup N, Konicek BW, Kadziola Z, Nunez M, Brnabic A, Schuster C. PMID: 39235051; PMCID: PMC11388106.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    123. Comparing antibiotic prescribing patterns for hidradenitis suppurativa between dermatology and non-dermatology ambulatory providers. Skin Health Dis. 2024 Oct; 4(5):e451. Tolson H, Kikuchi R, Yamamoto RK, Sadrolashrafi K, Guo L, Hao A, Bilimoria S, Yee D, Armstrong AW. PMID: 39355735; PMCID: PMC11442064.
      View in: PubMed   Mentions:
    124. Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis. Dermatol Ther (Heidelb). 2024 Sep; 14(9):2577-2589. Armstrong AW, Foley P, Liu Y, Miller M, Teneralli RE, Bewley A, Gordon KB, Papp KA, Han C. PMID: 39177870; PMCID: PMC11393263.
      View in: PubMed   Mentions: 3  
    125. Treatment burden and the perspectives of patients with psoriasis using topical treatments: results from a national survey of adults with psoriasis in the United States. J Dermatolog Treat. 2024 Dec; 35(1):2389174. Armstrong A, Young M, Seal MS, Higham RC, Greiling T. PMID: 39128848.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    126. Teledermatology Use in the Elderly: An Analysis of Teledermatology Utilization Patterns Across Age Groups. Telemed J E Health. 2024 11; 30(11):2669-2675. Hao A, Sadrolashrafi K, Kikuchi R, Guo L, Yamamoto RK, Tolson HC, Bilimoria S, Yee D, Hu JC, Armstrong AW. PMID: 39119704.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    127. Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel. J Drugs Dermatol. 2024 Aug 01; 23(8):592-599. Burshtein J, Shah M, Zakria D, Armstrong AW, Golant AK, Gottlieb AB, Weinberg JM, Kircik L, Han G, Langley RG, Neimann AL, Lebwohl M. PMID: 39093660.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    128. Correction: Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity. Dermatol Ther (Heidelb). 2024 Aug; 14(8):2297. Armstrong AW, Jaleel T, Merola JF, Gottlieb AB, Khattri S, Helt CC, Malatestinic WN, Ross SE, Ngantcha ME, de Vlam K. PMID: 38981938; PMCID: PMC11333380.
      View in: PubMed   Mentions:
    129. The Hidden Costs of Psoriasis: A Population-Based Study Evaluating How Psoriasis Severity Impacts Work Absenteeism. J Drugs Dermatol. 2024 Aug 01; 23(8):640-644. Lee K, Kingston P, Huang MY, Yee D, Peterson H, Korouri E, Agüero R, Armstrong A. PMID: 39093651.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    130. Benefits Over Five Years of Ixekizumab Treatment in Patients With Psoriasis Involving Challenging Body Areas. J Drugs Dermatol. 2024 Aug 01; 23(8):619-625. Gottlieb AB, Armstrong A, Blauvelt A, Griffiths CEM, Pinter A, Gooderham M, Lomaga M, Burge RT, Konicek BW, McDonald MF, See K, McKean-Matthews M, Mabuchi T. PMID: 39093657.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    131. Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis. Dermatol Ther (Heidelb). 2024 Sep; 14(9):2457-2465. Armstrong AW, Hong HC, Calimlim BM, Buessing MG, Crowell MM, Silverberg JI. PMID: 39078584; PMCID: PMC11393374.
      View in: PubMed   Mentions: 2  
    132. Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatol Ther (Heidelb). 2024 Aug; 14(8):2235-2248. Armstrong AW, Augustin M, Beaumont JL, Pham TP, Hudgens S, Gordon KB, Zhuo J, Becker B, Zhong Y, Kisa RM, Banerjee S, Papp KA. PMID: 39080153; PMCID: PMC11333388.
      View in: PubMed   Mentions: 5  
    133. Addressing Cardiovascular Risk in People With Psoriatic Disease Using a Care Coordinator Model: A Qualitative Analysis of a Pilot Study. J Psoriasis Psoriatic Arthritis. 2024 Oct; 9(4):125-135. Mason JB, Johnson C, Ogbuefi N, Wang S, Armstrong A, Barbieri JS, Cohen JB, Craig E, Fitzsimmons R, Garshick MS, Lieberman A, Mehta NN, Ogdie A, Papadopoulos M, Shin DB, Baez Vanderbeek S, Gelfand JM, Beidas RS. PMID: 42164263; PMCID: PMC13185527.
      View in: PubMed   Mentions:
    134. COVID-19 vaccinated children, adolescents, and young adults with acute lymphoblastic leukemia show spike reactive antibodies and multifunctional T-cells. Int J Cancer. 2024 Dec 15; 155(12):2190-2200. Parker RS, Le J, Villa M, Luong A, Lin TY, Lee Y, Doan A, Aguayo-Hiraldo P, Pannaraj PS, Yoon SJ, Wallace WD, Armstrong A, O'Gorman MR, Bard JD, Parekh C. PMID: 39005114; PMCID: PMC11499007.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    135. Prevalence, incidence, and risk of chronic obstructive pulmonary disease among psoriasis patients. Respir Med. 2024 09; 231:107729. Guo L, Bilimoria SN, Kikuchi R, Hao A, Tolson H, Yamamoto RK, Sadrolashrafi K, Yee D, Armstrong AW. PMID: 38964424.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    136. Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials. J Dermatolog Treat. 2024 Dec; 35(1):2371045. Korman NJ, Warren RB, Bagel J, Armstrong AW, Gooderham M, Strober B, Thaçi D, Morita A, Imafuku S, Foley P, Sofen H, Zheng M, Hippeli L, Kisa RM, Banerjee S, Blauvelt A. PMID: 38945549.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    137. Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis. Dermatol Ther (Heidelb). 2024 Jul; 14(7):1929-1943. Lio PA, Armstrong A, Gutermuth J, Nosbaum A, Sofen H, Gil EG, Casillas M, Chen S, Sun L, Pierce E, Elmaraghy H, Dawson Z, Torres T. PMID: 38922484; PMCID: PMC11265048.
      View in: PubMed   Mentions: 2  
    138. Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2. J Invest Dermatol. 2024 Dec; 144(12):2816-2819.e2. Blauvelt A, Gordon KB, Langley RG, Branigan PJ, Chen Y, Miller M, Han C, Fakharzadeh S, Muñoz-Elías EJ, Armstrong AW. PMID: 38936766.
      View in: PubMed   Mentions: 1     Fields:    
    139. Cumulative Benefit Over 52 Weeks With Deucravacitinib Versus Apremilast in Moderate to Severe Plaque Psoriasis: POETYK PSO-1 Post Hoc Analysis. Dermatol Ther (Heidelb). 2024 Jul; 14(7):1891-1899. Armstrong AW, Park SH, Patel V, Nicolas P, Wang WJ, Colombo MJ, Chirikov V. PMID: 38907877; PMCID: PMC11265040.
      View in: PubMed   Mentions:
    140. Predicting Abrocitinib Efficacy at Week 12 Based on Clinical Response at Week 4: A Post Hoc Analysis of Four Randomized Studies in Moderate-to-Severe Atopic Dermatitis. Dermatol Ther (Heidelb). 2024 Jul; 14(7):1849-1861. Armstrong AW, Alexis AF, Blauvelt A, Silverberg JI, Feeney C, Levenberg M, Chan G, Zhang F, Fostvedt L. PMID: 38896380; PMCID: PMC11264490.
      View in: PubMed   Mentions: 1  
    141. Patient Perspectives on the Prevalence and Burden of Intertriginous Psoriasis: Results from a National Survey of Adults with Psoriasis in the United States. Dermatol Ther (Heidelb). 2024 Jul; 14(7):1839-1847. Greiling T, Young M, Seal MS, Higham RC, Armstrong A. PMID: 38874893; PMCID: PMC11265023.
      View in: PubMed   Mentions: 3  
    142. Psoriatic arthritis: A comprehensive review for the dermatologist part I: Epidemiology, comorbidities, pathogenesis, and diagnosis. J Am Acad Dermatol. 2025 05; 92(5):969-982. Perez-Chada LM, Elman S, Villa-Ruiz C, Armstrong AW, Gottlieb AB, Merola JF. PMID: 38857765.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    143. Psoriatic arthritis: A comprehensive review for the dermatologist-Part II: Screening and management. J Am Acad Dermatol. 2025 05; 92(5):985-998. Elman SA, Perez-Chada LM, Armstrong A, Gottlieb AB, Merola JF. PMID: 38857766.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    144. Implant-Positioning and Patient Factors Associated with Acromial and Scapular Spine Fractures After Reverse Shoulder Arthroplasty: A Study by the ASES Complications of RSA Multicenter Research Group. J Bone Joint Surg Am. 2024 Aug 07; 106(15):1384-1394. Moverman MA, Puzzitiello RN, Glass EA, Swanson DP, Efremov K, Lohre R, Bowler AR, Mahendraraj KA, Le K, Dunn WR, Cannon DJ, Friedman LGM, Gaudette JA, Green J, Grobaty L, Gutman M, Kakalecik J, Kloby MA, Konrade EN, Knack MC, Loveland A, Mathew JI, Myhre L, Nyfeler J, Parsell DE, Pazik M, Polisetty TS, Ponnuru P, Smith KM, Sprengel KA, Thakar O, Turnbull L, Vaughan A, Wheelwright JC, Abboud J, Armstrong A, Austin L, Brolin T, Entezari V, Garrigues GE, Grawe B, Gulotta LV, Hobgood R, Horneff JG, Hsu JE, Iannotti J, Khazzam M, King JJ, Kirsch JM, Levy JC, Murthi A, Namdari S, Nicholson GP, Otto RJ, Ricchetti ET, Tashjian R, Throckmorton T, Wright T, Jawa A, ASES Complications of RSA Multicenter Research Group. PMID: 40305832.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    145. Consensus Statements on the Use of Novel Formulations of Isotretinoin: A Modified Delphi Process. J Drugs Dermatol. 2024 Jun 01; 23(6):429-432. Kingston P, Kircik L, Bhatia N, Del Rosso J, Desai SR, Harper JC, Gold LS, Hougeir F, Armstrong AW. PMID: 38834212.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    146. Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity. Dermatol Ther (Heidelb). 2024 Jun; 14(6):1615-1631. Armstrong AW, Jaleel T, Merola JF, Gottlieb AB, Khattri S, Helt CC, Malatestinic WN, Ross SE, Ngantcha ME, de Vlam K. PMID: 38814433; PMCID: PMC11169211.
      View in: PubMed   Mentions:
    147. Shared decision-making in psoriasis care: Evaluation of how patients' perception of clinicians' delivery of care changes by age and sex. PLoS One. 2024; 19(5):e0303058. Kikuchi R, Kingston P, Hao A, Sadrolashrafi K, Yamamoto RK, Tolson H, Bilimoria SN, Guo L, Yee D, Ochoa MT, Armstrong AW. PMID: 38728289; PMCID: PMC11086864.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    148. The most effective corticosteroid dose in the treatment of glenohumeral osteoarthritis: Feasibility pilot and protocol for double blinded randomized controlled trial. Osteoarthr Cartil Open. 2024 Sep; 6(3):100484. Onks C, Weaver L, Latorre J, Silvis M, Berg A, Phillips S, Loeffert J, French C, Armstrong A. PMID: 38800822; PMCID: PMC11126843.
      View in: PubMed   Mentions: 1  Translation:CTClinical Trials
    149. Brodalumab: 5-Year US Pharmacovigilance Report. Dermatol Ther (Heidelb). 2024 May; 14(5):1349-1357. Lebwohl MG, Koo JY, Armstrong AW, Strober BE, Martin GM, Rawnsley NN, Goehring EL, Jacobson AA. PMID: 38724839; PMCID: PMC11116300.
      View in: PubMed   Mentions: 8  
    150. Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis: A Systematic Review. JAMA Dermatol. 2024 05 01; 160(5):550-563. Pérez-Chada LM, Hopkins ZH, Balak DMW, Rashid S, Creadore A, Chu B, Villa C, Woodbury MJ, Armstrong AW, Strand V, Gottlieb AB, Merola JF, Barbieri JS. PMID: 38265774; PMCID: PMC11096065.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    151. Patient-and Clinician-Reported Outcomes for Tirbanibulin in Actinic Keratosis in Clinical Practice Across the United States (PROAK) J Drugs Dermatol. 2024 05 01; 23(5):338-346. Schlesinger T, Kircik L, Lebwohl M, Patel VA, Berman B, Bhatia N, Rigel D, Armstrong A, Rosso JD, Narayanan S, Koscielny V, Kasujee I. PMID: 38709702.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    152. Sustained Improvements in Clinical and Patient-Reported Outcomes and Quality of Life Through 5 Years Among Ixekizumab-Treated Patients with Complete Clearance of Scalp Psoriasis by Week 60. Dermatol Ther (Heidelb). 2024 Apr; 14(4):1007-1018. Egeberg A, Hawkes JE, Somani N, Burge R, See K, Gallo G, McKean-Matthews M, Gooderham M, Han G, Armstrong A. PMID: 38647975; PMCID: PMC11052960.
      View in: PubMed   Mentions: 2  
    153. Efficacy of risankizumab across subgroups in patients with active psoriatic arthritis: a post hoc integrated analysis of the phase 3 KEEPsAKE 1 and KEEPsAKE 2 randomized controlled trials. J Dermatolog Treat. 2024 Dec; 35(1):2342383. Merola JF, Armstrong A, Khattri S, Paek SY, Padilla B, Yue C, Photowala H, Kaplan B, Kristensen LE. PMID: 38632977.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    154. Bimekizumab safety in moderate to severe plaque psoriasis: Rates of hepatic events and changes in liver parameters over 2 years in randomized phase 3/3b trials. J Am Acad Dermatol. 2024 08; 91(2):281-289. Lebwohl M, Merola JF, Strober B, Armstrong A, Yoshizaki A, Gisondi P, Szilagyi B, Peterson L, de Cuyper D, Cross N, Davies O, Gottlieb AB. PMID: 38588819.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    155. An OX-Tra'Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis. Cells. 2024 03 28; 13(7). Sadrolashrafi K, Guo L, Kikuchi R, Hao A, Yamamoto RK, Tolson HC, Bilimoria SN, Yee DK, Armstrong AW. PMID: 38607026; PMCID: PMC11011471.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    156. Comparing Achievement of National Psoriasis Foundation Treatment Targets among Patients with Plaque Psoriasis Treated with Ixekizumab versus Other Biologics in Clinical and Real-World Studies. Dermatol Ther (Heidelb). 2024 Apr; 14(4):933-952. Armstrong A, González-Cantero A, Khattri S, Muzy G, Malatestinic WN, Lampropoulou A, Feely M, See SK, Mert C, Blauvelt A. PMID: 38521874; PMCID: PMC11052751.
      View in: PubMed   Mentions: 3  
    157. Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2024 08; 91(2):251.e1-251.e11. James WA, Rosenberg AL, Wu JJ, Hsu S, Armstrong A, Wallace EB, Lee LW, Merola J, Schwartzman S, Gladman D, Liu C, Koo J, Hawkes JE, Reddy S, Prussick R, Yamauchi P, Lewitt M, Soung J, Weinberg J, Lebwohl M, Glick B, Kircik L, Desai S, Feldman SR, Zaino ML. PMID: 38499181.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    158. Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis. Acta Derm Venereol. 2024 03 12; 104:adv20329. Maul JT, Maul LV, Didaskalu JA, Valenzuela F, Romiti R, Peterson H, Korouri E, Novoa F, Oon HH, Zheng M, Wu JJ, Thyssen JP, Egeberg A, Armstrong AW, Nielsen ML. PMID: 38470165; PMCID: PMC10949083.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    159. Deucravacitinib in moderate-to-severe plaque psoriasis: Pooled safety and tolerability over 52 weeks from two phase 3 trials (POETYK PSO-1 and PSO-2). J Eur Acad Dermatol Venereol. 2024 Aug; 38(8):1543-1554. Strober B, Blauvelt A, Warren RB, Papp KA, Armstrong AW, Gordon KB, Morita A, Alexis AF, Lebwohl M, Foley P, Kisa RM, Colston E, Wang T, Banerjee S, Thaçi D. PMID: 38451052.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    160. Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials. J Am Acad Dermatol. 2024 07; 91(1):72-81. Blauvelt A, Armstrong A, Merola JF, Strober B, de Cuyper D, Peterson L, Davies O, Stark JL, Lebwohl M. PMID: 38447700.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    161. Complementary and Alternative Medicine for Hidradenitis Suppurativa Discussed on TikTok: A Cross-Sectional Analysis. J Drugs Dermatol. 2024 Mar 01; 23(3):e93-e96. Peterson H, Kingston P, Lee K, Yee D, Huang MY, Korouri E, Aguero R, Armstrong AW. PMID: 38443128.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    162. Comparing Cosmetic Outcomes of Straight-Line Versus W-Plasty Techniques for Linear Postauricular Wound Closure: A Randomized Evaluator Blind Split-Scar Trial. Dermatol Surg. 2024 05 01; 50(5):423-427. Mehrzad M, Kang AS, Armstrong AW, Eisen DB. PMID: 38416811.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    163. Lebrikizumab in Uncontrolled Asthma: Reanalysis in a Well-Defined Type 2 Population. J Allergy Clin Immunol Pract. 2024 05; 12(5):1215-1224.e3. Corren J, Szefler SJ, Sher E, Korenblat P, Soong W, Hanania NA, Berman G, Brusselle G, Zitnik R, Natalie CR, Sun L, Siu K, Wu WS, Lio P, Armstrong AW. PMID: 38360213.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsCTClinical Trials
    164. Depression screening for psoriasis in the United States: A population-based study. J Eur Acad Dermatol Venereol. 2024 Aug; 38(8):e698-e700. Huang MY, Kingston P, Peterson H, Yee D, Lee K, Korouri E, Agüero R, Armstrong AW. PMID: 38344934.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    165. Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2024 06; 90(6):1170-1181. Chat VS, Ellebrecht CT, Kingston P, Gondo G, Bell S, Cordoro KM, Desai SR, Duffin KC, Feldman SR, Garg A, Gelfand JM, Gladman D, Green LJ, Gudjonsson J, Han G, Hawkes JE, Kircik L, Koo J, Langley R, Lebwohl M, Michael Lewitt G, Liao W, Martin G, Orbai AM, Reddy SM, Richardson V, Ritchlin CT, Schwartzman S, Siegel EL, Van Voorhees AS, Wallace EB, Weinberg JM, Winthrop KL, Yamauchi P, Armstrong AW. PMID: 38331098.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsPHPublic Health
    166. Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary: A Secondary Analysis of a Randomized Clinical Trial. JAMA Dermatol. 2024 02 01; 160(2):204-209. Papp KA, Gordon K, Strober B, Zhuo J, Becker B, Zhong Y, Beaumont JL, Pham TP, Kisa R, Napoli AA, Banerjee S, Armstrong AW. PMID: 38117487; PMCID: PMC10733845.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    167. Tips, Trends, and Truths: A Study of Psoriasis Treatment Content on TikTok. J Drugs Dermatol. 2024 Feb 01; 23(2):e67-e69. Khan S, Reddy R, Maynard N, Zagona-Prizio C, Mehta M, Yee D, Khan S, Armstrong AW. PMID: 38306133.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    168. Evaluating Treatment Choice in Patients with Moderate to Severe Psoriasis in the United States: Results from a US Patient Survey. Dermatol Ther (Heidelb). 2024 Feb; 14(2):421-439. Armstrong AW, Jayade S, Rege S, Joshi N, Patel V, Kalirai S, Wolin D, Boyle K, Patel D, Seigel L. PMID: 38252376; PMCID: PMC10891029.
      View in: PubMed   Mentions: 3  
    169. Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial). J Eur Acad Dermatol Venereol. 2024 May; 38(5):864-872. Strober B, Bachelez H, Crowley J, Elewski BE, Gooderham M, Menter A, Strohal R, Chen MM, Wu T, Zhan T, Photowala H, Armstrong A. PMID: 38179809.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    170. A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study. J Invest Dermatol. 2024 Jun; 144(6):1405-1409.e1. Song WB, Garshick MS, Barbieri JS, Shin DB, Báez S, Papadopoulos M, Neopaney A, Fitzsimmons R, Kalb RE, Mease PJ, Craig ET, Koplin J, Takeshita J, Chiesa Fuxench ZC, Armstrong AW, Mehta NN, Beidas RS, Ogdie AR, Gelfand JM. PMID: 38184142; PMCID: PMC11116061.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    171. Correction to: Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids. Am J Clin Dermatol. 2024 Jan; 25(1):163. Silverberg JI, Armstrong A, Blauvelt A, Reich K. PMID: 38008857; PMCID: PMC10796704.
      View in: PubMed   Mentions:    Fields:    
    172. Evaluation of DermSat-7 for Assessing Treatment Satisfaction in Patients with Acne. JAMA Dermatol. 2024 01 01; 160(1):88-92. Shields A, Armstrong AW, Kaur MN, Layton A, Thiboutot D, Tan J, Barbieri JS. PMID: 37991774; PMCID: PMC10666038.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    173. Effect of abrocitinib on skin biomarkers in patients with moderate-to-severe atopic dermatitis. Allergy. 2024 05; 79(5):1258-1270. Guttman-Yassky E, Facheris P, Gomez-Arias PJ, Del Duca E, Da Rosa JC, Weidinger S, Bissonnette R, Armstrong AW, Seneschal J, Eyerich K, Estrada YD, Bose SN, Xu D, Chen A, Tatulych S, Güler E, Chan G, Page KM, Kerkmann U. PMID: 38108208.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    174. Trends in Patch-Test Positivity to Methylchloroisothiazolinone and Methylisothiazolinone Based on Regulatory Status: A Systematic Review. Dermatitis. 2024 Sep-Oct; 35(5):517-518. Kingston P, Khan S, Chan J, Pourali SP, Armstrong AW, DeLeo V, Adler BL. PMID: 38052035.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    175. Assessing the Quality, Comprehensiveness, and Readability of Online Patient Health Resources About Psoriasis in Skin of Color. J Clin Aesthet Dermatol. 2023 Dec; 16(12):52-54. Yee D, Lee K, Huang MY, Kingston P, Korouri E, Peterson H, Armstrong AW. PMID: 38125673; PMCID: PMC10729803.
      View in: PubMed   Mentions: 1  
    176. Tapinarof cream 1% once daily for the treatment of adults with mild to severe plaque psoriasis: A novel topical therapy targeting the aryl hydrocarbon receptor. J Manag Care Spec Pharm. 2023 Dec; 29(12-a Suppl):S1-S13. Armstrong AW, McConaha JL. PMID: 38051146; PMCID: PMC10996039.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    177. International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting. J Drugs Dermatol. 2023 Dec 01; 22(12):1153-1159. Lee K, Woodbury MJ, Zundell MP, Aguero R, Yousif J, Williams SC, Rosmarin D, Silverberg N, Thiboutot D, Larocca C, Shinohara MM, Mostaghimi A, Stander S, Martorell A, Jaleel T, Torbeck RL, Siegel DM, Perez-Chada L, Strand V, Armstrong AW, Merola JF, Gottlieb AB. PMID: 38051841.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    178. Real-world switching patterns and associated characteristics in patients with psoriasis treated with biologics in the United States. J Dermatolog Treat. 2023 Dec; 34(1):2200870. Armstrong AW, Patel M, Li C, Garg V, Mandava MR, Wu JJ. PMID: 37154473.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    179. Abrocitinib efficacy and safety in moderate-to-severe atopic dermatitis by race, ethnicity, and Fitzpatrick skin type. Ann Allergy Asthma Immunol. 2024 03; 132(3):383-389.e3. Alexis AF, Silverberg JI, Rice ZP, Armstrong AW, Desai SR, Fonacier L, Kabashima K, Biswas P, Cella RR, Chan GL, Levenberg M. PMID: 37949351.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    180. Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis. Dermatol Ther (Heidelb). 2023 Nov; 13(11):2605-2607. Armstrong AW, Park SH, Patel V, Hogan M, Wang WJ, Davidson D, Chirikov V. PMID: 37853229; PMCID: PMC10613162.
      View in: PubMed   Mentions:
    181. Safety and efficacy of eblasakimab, an interleukin 13 receptor α1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascending dose study. J Am Acad Dermatol. 2024 03; 90(3):504-511. Veverka KA, Thng STG, Silverberg JI, Armstrong AW, Menezes J, Kaoukhov A, Blauvelt A. PMID: 37866456.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    182. The effect of perceived health status on satisfaction with care among acne patients: A population-based study. Dermatol Online J. 2023 Oct 15; 29(5). Kingston P, Korouri E, Peterson H, Lee K, Aguero R, Huang MY, Yee D, Armstrong AW. PMID: 38478654.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    183. Generalized pustular psoriasis: A consensus statement from the National Psoriasis Foundation. J Am Acad Dermatol. 2024 04; 90(4):727-730. Armstrong AW, Elston CA, Elewski BE, Ferris LK, Gottlieb AB, Lebwohl MG, Medical Board of the National Psoriasis Foundation. PMID: 37838256.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    184. Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis. Dermatol Ther (Heidelb). 2023 Nov; 13(11):2839-2857. Armstrong AW, Warren RB, Zhong Y, Zhuo J, Cichewicz A, Kadambi A, Junqueira D, Westley T, Kisa R, Daamen C, Augustin M. PMID: 37801281; PMCID: PMC10613195.
      View in: PubMed   Mentions: 18  
    185. Atopic Dermatitis and the Risk of Actinic Keratosis Development: A Population-Based Study. Dermatitis. 2024 Jul-Aug; 35(4):402-404. Huang MY, Peterson H, Yee D, Lee K, Korouri E, Kingston P, Agüero R, Lung K, Armstrong AW. PMID: 37792323.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    186. Mechanism of Action of Brodalumab May Correlate With Efficacy in Patients With Inflammatory Skin Diseases. J Drugs Dermatol. 2023 Oct 01; 22(10):994-1000. Armstrong A, Fried R, Koo J, Gottlieb A, Jackson A. PMID: 37801526.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    187. Skin Clearance is Associated with Reduced Treatment Failure in Patients with Psoriasis: Real-World Evidence from the CorEvitas Psoriasis Registry. Dermatol Ther (Heidelb). 2023 Nov; 13(11):2739-2751. McLean RR, Sima AP, Beaty S, Low R, Spitzer RL, Stark JL, Lesser E, Lee E, Armstrong A. PMID: 37755689; PMCID: PMC10613186.
      View in: PubMed   Mentions: 1  
    188. Durability of Near-Complete Skin Clearance in Patients with Psoriasis Using Systemic Biologic Therapies: Real-World Evidence from the CorEvitas Psoriasis Registry. Dermatol Ther (Heidelb). 2023 Nov; 13(11):2753-2768. McLean RR, Sima AP, Beaty S, Jones EA, Eckmann T, Low R, McClung L, Spitzer RL, Stark J, Armstrong A. PMID: 37759099; PMCID: PMC10613189.
      View in: PubMed   Mentions: 4  
    189. Developing a questionnaire for assessing clinician- and patient-reported outcomes in actinic keratosis: Results from an expert panel. JAAD Int. 2024 Sep; 16:192-198. Berman B, Armstrong A, Lebwohl M, Grada A, Bhatia N, Patel VA, Rigel D, Del Rosso J, Schlesinger T, Kircik L, Salem R, Narayanan S, Kasujee I. PMID: 39040844; PMCID: PMC11262182.
      View in: PubMed   Mentions:
    190. Development of the Generalized Pustular Psoriasis Clinical Assessment Tool. J Am Acad Dermatol. 2024 01; 90(1):192-195. Garg A, Noe MH, Anadkat MJ, Armstrong A, Bhutani T, Farberg A, Han G, Hawkes JE, Lebwohl M, Rekhtman S, Song EJ, Strunk A, Duffin KC. PMID: 37739266.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    191. Real-world effectiveness of risankizumab in patients with moderate-to-severe psoriasis using the CorEvitas Psoriasis Registry. J Am Acad Dermatol. 2024 01; 90(1):82-90. Strober B, Ferris L, Callis Duffin K, Janak JC, Sima AP, Eckmann T, Patel M, Photowala H, Garg V, Armstrong A. PMID: 37739267.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    192. Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids. Am J Clin Dermatol. 2023 Nov; 24(6):913-925. Silverberg JI, Armstrong A, Blauvelt A, Reich K. PMID: 37695504; PMCID: PMC10570226.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    193. Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials. Am J Clin Dermatol. 2023 Nov; 24(6):939-952. Simpson EL, Pink AE, Blauvelt A, Gooderham M, Armstrong AW, Worm M, Katoh N, Peris K, Puig L, Barbarot S, Mark T, Steffensen LA, Tindberg AM, Wollenberg A. PMID: 37682422; PMCID: PMC10570233.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    194. Deucravacitinib: a novel TYK2 inhibitor for the treatment of moderate-to-severe psoriasis. J Psoriasis Psoriatic Arthritis. 2023 Oct; 8(4):156-165. Kingston P, Blauvelt A, Strober B, Armstrong AW. PMID: 38188537; PMCID: PMC10768812.
      View in: PubMed   Mentions: 14  
    195. INDIVIDUAL ARTICLE: Vehicles Matter: Calcipotriene and Betamethasone Dipropionate Foam as a Topical Psoriasis Therapy. J Drugs Dermatol. 2023 Sep 01; 22(9):s5-s14. Lee K, Kircik L, Armstrong AW. PMID: 37874778.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    196. Comparative Efficacy of Targeted Systemic Therapies for Moderate-to-Severe Atopic Dermatitis without Topical Corticosteroids: An Updated Network Meta-analysis. Dermatol Ther (Heidelb). 2023 Oct; 13(10):2247-2264. Silverberg JI, Hong HC, Calimlim BM, Lee WJ, Teixeira HD, Collins EB, Crowell MM, Johnson SJ, Armstrong AW. PMID: 37658223; PMCID: PMC10539231.
      View in: PubMed   Mentions: 21  
    197. Real-World Evidence on the Use of Calcipotriene and Betamethasone Dipropionate Aerosol Foam 0.005%/0.064% in the Treatment of Psoriasis: A Review of Investigator-Initiated Studies Around the Globe. J Drugs Dermatol. 2023 Sep 01; 22(9):s5-14. Lee K, Kircik L, Armstrong AW. PMID: 37930660.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    198. Comorbidity Burden in Psoriasis Patients with Skin of Color. J Psoriasis Psoriatic Arthritis. 2024 Jan; 9(1):16-22. Peterson H, Huang MY, Lee K, Kingston P, Yee D, Korouri E, Agüero R, Armstrong AW. PMID: 38516030; PMCID: PMC10957134.
      View in: PubMed   Mentions: 3  
    199. Shared decision-making and satisfaction with care: a population-based study in patients with acne with skin of colour in the USA. Clin Exp Dermatol. 2023 Aug 25; 48(9):1032-1035. Kingston P, Yee D, Huang MY, Korouri E, Peterson H, Lee K, Agüero R, Armstrong AW. PMID: 37098265.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    200. No Racial Differences Found in Access to Biologics: A Population-Based Study of Psoriasis Patients in the United States. J Drugs Dermatol. 2023 08 01; 22(8):835-837. Reddy R, Khan S, Yee D, Maynard N, Mehta M, Zagona-Prizio C, Khan S, Chat V, Wu K, Armstrong AW. PMID: 37556529.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    201. INDIVIDUAL ARTICLE: Fixed Combination Calcipotriene/Betamethasone (Cal/BDP) Cream: Evaluating the Role of Polyaphron Dispersion (PAD) Technology in Psoriasis Treatment. J Drugs Dermatol. 2023 Aug 01; 22(8):SF381621s5-SF381621s10. Reddy R, Khan S, Kircik L, Armstrong AW. PMID: 37556526.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    202. Consensus Statements on the Use of Corticosteroid-Containing Topical Medications in Psoriasis. J Drugs Dermatol. 2023 Aug 01; 22(8):736-741. Armstrong AW, Reddy R, Khan S, Chovatiya R, Green L, Gold LS, Kwong P, Lebwohl M, Kircik L. PMID: 37556522.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    203. Proceedings of the GRAPPA 2022 Executive Retreat. J Rheumatol. 2023 11; 50(Suppl 2):71-77. Ng BCK, Jadon D, Adebajo A, Ayan G, Duffin KC, Chandran V, Coates LC, D'Agostino MA, de Vlam K, Deodhar A, Eder L, Garg A, Gladman DD, Goel N, Gottlieb AB, Husni ME, Katz A, Kavanaugh A, Lubrano E, Mease PJ, Merola JF, Nash P, Ogdie A, Pennington SR, Perez-Chada LM, Proft F, Rosen CF, Savage L, Goldenstein-Schainberg C, Siebert S, Soriano ER, Steinkoenig I, Tillett W, Armstrong AW, FitzGerald O. PMID: 37527861.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    204. Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis. Dermatol Ther (Heidelb). 2023 Nov; 13(11):2589-2603. Armstrong AW, Park SH, Patel V, Hogan M, Wang WJ, Davidson D, Chirikov V. PMID: 37525000; PMCID: PMC10613163.
      View in: PubMed   Mentions: 7  
    205. Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies. Dermatol Ther (Heidelb). 2023 Sep; 13(9):2031-2044. Stein Gold L, Pinter A, Armstrong A, Augustin M, Arenberger P, Bhatia N, Praestegaard M, Iversen L, Reich A. PMID: 37490268; PMCID: PMC10442307.
      View in: PubMed   Mentions: 3  
    206. Sociodemographic and clinical characteristics associated with multiple biologic failure in psoriasis: A 2015-2022 prospective cohort analysis of the CorEvitas psoriasis registry. J Am Acad Dermatol. 2023 11; 89(5):974-983. Jin JQ, Cronin A, Roberts-Toler C, Yeroushalmi S, Hadeler E, Spencer RK, Elhage KG, Gondo G, Wallace EB, Reddy SM, Han G, Kaffenberger J, Davis MS, Hakimi M, Scher JU, Armstrong AW, Bhutani T, McLean RR, Liao W. PMID: 37495173.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    207. Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting. J Rheumatol. 2023 11; 50(Suppl 2):47-50. Zundell MP, Woodbury MJ, Lee K, Perez-Chada LM, Armstrong AW, Strand V, Merola JF, Gottlieb AB. PMID: 37453734.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    208. GRAPPA 2022 Trainee Symposium: A Summary of Oral and Poster Presentations. J Rheumatol. 2023 Jul 15; 41-46. Husni ME, Kaur R, Armstrong AW, Eder L. PMID: 37453732.
      View in: PubMed   Mentions:    Fields:    
    209. GRAPPA 2021 Pilot Grant Award Reports. J Rheumatol. 2023 11; 50(Suppl 2):36-37. Kasiem FR, Yamada D, Marin J, Vis M, Tillett W, Hwang ST, Soriano ER, FitzGerald O, Armstrong AW. PMID: 37419628.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    210. Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 Annual Meeting. J Rheumatol. 2023 11; 50(Suppl 2):1-3. Gottlieb AB, Armstrong AW, FitzGerald O, Gladman DD. PMID: 37419627.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    211. Interleukin (IL)-17 Versus IL-23 Inhibitors: Which Is Better to Treat Patients With Moderate-to-Severe Psoriasis and Mild Psoriatic Arthritis in Dermatology Clinics? J Rheumatol. 2023 11; 50(Suppl 2):11-13. Agüero R, Woodbury MJ, Lee K, Johnsson HJ, Merola JF, Armstrong AW. PMID: 37419622.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    212. The impact of race on mental health outcomes among patients with hidradenitis suppurativa: A population-based study in the United States. J Eur Acad Dermatol Venereol. 2023 11; 37(11):e1280-e1282. Kingston P, Huang MY, Lee K, Peterson H, Korouri E, Agüero R, Yee D, Armstrong AW. PMID: 37328920.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    213. A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf. ERJ Open Res. 2023 May; 9(3). Chalmers JD, Gupta A, Chotirmall SH, Armstrong A, Eickholz P, Hasegawa N, McShane PJ, O'Donnell AE, Shteinberg M, Watz H, Eleftheraki A, Diefenbach C, Sauter W. PMID: 37465817; PMCID: PMC10351677.
      View in: PubMed   Mentions: 23  
    214. Chronic Spontaneous Urticaria: How to Measure It and the Need to Define Treatment Success. Dermatol Ther (Heidelb). 2023 Aug; 13(8):1629-1646. Armstrong AW, Soong W, Bernstein JA. PMID: 37354293; PMCID: PMC10366057.
      View in: PubMed   Mentions: 8  
    215. Patient-reported outcomes with sarecycline treatment for acne vulgaris: Pooled analysis of phase 3 clinical studies. J Am Acad Dermatol. 2023 10; 89(4):832-834. Harper JC, Armstrong A, Fried RG, Rieder EA, Alexis AF, Salem RJ, Kasujee I, Grada A. PMID: 37321481.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    216. The More Things Change, the More They Stay the Same: Residents Perspectives on Learning to Teach Over 7 Years. JB JS Open Access. 2023 Apr-Jun; 8(2). Jarvis-Selinger S, Armstrong A, Wisener K. PMID: 37274129; PMCID: PMC10237712.
      View in: PubMed   Mentions: 1  
    217. Individual Article: Clascoterone Cream 1%: Mechanism of Action, Efficacy, and Safety of a Novel, First-in-Class Topical Antiandrogen Therapy for Acne. J Drugs Dermatol. 2023 Jun 01; 22(6):SF350992s7-SF350992s14. Peterson H, Kircik L, Armstrong AW. PMID: 37276168.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    218. Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus Panel. J Drugs Dermatol. 2023 Jun 01; 22(6):588-593. Zakria D, Brownstone N, Armstrong AW, Boh EE, Koo JYM, Merola JF, Pariser D, Lebwohl M. PMID: 37276166.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    219. Treatment of plaque psoriasis with deucravacitinib (POETYK PSO-1 study): a plain language summary. Immunotherapy. 2023 08; 15(12):963-973. Armstrong AW, Gooderham M, Warren RB, Papp KA, Strober B, Thaçi D, Morita A, Szepietowski JC, Imafuku S, Colston E, Throup J, Kundu S, Schoenfeld S, Linaberry M, Banerjee S, Blauvelt A. PMID: 37150952.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    220. Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey. Dermatology. 2023; 239(4):621-634. Armstrong AW, Bohannan B, Mburu S, Coates LC, Ogdie A, Alarcon I, Kasparek T, Frade S, Barrio SF, Augustin M. PMID: 37075723; PMCID: PMC10357389.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    221. Out of thin air? Investigating the association between pollution and psoriasis in the United States. Dermatol Online J. 2023 04 15; 29(2). Mehta MD, Yee D, Khan S, Zagona-Prizio C, Khan S, Maynard N, Reddy R, Armstrong AW. PMID: 37220296.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    222. Readability, quality, and comprehensiveness of online health resources for skin cancer in skin of color. Int J Dermatol. 2023 10; 62(10):e532-e534. Lee K, Yee D, Peterson H, Huang MY, Kingston P, Agüero R, Korouri E, Armstrong AW. PMID: 37039526.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    223. National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine. JAAD Int. 2023 Sep; 12:32-36. Pelet Del Toro N, Yahia R, Feldman SR, Van Voorhees A, Green L, Schwartzman S, Siegel E, Cordoro KM, Desai SR, Kircik L, Liao W, Hawkes JE, Weinberg J, Koo J, Wallace EB, Howard LM, Armstrong A, Han G. PMID: 37274387; PMCID: PMC10238745.
      View in: PubMed   Mentions: 1  
    224. The Impact of Immune-Modulating Treatments for Dermatological Diseases on the Risk of Infection with SARS-CoV-2 and Outcomes Associated with COVID-19 Illness. Curr Dermatol Rep. 2023; 12(2):45-55. Maynard N, Armstrong AW. PMID: 37304177; PMCID: PMC10068706.
      View in: PubMed   Mentions: 1  
    225. Shared decision-making and satisfaction with care in patients with psoriasis: A population-based study in the United States. J Am Acad Dermatol. 2023 11; 89(5):920-926. Yee D, Kingston P, Lee K, Huang M, Peterson H, Korouri E, Armstrong AW. PMID: 37011814.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    226. Brodalumab: 4-Year US Pharmacovigilance Report. J Drugs Dermatol. 2023 04 01; 22(4):419-422. Lebwohl M, Koo J, Leonardi C, Armstrong A, Rawnsley N, Goehring E, Jacobson A. PMID: 37026879.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    227. The Effectiveness of Guselkumab by BMI Category Among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry. Adv Ther. 2023 05; 40(5):2493-2508. Armstrong AW, Fitzgerald T, McLean RR, Teeple A, Uy JP, Olurinde M, Rowland K, Guo L, Shan Y, Callis Duffin K. PMID: 36930429.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    228. Trends in Oral Antibiotic Use for Acne Treatment: A Retrospective, Population-Based Study in the United States, 2014 to 2016. J Drugs Dermatol. 2023 Mar 01; 22(3):265-270. Grada A, Armstrong A, Bunick C, Salem R, Feldman S. PMID: 36877883.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    229. Evaluating Sentiment, Engagement, and Perception of Biologics Among Patients with Psoriasis and Psoriatic Arthritis on Reddit. J Drugs Dermatol. 2023 03 01; 22(3):306-309. Maynard N, Yee D, Carranza C, Mehta M, Reddy R, Zagona-Prizio C, Khan S, Khan S, Armstrong A. PMID: 36877885.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    230. Differences in accessing dermatology offices, primary care offices, and emergency departments between Hispanics and Non-Hispanic White Patients. Dermatol Online J. 2023 Feb 15; 29(1). Zagona-Prizio C, Khan S, Yee DK, Khan S, Maynard N, Reddy R, Mehta MD, Wu K, Armstrong AW. PMID: 37040904.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    231. Psoriasis and fatigue: a cross-sectional population study of psoriasis patients in the United States using the Medical Expenditure Panel Surveys. Br J Dermatol. 2023 02 10; 188(2):301-303. Zagona-Prizio C, Khan S, Yee DK, Khan S, Maynard N, Reddy R, Mehta MD, Armstrong AW. PMID: 36763864.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    232. Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere). JAMA Dermatol. 2023 02 01; 159(2):182-191. Simpson EL, Gooderham M, Wollenberg A, Weidinger S, Armstrong A, Soung J, Ferrucci S, Lima RG, Witte MM, Xu W, ElMaraghy H, Natalie CR, Pierce E, Blauvelt A, ADhere Investigators. PMID: 36630140; PMCID: PMC9857439.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCTClinical Trials
    233. Meeting Patient Expectations of Topical Psoriasis Treatment: Evidence Supporting the Use of Fixed-Combination Halobetasol/Tazarotene Lotion. J Drugs Dermatol. 2023 Feb 01; 22(2):132-138. Del Rosso J, Han G, Armstrong A, Lewitt GM, Jacobson A. PMID: 36745378.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    234. Psoriasis improvements and inflammatory biomarker normalization with secukinumab: the randomized ObePso-S study. J Dermatol Sci. 2023 Jan; 109(1):12-21. Blauvelt A, Pariser DM, Tyring S, Bagel J, Alexis AF, Soung J, Armstrong AW, Muscianisi E, Kianifard F, Steadman J, Sarkar RP, Garcet S, Krueger JG. PMID: 36690571.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    235. A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30th EADV Congress 2021. J Eur Acad Dermatol Venereol. 2023 Jan; 37 Suppl 1:14-19. Pinter A, Gold LS, Reich A, Green LJ, Praestegaard M, Selmer J, Armstrong AW, Danø A, Dhawan S, Galván J, Stallknecht SE, Trebbien P, Augustin M. PMID: 36546465.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    236. Janus-kinase inhibitors in dermatology: A review of their use in psoriasis, vitiligo, systemic lupus erythematosus, hidradenitis suppurativa, dermatomyositis, lichen planus, lichen planopilaris, sarcoidosis and graft-versus-host disease. Indian J Dermatol Venereol Leprol. 2023 [SEASON]; 90(1):30-40. Huang MY, Armstrong AW. PMID: 38031699.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    237. Real-World Effectiveness of 9-12 Months of Guselkumab Therapy among Patients with Moderate-to-Severe Plaque Psoriasis in the CorEvitas Psoriasis Registry. Dermatol Ther (Heidelb). 2023 Feb; 13(2):629-640. Armstrong AW, Fitzgerald T, McLean RR, Teeple A, Uy JP, Olurinde M, Rowland K, Guo L, Shan Y, Callis Duffin K. PMID: 36585606; PMCID: PMC9884731.
      View in: PubMed   Mentions: 4  
    238. Effectiveness of Guselkumab Therapy among Patients with Plaque Psoriasis with Baseline IGA Score ≥ 2 in the CorEvitas Psoriasis Registry. Dermatol Ther (Heidelb). 2023 Feb; 13(2):487-504. Armstrong AW, Fitzgerald T, McLean RR, Teeple A, Uy JP, Olurinde M, Rowland K, Guo L, Shan Y, Callis Duffin K. PMID: 36484917; PMCID: PMC9884726.
      View in: PubMed   Mentions: 3  
    239. Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances. Allergy. 2023 02; 78(2):389-401. Kaplan A, Lebwohl M, Giménez-Arnau AM, Hide M, Armstrong AW, Maurer M. PMID: 36448493.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    240. Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial. JAMA Dermatol. 2022 12 01; 158(12):1394-1403. Gelfand JM, Shin DB, Armstrong AW, Tyring SK, Blauvelt A, Gottlieb S, Lockshin BN, Kalb RE, Fitzsimmons R, Rodante J, Parel P, Manyak GA, Mendelsohn L, Noe MH, Papadopoulos M, Syed MN, Werner TJ, Wan J, Playford MP, Alavi A, Mehta NN. PMID: 36129688; PMCID: PMC9494263.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    241. Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long-term efficacy and patient-reported outcomes. Dermatol Ther. 2022 12; 35(12):e15954. Simpson E, Armstrong A, Boguniewicz M, Chiesa Fuxench ZC, Feely M, Pierce E, Sun L, Chen YF, Angle R, Silverberg JI. PMID: 36270978.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    242. Perspectives on nonmedical switching and the COVID-19 pandemic: a narrative review. Am J Manag Care. 2022 11 01; 28(11):e417-e425. Merola JF, Armstrong AW, Phares S, Hass S, Yi E, Patil D, Lebwohl M. PMID: 36374660.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    243. A Response to: Letter to the Editor Regarding Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis. Dermatol Ther (Heidelb). 2022 Dec; 12(12):2867-2870. Armstrong AW, Soliman AM, Betts KA, Wang Y, Gao Y, Stakias V, Puig L. PMID: 36271222; PMCID: PMC9674807.
      View in: PubMed   Mentions:
    244. Perceptions of biologic treatment among hidradenitis suppurativa patients on social media: an analysis of content, engagement, and sentiment. Int J Dermatol. 2023 07; 62(7):e379-e382. Zagona-Prizio C, Maynard N, Khan S, Yee DK, Reddy R, Mehta MD, Khan S, Armstrong AW. PMID: 36250292.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    245. Factors Associated with Multi-Biologic Use in Psoriasis Patients at an Academic Medical Center and Review of Biologic Survival. J Psoriasis Psoriatic Arthritis. 2023 Jan; 8(1):11-18. Hadeler E, Kumar S, Yeroushalmi S, Hong J, Wallace E, Han G, Mosca M, Bartholomew E, Chung M, Hakimi M, Reddy S, Scher J, Bhutani T, Gondo G, Armstrong A, Bell S, Liao W. PMID: 39296952; PMCID: PMC11361481.
      View in: PubMed   Mentions: 2  
    246. Public Perception of SARS-CoV-2 Vaccines Among Psoriasis Patients in Social Media: Content, Sentiment, and Engagement Analysis. J Psoriasis Psoriatic Arthritis. 2022 Oct; 7(4):164-173. Yee D, Khan S, Zagona-Prizio C, Maynard N, Reddy R, Khan S, Mehta M, Armstrong AW. PMID: 38603111; PMCID: PMC9207593.
      View in: PubMed   Mentions:
    247. Differences in Face-to-Face Time Spent With a Dermatologist Among Patients With Psoriasis Based on Race and Ethnicity. JAMA Dermatol. 2022 Oct 01; 158(10):1210-1212. Wu KK, Armstrong AW. PMID: 35921118; PMCID: PMC9350842.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    248. Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3. Dermatol Ther (Heidelb). 2022 Nov; 12(11):2499-2516. Blauvelt A, Gooderham M, Bhatia N, Langley RG, Schneider S, Zoidis J, Kurbasic A, Armstrong A, Silverberg JI. PMID: 36152216; PMCID: PMC9588100.
      View in: PubMed   Mentions: 3  
    249. Impact of Mycobacterium leprae and Mycobacterium lepromatosis on immune reactions and clinical outcomes in Hansen's disease: A single-center retrospective analysis. J Am Acad Dermatol. 2023 Mar; 88(3):722-724. Khan S, Adler BL, Armstrong AW, Lahiri R, Ochoa MT. PMID: 36156303.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    250. Biologics to breast milk: A cross-sectional study of popular eczema treatment content on TikTok. Pediatr Dermatol. 2022 Nov; 39(6):920-922. Khan S, Yee D, Khan S, Mehta M, Zagona-Prizio C, Maynard N, Reddy R, Armstrong AW. PMID: 35977757; PMCID: PMC10087350.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    251. Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis. Dermatol Ther (Heidelb). 2022 Sep; 12(9):2087-2103. Armstrong A, Xia Q, John AR, Patel V, Seigel L. PMID: 35947341; PMCID: PMC9464286.
      View in: PubMed   Mentions: 7  
    252. Complementary and alternative medicine use among adults with eczema: A population-based study. JAAD Int. 2022 Sep; 8:154-156. Khan S, Zagona-Prizio C, Yee D, Reddy R, Mehta M, Maynard N, Khan S, Armstrong AW. PMID: 35942061; PMCID: PMC9356148.
      View in: PubMed   Mentions: 1  
    253. "I'm Off My Meds": Public Perception of Interactions Between SARS-CoV-2 Vaccines and Anti-Psoriatic Treatments Online. J Drugs Dermatol. 2022 Aug 01; 21(8):901-905. Yee D, Reddy R, Khan S, Mehta M, Khan S, Maynard N, Zagona-Prizio C, Armstrong A. PMID: 35946967.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    254. International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting. J Drugs Dermatol. 2022 Aug 01; 21(8):867-874. Zagona-Prizio C, Yousif J, Grant C, Mehta M, Rosmarin D, Silverberg N, Tan J, Larocca C, Shinohara M, Mostaghimi A, Kim B, Gulliver S, Gulliver W, Siegel D, Perez-Chada L, Merola J, Gottlieb A, Armstrong A. PMID: 35946973.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    255. Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders. J Dermatolog Treat. 2022 Nov; 33(7):2991-2996. Strober B, Armstrong A, Rubant S, Patel M, Wu T, Photowala H, Crowley J. PMID: 35839335.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    256. Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriatic Arthritis. Dermatol Ther (Heidelb). 2022 Aug; 12(8):1885-1895. Gondo G, Mosca M, Hong J, Maverakis E, Merola JF, Armstrong AW, Bhutani T, Bell SJ, Liao W. PMID: 35864377; PMCID: PMC9357585.
      View in: PubMed   Mentions: 2  
    257. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial. J Am Acad Dermatol. 2023 01; 88(1):29-39. Armstrong AW, Gooderham M, Warren RB, Papp KA, Strober B, Thaçi D, Morita A, Szepietowski JC, Imafuku S, Colston E, Throup J, Kundu S, Schoenfeld S, Linaberry M, Banerjee S, Blauvelt A. PMID: 35820547.
      View in: PubMed   Mentions: 141     Fields:    Translation:HumansCTClinical Trials
    258. Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis. Dermatol Ther (Heidelb). 2022 Aug; 12(8):1777-1792. Armstrong A, Fahrbach K, Leonardi C, Augustin M, Neupane B, Kazmierska P, Betts M, Freitag A, Kiri S, Taieb V, Slim M, Gomez NN, Warren RB. PMID: 35798920; PMCID: PMC9357587.
      View in: PubMed   Mentions: 24  
    259. One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial. J Am Acad Dermatol. 2022 10; 87(4):800-806. Strober B, Stein Gold L, Bissonnette R, Armstrong AW, Kircik L, Tyring SK, Piscitelli SC, Brown PM, Rubenstein DS, Tallman AM, Lebwohl MG. PMID: 35772599.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    260. Interrupted subcuticular suture spacing during linear wound closures and the effect on wound cosmesis: a randomized evaluator-blinded split-wound comparative effectiveness trial. Br J Dermatol. 2022 09; 187(3):318-323. Eshagh K, Sklar LR, Pourang A, Armstrong AW, Dhaliwal H, Eisen DB. PMID: 35474448.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    261. Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset. Dermatol Ther (Heidelb). 2022 Jun; 12(6):1337-1350. Eichenfield LF, Armstrong A, Guttman-Yassky E, Lio PA, Chen CC, Hines DM, McGuiness CB, Ganguli S, Delevry D, Sierka D, Mallya UG. PMID: 35543920; PMCID: PMC9209584.
      View in: PubMed   Mentions: 4  
    262. Development of a core outcome set for basal cell carcinoma. J Am Acad Dermatol. 2022 09; 87(3):573-581. Schlessinger DI, Reynolds KA, Dirr MA, Ibrahim SA, Yanes AF, Lazaroff JM, Godinez-Puig V, Chen BR, Kurta AO, Cotseones JK, Chiren SG, Furlan KC, Iyengar S, Behshad R, DeHoratius DM, Denes P, Drucker AM, Dzubow LM, Etzkorn JR, Harwood CA, Kim JYS, Lawrence N, Lee EH, Lissner GS, Marghoob AA, Matin RN, Mattox AR, Mittal BB, Thomas JR, Zhou XA, Zloty D, Schmitt J, Kirkham JJ, Armstrong AW, Basset-Seguin N, Billingsley EM, Bordeaux JS, Brewer J, Brown M, Brown M, Collins SAB, Fargnoli MC, De Azevedo SJ, Dummer R, Eggermont A, Goldman GD, Haedersdal M, Hale EK, Hanlon A, Harms KL, Huang CC, Hurst EA, In GK, Kelleners-Smeets N, Kheterpal M, Leshin B, Mcdonald M, Miller SJ, Miller A, Mostow EN, Trakatelli M, Nehal KS, Ratner D, Rogers H, Sarin KY, Soon SL, Stasko T, Storrs PA, Tagliaferri L, Vidimos AT, Wong SL, Yu SS, Zalaudek I, Zeitouni NC, Zitelli JA, Poon E, Sobanko JF, Cartee TV, Maher IA, Alam M. PMID: 35551965.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    263. The Psoriasis Glycome: Differential Expression of Cholesterol Particle Glycans and IgA Glycans Linked to Disease Severity. J Invest Dermatol. 2022 10; 142(10):2817-2820.e7. Maverakis E, Liakos W, Park D, Patel F, Siddiqui F, Kailemia MJ, Ruhaak LR, Marusina AI, Luxardi G, Gudjonsson JE, Le ST, Armstrong AW, Liao W, Merleev AA, Lebrilla CB. PMID: 35469905.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    264. Comparative Efficacy of Targeted Systemic Therapies for Moderate to Severe Atopic Dermatitis without Topical Corticosteroids: Systematic Review and Network Meta-analysis. Dermatol Ther (Heidelb). 2022 May; 12(5):1181-1196. Silverberg JI, Hong HC, Thyssen JP, Calimlim BM, Joshi A, Teixeira HD, Collins EB, Crowell MM, Johnson SJ, Armstrong AW. PMID: 35435637; PMCID: PMC9110624.
      View in: PubMed   Mentions: 27  
    265. 2021 GRAPPA Meet the Experts Session: A Summary of Presentations. J Rheumatol. 2022 06; 49(6 Suppl 1):32-36. Armstrong AW, Reddy RM, FitzGerald O, Duffin KC, Helliwell PS, Mease PJ, Kavanaugh A, Merola JF, Tillet W, Wit M. PMID: 35428707.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    266. 2021 GRAPPA Trainee Symposium: A Summary of Oral and Poster Presentations. J Rheumatol. 2022 Apr 15; 4-9. Armstrong AW, Reddy RM, Colaco K, Diaz PA, Kaur R, Simon D, Vecellio M, Husni ME. PMID: 35428726.
      View in: PubMed   Mentions:    Fields:    
    267. Treatment Goals for Psoriasis as Measured by Patient Benefit Index: Results of a National Psoriasis Foundation Survey. Adv Ther. 2022 06; 39(6):2657-2667. Armstrong A, Edson-Heredia E, Zhu B, Burge R, Bell S, Crowley JJ, Smith S. PMID: 35399114; PMCID: PMC9122869.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    268. A Novel Drug Delivery Method: Retrometabolic Drug Design J Drugs Dermatol. 2022 04 01; 21(4):s5-s10. Armstrong A, Reddy R, Chadha D, Kircik L. PMID: 35389593.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    269. Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) Meeting. J Rheumatol. 2022 06; 49(6 Suppl 1):57-63. Stober C, McInnes IB, Raychaudhuri S, Mease PJ, Pennington SR, Scher JU, Chandran V, Armstrong AW, Wit M, Cauli A, Jadon DR, Löve TJ, Ogdie A, O'Sullivan D, van Mens LJJ, Ritchlin CT, FitzGerald O. PMID: 35365578.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    270. Report of the Skin Research Working Groups from the GRAPPA 2021 Annual Meeting. J Rheumatol. 2022 06; 49(6 Suppl 1):40-43. Yousif JE, Merola JF, Perez-Chada LM, Zagona-Prizio C, Armstrong AW, Ogdie A, Shin S, Gottlieb AB. PMID: 35365577.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    271. Impact of Psoriatic Disease on Quality of Life: Interim Results of a Global Survey. Dermatol Ther (Heidelb). 2022 Apr; 12(4):1055-1064. Armstrong A, Bohannan B, Mburu S, Alarcon I, Kasparek T, Toumi J, Frade S, Barrio SF, Augustin M. PMID: 35286611; PMCID: PMC8918421.
      View in: PubMed   Mentions: 19  
    272. Economic Burden of Chronic Hand Eczema: A Review. Am J Clin Dermatol. 2022 May; 23(3):287-300. Armstrong A, Hahn-Pedersen J, Bartlett C, Glanville J, Thyssen JP. PMID: 35258783; PMCID: PMC9142418.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    273. Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis. Dermatol Ther (Heidelb). 2022 Mar; 12(3):753-760. Gondo G, Hadeler E, Brownstone N, Maverakis E, Merola JF, Armstrong AW, Bhutani T, Bell SJ, Liao W. PMID: 35254634; PMCID: PMC8941001.
      View in: PubMed   Mentions: 3  
    274. Analysis of Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons With Psoriatic Disease. JAMA Dermatol. 2022 03 01; 158(3):252-259. Barbieri JS, Beidas RS, Gondo GC, Fishman J, Williams NJ, Armstrong AW, Ogdie AR, Mehta N, Gelfand JM. PMID: 35044419; PMCID: PMC8771437.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    275. Pooled Analysis Demonstrating Superior Patient- Reported Psoriasis Treatment Outcomes for Calcipotriene/ Betamethasone Dipropionate Cream Versus Suspension/Gel. J Drugs Dermatol. 2022 Mar 01; 21(3):242-248. Armstrong A, Pinter A, Selmer J, Præstegaard M, Reich A, Koo J. PMID: 35254765.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    276. Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis. Dermatol Ther (Heidelb). 2022 Mar; 12(3):727-740. Blauvelt A, Gooderham M, Griffiths CEM, Armstrong AW, Zhu B, Burge R, Gallo G, Guo J, Garrelts A, Lebwohl M. PMID: 35195887; PMCID: PMC8941028.
      View in: PubMed   Mentions: 8  
    277. A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17. Dermatol Ther (Heidelb). 2022 Mar; 12(3):787-800. Armstrong AW, Blauvelt A, Mrowietz U, Strober B, Gisondi P, Merola JF, Langley RG, Ståhle M, Lebwohl M, Netea MG, Nunez Gomez N, Warren RB. PMID: 35167107; PMCID: PMC8941045.
      View in: PubMed   Mentions: 5  
    278. Re-Classification of Psoriasis Severity: Perspectives and Controversy. J Psoriasis Psoriatic Arthritis. 2022 Jan; 7(1):7-8. Yee D, Armstrong AW. PMID: 39296729; PMCID: PMC11361511.
      View in: PubMed   Mentions: 1  
    279. Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States. JAMA Dermatol. 2022 Jan 01; 158(1):68-72. Noe MH, Wan MT, Mostaghimi A, Gelfand JM, Pustular Psoriasis in the US Research Group, Agnihothri R, Armstrong AW, Bhutani T, Bridges A, Brownstone N, Butt M, Duffin KPC, Carr C, Creadore A, DeNiro KL, Desai S, Dominguez AR, Duffy EK, Fairley JA, Femia A, Gudjonsson JE, Kaffenberger JA, Katz KL, Kirby JS, Le ST, Martinez E, Maverakis E, Myers B, Naik HB, Nelson CA, Ortega-Loayza AG, Plovanich ME, Rangel LK, Ravi V, Reddy VD, Saleh JZ, Sandhu JK, Shakshouk H, Shields BE, Sharif-Sidi Z, Smith J, Steahr A, Toussi A, Wanat KA, Wang B, Wei BM, Weinhammer A, Worswick SD, Yang A. PMID: 34878495; PMCID: PMC8655660.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    280. Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States. JAMA Dermatol. 2022 Jan 01; 158(1):73-78. Noe MH, Wan MT, Mostaghimi A, Gelfand JM, Pustular Psoriasis in the US Research Group, Agnihothri R, Armstrong AW, Bhutani T, Bridges A, Brownstone N, Butt M, Duffin KPC, Carr C, Creadore A, DeNiro KL, Desai S, Dominguez AR, Duffy EK, Fairley JA, Femia A, Gudjonsson JE, Kaffenberger JA, Katz KL, Le ST, Martinez E, Maverakis E, Myers B, Naik HB, Nelson CA, Ortega-Loayza AG, Plovanich ME, Rangel LK, Ravi V, Reddy VD, Saleh JZ, Kirby JS, Sandhu JK, Shakshouk H, Shields BE, Sharif-Sidi Z, Smith J, Steahr A, Toussi A, Wanat KA, Wang B, Wei BM, Weinhammer A, Worswick SD, Yang A. PMID: 34878491; PMCID: PMC8655659.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    281. The Association Between Allergic Contact Dermatitis and Erythema Multiforme: A Systematic Review of the Literature. Dermatitis. 2022 Sep-Oct 01; 33(5):308-322. Kohn AH, Pourali SP, Adler BL, Armstrong AW. PMID: 34967766.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    282. Misconceptions of photoprotection in skin of color. J Am Acad Dermatol. 2022 03; 86(3S):S9-S17. Taylor SC, Alexis AF, Armstrong AW, Chiesa Fuxench ZC, Lim HW. PMID: 34942293.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    283. Photoprotection for skin of all color: Consensus and clinical guidance from an expert panel. J Am Acad Dermatol. 2022 03; 86(3S):S1-S8. Rigel DS, Taylor SC, Lim HW, Alexis AF, Armstrong AW, Chiesa Fuxench ZC, Draelos ZD, Hamzavi IH. PMID: 34942296.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    284. Continued Treatment with Dupilumab is Associated with Improved Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Not Achieving Optimal Responses with Short-Term Treatment. Dermatol Ther (Heidelb). 2022 01; 12(1):195-202. Armstrong A, Blauvelt A, Simpson EL, Smith CH, Herranz P, Kataoka Y, Seo SJ, Ferrucci SM, Chao J, Chen Z, Rossi AB, Shumel B, Tomondy P. PMID: 34897582; PMCID: PMC8776941.
      View in: PubMed   Mentions: 6  
    285. Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis. N Engl J Med. 2021 12 09; 385(24):2219-2229. Lebwohl MG, Stein Gold L, Strober B, Papp KA, Armstrong AW, Bagel J, Kircik L, Ehst B, Hong HC, Soung J, Fromowitz J, Guenthner S, Piscitelli SC, Rubenstein DS, Brown PM, Tallman AM, Bissonnette R. PMID: 34879448.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCTClinical Trials
    286. Are we contributing to the opioid epidemic? A systematic review on systemic opioid use in dermatology. Int J Dermatol. 2022 09; 61(9):1056-1068. Pourali SP, Gutierrez Y, Jones ME, Rajkumar JR, Kucharik AH, Armstrong AW. PMID: 34870325.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    287. Long-Term Benefit-Risk Profiles of Treatments for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis. Dermatol Ther (Heidelb). 2022 Jan; 12(1):167-184. Armstrong AW, Soliman AM, Betts KA, Wang Y, Gao Y, Stakias V, Puig L. PMID: 34862951; PMCID: PMC8776931.
      View in: PubMed   Mentions: 21  
    288. Bullous Dermatoses and Depression: A Systematic Review. JAMA Dermatol. 2021 Dec 01; 157(12):1487-1495. Pourali SP, Gutierrez Y, Kucharik AH, Rajkumar JR, Jones ME, Ortiz I, David M, Armstrong AW. PMID: 34668929.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    289. Defining Psoriasis Remission Based on Histopathologic and Molecular Criteria: A Systematic Literature Review. J Invest Dermatol. 2022 07; 142(7):2026-2029.e4. Balak DMW, Perez-Chada LM, Guo LN, Mita C, Armstrong AW, Bell SJ, Gondo GC, Liao W, Merola JF. PMID: 34838615.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    290. Aesthetic outcome of simple cuticular suture distance from the wound edge on the closure of linear wounds on the head and neck: A randomized evaluator blinded split-wound comparative effect trial. J Am Acad Dermatol. 2022 04; 86(4):863-867. Weinkle A, Harrington A, Kang A, Armstrong AW, Eisen DB. PMID: 34757148.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    291. Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatol Ther (Heidelb). 2021 Dec; 11(6):2147-2157. Yosipovitch G, de Bruin-Weller M, Armstrong A, Wu JJ, Herranz P, Thaçi D, Delevry D, Bagousse GB, Zhang R, Shumel B, Rossi AB, Chao J. PMID: 34714527; PMCID: PMC8611171.
      View in: PubMed   Mentions: 3  
    292. Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis. Am J Clin Dermatol. 2022 Jan; 23(1):1-11. Silverberg JI, Simpson EL, Armstrong AW, de Bruin-Weller MS, Irvine AD, Reich K. PMID: 34699031; PMCID: PMC8776679.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    293. Alopecia areata in the United States: a ten-year analysis of patient characteristics, comorbidities, and treatment patterns. Dermatol Online J. 2021 Oct 15; 27(10). Gutierrez Y, Pourali SP, Jones ME, Rajkumar JR, Kohn AH, Compoginis GS, Armstrong AW. PMID: 35130392.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    294. Topical opioid use in dermatologic disease: A systematic review. Dermatol Ther. 2021 11; 34(6):e15150. Gutierrez Y, Pourali SP, Kucharik AH, Jones ME, Rajkumar JR, Armstrong AW. PMID: 34605133.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    295. INDIVIDUAL ARTICLE: Safety and Tolerability of Topical Agents for Actinic Keratosis: A Systematic Review of Phase 3 Clinical Trials. J Drugs Dermatol. 2021 Oct 01; 20(10):s4s4-s14. Rajkumar JR, Armstrong AW, Kircik LH. PMID: 34636523.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    296. Undermining during cutaneous wound closure for wounds less than 3 cm in diameter: a randomized split wound comparative effectiveness trial. Arch Dermatol Res. 2022 Sep; 314(7):697-703. Joo J, Pourang A, Tchanque-Fossuo CN, Armstrong AW, Tartar DM, King TH, Sivamani RK, Eisen DB. PMID: 34546436; PMCID: PMC9307554.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    297. A Blueprint for the Conduct of Large, Multisite Trials in Telemedicine. J Med Internet Res. 2021 09 20; 23(9):e29511. Commiskey P, Armstrong AW, Coker TR, Dorsey ER, Fortney JC, Gaines KJ, Gibbons BM, Nguyen HQ, Singla DR, Szigethy E, Krupinski EA. PMID: 34542417; PMCID: PMC8491114.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    298. Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United States. J Am Acad Dermatol. 2022 04; 86(4):748-757. Merola JF, Tian H, Patil D, Richardson C, Scott A, Chen YH, Kim N, Hur P, Armstrong AW. PMID: 34547358.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    299. International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting. Dermatology. 2022; 238(3):430-437. Kohn AH, Alavi A, Armstrong AW, Babalola F, Garg A, Gottlieb AB, Grilli L, Jemec GBE, Latella J, Marcus K, Merola JF, Ortega-Loayza AG, Siegel DM, Strand V, Tan JKL, Perez-Chada LM. PMID: 34537770; PMCID: PMC9153366.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    300. Differences in acne therapy prescribing patterns between dermatologists and pediatricians: A population-based study. Pediatr Dermatol. 2021 Sep; 38(5):1150-1156. Jones ME, Pourali SP, Kohn AH, Gutierrez Y, Rajkumar JR, Armstrong AW. PMID: 34514637.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    301. Three-year U.S. pharmacovigilance report of brodalumab. Dermatol Ther. 2021 11; 34(6):e15105. Lebwohl M, Leonardi C, Armstrong A, Rawnsley N, Alexander B, Goehring E, Kerdel F, Jacobson A. PMID: 34418244; PMCID: PMC9286594.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    302. Real-World Satisfaction with Secukinumab in Clearing the Skin of Patients with Plaque Psoriasis through 24 Months of Follow-Up: Results from US Dermatology Electronic Medical Records. Dermatol Ther (Heidelb). 2021 Oct; 11(5):1733-1749. Armstrong AW, Patil D, Levi E, McGuiness CB, Wang X, Wang Y, Chen CC, Nguyen E, Yamauchi PS. PMID: 34455554; PMCID: PMC8484392.
      View in: PubMed   Mentions: 4  
    303. The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statement. J Dermatolog Treat. 2022 06; 33(4):2397-2399. Butler DC, Simpson E, Guttman-Yassky E, Eichenfield LF, Golant AK, Koo JYM, Armstrong AW, Alexis AF, Lio PA, Marson JW, Lebwohl M. PMID: 34365875.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    304. Chronic spontaneous urticaria: a 16-year analysis of pediatric patient demographics, treatment patterns, and comorbidities. Dermatol Online J. 2021 Aug 15; 27(8). Pourali SP, Kohn AH, Jones ME, Armstrong AW. PMID: 34755971.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    305. Corrigendum: Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic. Dermatol Online J. 2021 08 15; 27(8). Yim RM, Singh I, Armstrong AW. PMID: 34755972.
      View in: PubMed   Mentions:    Fields:    
    306. Trichotillomania in the United States: An epidemiologic study of patient characteristics, comorbidities, and treatment patterns. Dermatol Online J. 2021 Aug 15; 27(8). Gutierrez Y, Jones ME, Rajkumar JR, Kohn AH, Pourali SP, Chen A, Compoginis GS, Armstrong AW. PMID: 34755970.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    307. Chronic spontaneous urticaria in the United States: patient characteristics and treatment patterns. Int J Dermatol. 2022 08; 61(8):e308-e309. Pourali SP, Gutierrez Y, Kucharik AH, Rajkumar JR, Jones ME, Armstrong AW. PMID: 34370872.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    308. Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study. J Dermatolog Treat. 2022 Jun; 33(4):2317-2324. Blauvelt A, Armstrong AW, Langley RG, Gebauer K, Thaçi D, Bagel J, Guenther LC, Paul C, Randazzo B, Flavin S, Hsu MC, You Y, Reich K. PMID: 34348574.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    309. Advances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report. J Drugs Dermatol. 2021 Aug 01; 20(8):888-893. Rosso JD, Armstrong AW, Berman B, Bhatia N, Cockerell C, Goldenberg G, Kirby J, Lebwohl M, Stein Gold L, Marson JW, Rigel DS. PMID: 34397199.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    310. Psoriasis Prevalence in Adults in the United States. JAMA Dermatol. 2021 Aug 01; 157(8):940-946. Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. PMID: 34190957; PMCID: PMC8246333.
      View in: PubMed   Mentions: 209     Fields:    Translation:Humans
    311. Opiate use in dermatology: A population-based study using the National Ambulatory Medical Care Survey in the United States. J Am Acad Dermatol. 2022 07; 87(1):174-176. Pourali SP, Kucharik AH, Gutierrez Y, Jones ME, Rajkumar JR, Kostandy G, Armstrong AW. PMID: 34274414.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    312. Differences in health care resource utilization and costs for keratinocyte carcinoma among racioethnic groups: A population-based study. J Am Acad Dermatol. 2022 02; 86(2):373-378. Sierro TJ, Blumenthal LY, Hekmatjah J, Chat VS, Kassardjian AA, Read C, Armstrong AW. PMID: 34246700.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    313. Mental health outcomes and their association to race and ethnicity in acne patients: A population-based study. J Am Acad Dermatol. 2022 07; 87(1):140-142. Kucharik AH, Pourali SP, Rajkumar JR, Hekmatjah J, Armstrong AW. PMID: 34216719.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    314. Operative Management of Failed Rotator Cuff Repair With Soft Tissue Release. Cureus. 2021 Jun; 13(6):e15970. Bertha N, Updegrove G, Staity G, Ponnuru P, Armstrong A. PMID: 34336462; PMCID: PMC8315784.
      View in: PubMed   Mentions:
    315. Anogenital warts and relationship to child sexual abuse: Systematic review and meta-analysis. Pediatr Dermatol. 2021 Jul; 38(4):842-850. Awasthi S, Ornelas J, Armstrong A, Johnson JA, Eisen DB. PMID: 34060139.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    316. GRAPPA Trainee Symposium 2020: A Summary of Oral and Poster Presentations. J Rheumatol Suppl. 2021 Jun; 97:19-23. Ritchlin CT, Armstrong A, Johnsson H, Mulder MLM. PMID: 34074661.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    317. Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. J Rheumatol Suppl. 2021 Jun; 97:4-9. Stober C, Jadon DR, Armstrong AW, Chandran V, de Wit M, Helliwell PS, Mease PJ, Ogdie A, O'Sullivan D, Pennington SR, Löve T, Cauli A, van Mens L, Waxman R, Scher JU, Barton A, Ritchlin CT, FitzGerald O. PMID: 34074658.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    318. The Use of Biologics During the COVID-19 Pandemic. Dermatol Clin. 2021 10; 39(4):545-553. Jones ME, Kucharik AH, Pourali SP, Rajkumar JR, Gutierrez Y, Yim RM, Armstrong AW. PMID: 34556244; PMCID: PMC8166518.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    319. Vitiligo Health Education: A Study of Accuracy and Engagement of Online Educational Materials. J Drugs Dermatol. 2021 Jun 01; 20(6):623-629. Read C, Wu KK, Young PM, Armstrong AW. PMID: 34076397.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    320. Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting. J Rheumatol Suppl. 2021 Jun; 97:10-16. Perez-Chada LM, Kohn A, Gottlieb AB, Armstrong AW, Eder L, Mease PJ, Ogdie A, Strand V, Merola JF. PMID: 34074659.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    321. Mental health outcomes in White patients versus patients with skin of color with psoriasis. Dermatol Online J. 2021 May 15; 27(5). Kohn AH, Pourali SP, Gutierrez Y, Jones ME, Rajkumar JR, Read C, Armstrong AW. PMID: 34118808.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    322. ARTICLE: Advances in Oral Isotretinoin Therapy. J Drugs Dermatol. 2021 May 01; 20(5):s5-s11. Jones M, Armstrong AW, Baldwin H, Stein Gold L, Kircik LH. PMID: 33938693.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    323. Analysis of Long-Term Outcomes Following Surgical Contracture Release of the Elbow: A Case Series. Cureus. 2021 Apr 26; 13(4):e14691. Ammerman BM, Updegrove G, Ponnuru P, Armstrong A. PMID: 34055535; PMCID: PMC8152451.
      View in: PubMed   Mentions: 1  
    324. Bimekizumab versus Adalimumab in Plaque Psoriasis. N Engl J Med. 2021 07 08; 385(2):130-141. Warren RB, Blauvelt A, Bagel J, Papp KA, Yamauchi P, Armstrong A, Langley RG, Vanvoorden V, De Cuyper D, Cioffi C, Peterson L, Cross N, Reich K. PMID: 33891379.
      View in: PubMed   Mentions: 92     Fields:    Translation:HumansCTClinical Trials
    325. The time to offer treatments for COVID-19. Expert Opin Investig Drugs. 2021 May; 30(5):505-518. Ngo BT, Marik P, Kory P, Shapiro L, Thomadsen R, Iglesias J, Ditmore S, Rendell M, Varon J, Dubé M, Nanda N, In G, Arkfeld D, Chaudhary P, Campese VM, Hanna DL, Sawcer DE, Ehresmann G, Peng D, Smogorewski M, Armstrong A, Dasgupta R, Sattler F, Brennan-Rieder D, Mussini C, Mitja O, Soriano V, Peschanski N, Hayem G, Confalonieri M, Piccirillo MC, Lobo-Ferreira A, Bello Rivero I, Turkia M, Vinjevoll EH, Griffin D, Hung IF. PMID: 33721548; PMCID: PMC8074648.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    326. Validation of Patient-Reported Psoriasis Diagnosis from a Global Online Research Network. J Invest Dermatol. 2021 10; 141(10):2539-2541. Armstrong AW, Archuleta L, Gutierrez Y, Liao W, Bell SJ, Gondo G. PMID: 33862067.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    327. Childhood atopic dermatitis: outpatient visit trends, demographics, and topical agents in the United States, 1995-2015. Int J Dermatol. 2021 Oct; 60(10):e423-e424. Gutierrez Y, Borba AJ, Grisafe DJ, Armstrong AW. PMID: 33844279.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    328. Pemphigus and bullous pemphigoid in the United States: a 21-year analysis of patient characteristics, treatment patterns, and comorbidities. J Dermatolog Treat. 2022 06; 33(4):2383-2385. Gutierrez Y, Pourali SP, Singh I, Armstrong AW. PMID: 33769922.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    329. Psoriasis. Lancet. 2021 04 03; 397(10281):1301-1315. Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. PMID: 33812489.
      View in: PubMed   Mentions: 1021     Fields:    Translation:Humans
    330. GRAPPA Trainee Symposium 2020: A Summary of Oral and Poster Presentations. J Rheumatol. 2021 Apr 01. Richlin CT, Armstrong A, Johnsson H, Mulder MLM. PMID: 33795328.
      View in: PubMed   Mentions:    Fields:    
    331. Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis. Dermatol Ther (Heidelb). 2021 Jun; 11(3):885-905. Armstrong AW, Soliman AM, Betts KA, Wang Y, Gao Y, Puig L, Augustin M. PMID: 33788177; PMCID: PMC8163943.
      View in: PubMed   Mentions: 25  
    332. Report of the Skin Research Working Groups From the GRAPPA 2020 Annual Meeting. J Rheumatol. 2021 Mar 15. Perez-Chada LM, Kohn A, Gottlieb AB, Armstrong AW, Eder L, Mease PJ, Ogdie A, Strand V, Merola JF. PMID: 33722941.
      View in: PubMed   Mentions: 1     Fields:    
    333. Tapinarof-associated folliculitis is generally mild, self-limiting, and rarely interferes with therapy. J Am Acad Dermatol. 2021 07; 85(1):e39-e40. Bissonnette R, Gold LS, Rubenstein DS, Tallman AM, Armstrong AW. PMID: 33676999.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    334. The preponderance of evidence supports an aryl hydrocarbon receptor-dependent mechanism of action of tapinarof. J Am Acad Dermatol. 2021 07; 85(1):e35-e36. Bissonnette R, Gold LS, Rubenstein DS, Tallman AM, Armstrong AW. PMID: 33677005.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    335. Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data. J Am Acad Dermatol. 2021 09; 85(3):572-581. Shear NH, Betts KA, Soliman AM, Joshi A, Wang Y, Zhao J, Gisondi P, Sinvhal R, Armstrong AW. PMID: 33631216.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    336. Rosacea videos on social media: A comparison of accuracy, quality, and viewer engagement. Dermatol Online J. 2021 Feb 15; 27(2). Chen AY, Azizi B, Borba AJ, Armstrong AW. PMID: 33818977.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    337. Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting. J Rheumatol. 2021 Feb 15. Stober C, Jadon DR, Armstrong AW, Chandran V, de Wit M, Helliwell PS, Mease P, Ogdie A, O'Sullivan D, Pennington SR, Löve T, Cauli A, van Mens L, Waxman R, Scher JU, Barton A, Ritchlin CT, FitzGerald O. PMID: 33589562.
      View in: PubMed   Mentions:    Fields:    
    338. Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial. Lancet. 2021 02 06; 397(10273):487-498. Reich K, Papp KA, Blauvelt A, Langley RG, Armstrong A, Warren RB, Gordon KB, Merola JF, Okubo Y, Madden C, Wang M, Cioffi C, Vanvoorden V, Lebwohl M. PMID: 33549193.
      View in: PubMed   Mentions: 122     Fields:    Translation:Humans
    339. Differences in Depression and Distress Between Acne Patients on Isotretinoin vs Oral Antibiotics. J Drugs Dermatol. 2021 02 01; 20(2):172-177. Hekmatjah J, Chat VS, Sierro TJ, Read C, Kassardjian AA, Armstrong AW. PMID: 33538565.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    340. Brodalumab in an Organ Transplant Recipient With Psoriasis. Cutis. 2021 Feb; 107(2):104-106. Singh I, Uy A, Kassardjian A, Armstrong AW. PMID: 33891842.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    341. Reply to "Comment on 'Dermatologists in social media: A study on top influencers, posts, and user engagement': Dermatologist influencers on TikTok". J Am Acad Dermatol. 2022 02; 86(2):e75. Sierro TJ, Young PM, Kassabian SK, Wu KK, Armstrong A. PMID: 33529698.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    342. National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments. J Am Acad Dermatol. 2021 05; 84(5):1254-1268. Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Gondo G, Heydon S, Koons S, Ritchlin CT. PMID: 33422626; PMCID: PMC7788316.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansPHPublic Health
    343. Economics of Teledermatology-Does the Math Add Up? JAMA Dermatol. 2021 01 01; 157(1):27-28. Armstrong AW, Singh I. PMID: 33206120.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    344. Two-Year US Pharmacovigilance Report on Brodalumab. Dermatol Ther (Heidelb). 2021 Feb; 11(1):173-180. Lebwohl M, Leonardi C, Wu JJ, Armstrong A, Rawnsley N, Merchant M, Alexander B, Jacobson A. PMID: 33337520; PMCID: PMC7859129.
      View in: PubMed   Mentions: 11  
    345. Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study. Am J Clin Dermatol. 2020 Dec; 21(6):881-890. Reich K, Armstrong AW, Foley P, Song M, Miller M, Shen YK, You Y, Han C, Gordon KB. PMID: 32910434.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    346. Tapinarof in the treatment of psoriasis: A review of the unique mechanism of action of a novel therapeutic aryl hydrocarbon receptor-modulating agent. J Am Acad Dermatol. 2021 Apr; 84(4):1059-1067. Bissonnette R, Stein Gold L, Rubenstein DS, Tallman AM, Armstrong A. PMID: 33157177.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCells
    347. Oral Tetracyclines and Acne: A Systematic Review for Dermatologists. J Drugs Dermatol. 2020 11 01; 19(11):s6-s13. Armstrong AW, Hekmatjah J, Kircik LH. PMID: 33196746.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    348. Report from the International Dermatology Outcome Measures Initiative. J Investig Dermatol Symp Proc. 2020 11; 20(1):S80-S83. Perez-Chada LM, Merola JF, Armstrong AW, Garg A, Latella J, Gottlieb AB. PMID: 33099394; PMCID: PMC9393900.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    349. Response to Letter to the Editor commenting on: "Dermatologists in social media: A study on top influencers, posts, and user engagement". J Am Acad Dermatol. 2021 03; 84(3):e165. Sierro TJ, Young PM, Kassabian SK, Wu KK, Armstrong AW. PMID: 33470205.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    350. Who sees you matters: a population study examining topical corticosteroid prescribing patterns between primary care providers and dermatologists for atopic dermatitis. J Dermatolog Treat. 2022 May; 33(3):1507-1510. Singh I, Chat VS, Uy A, Borba A, Chen AY, Armstrong AW. PMID: 33043730.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    351. Strategies to maximize clinical efficiency while maintaining patient safety during the COVID-19 pandemic: an interview-based study from private practice dermatologists. J Dermatolog Treat. 2022 May; 33(3):1503-1506. Yim KM, Yim RM, Gaspard S, MacDougall J, Armstrong AW. PMID: 33054453.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    352. Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic. Dermatol Online J. 2020 Oct 15; 26(10). Yim RM, Singh I, Armstrong AW. PMID: 33147660.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsPHPublic Health
    353. Language proficiency and biologics access: a population study of psoriasis patients in the United States. J Dermatolog Treat. 2022 May; 33(3):1413-1417. Chat VS, Hekmatjah J, Sierro TJ, Kassardjian AA, Read C, Armstrong AW. PMID: 32928008.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    354. National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1. J Am Acad Dermatol. 2020 Dec; 83(6):1704-1716. Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Smith J, Gondo G, Heydon S, Koons S, Ritchlin CT. PMID: 32891785; PMCID: PMC7471802.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCellsPHPublic Health
    355. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021 Feb; 84(2):432-470. Elmets CA, Korman NJ, Prater EF, Wong EB, Rupani RN, Kivelevitch D, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Siegel M, Stoff B, Strober B, Wu JJ, Hariharan V, Menter A. PMID: 32738429.
      View in: PubMed   Mentions: 123     Fields:    Translation:Humans
    356. Association Between the Mental Health of Patients With Psoriasis and Their Satisfaction With Physicians. JAMA Dermatol. 2020 07 01; 156(7):754-762. Read C, Armstrong AW. PMID: 32374350; PMCID: PMC7203668.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    357. Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States. J Dermatolog Treat. 2022 Mar; 33(2):740-748. Jia X, Zhao Y, Carrico J, Brodtkorb TH, Mendelsohn AM, Lowry S, Feldman S, Wu JJ, Armstrong AW. PMID: 32602762.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    358. Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics. Dermatol Ther (Heidelb). 2020 Aug; 10(4):615-621. Menter A, Armstrong A, Van Voorhees A, Liu C, Jacobson A. PMID: 32533554; PMCID: PMC7367951.
      View in: PubMed   Mentions: 5  
    359. Wound eversion versus planar closure for wounds on the face or neck: A randomized split-wound comparative effectiveness trial. J Am Acad Dermatol. 2020 Nov; 83(5):1439-1440. Alexanian CC, Zhuang AR, Crispin MK, Armstrong AW, Eisen DB. PMID: 32531302.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    360. Investigator and Patient Global Assessment Measures for Psoriasis Clinical Trials: A Systematic Review on Measurement Properties from the International Dermatology Outcome Measures (IDEOM) Initiative. Am J Clin Dermatol. 2020 Jun; 21(3):323-338. Perez-Chada LM, Salame NF, Ford AR, Duffin KC, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. PMID: 31950353.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    361. Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting. J Rheumatol Suppl. 2020 Jun; 96:25-30. Waxman R, Stober C, Jadon DR, Orbai AM, Chandran V, Ogdie A, Pennington SR, de Wit M, O'Sullivan D, Mease PJ, Armstrong AW, Callis Duffin K, Helliwell PS, van Mens LJJ, Ritchlin CT, FitzGerald O. PMID: 32482764.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    362. Report of the Skin Research Workgroups from the GRAPPA 2019 Annual Meeting. J Rheumatol Suppl. 2020 Jun; 96:36-40. Perez-Chada LM, Merola JF, Armstrong AW, Gottlieb AB. PMID: 32482766.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    363. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis: A Review. JAMA. 2020 May 19; 323(19):1945-1960. Armstrong AW, Read C. PMID: 32427307.
      View in: PubMed   Mentions: 1016     Fields:    Translation:Humans
    364. Importance of Complete Skin Clearance in Psoriasis as a Treatment Goal: Implications for Patient-Reported Outcomes. J Drugs Dermatol. 2020 May 01; 19(5):487-492. Blauvelt A, Wu JJ, Armstrong A, Menter A, Liu C, Jacobson A. PMID: 32484628.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    365. Comparison of 2-Octylcyanoacrylate Versus 5-0 Fast-Absorbing Gut During Linear Wound Closures and the Effect on Wound Cosmesis. Dermatol Surg. 2020 05; 46(5):628-634. Zhuang AR, Beroukhim K, Armstrong AW, Sivamani RK, Eisen DB. PMID: 31403536.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    366. Evaluation of Changes in Skin and Joint Outcomes and Associated Treatment Changes in Psoriatic Arthritis (PsA): Experience From the Corrona PsA/SpA Registry. J Rheumatol. 2021 03; 48(3):376-384. Mease PJ, Etzel CJ, Huster WJ, Armstrong AW, Muram TM, Lisse J, Rebello S, Dodge R, Murage MJ, Greenberg JD, Malatestinic WN. PMID: 32358158.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    367. Reply to: "Comment on 'Dermatologists in social media: A study on top influencers, posts, and user engagement'". J Am Acad Dermatol. 2022 02; 86(2):e51. Sierro TJ, Young PM, Kassabian SK, Wu KK, Armstrong AW. PMID: 32330636.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    368. Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis. J Dermatolog Treat. 2021 Nov; 32(7):693-700. Wu JJ, Jia X, Zhao Y, Carrico J, Brodtkorb TH, Mendelsohn A, Lowry S, Feldman SR, Armstrong A. PMID: 32233828.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    369. Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial. JAMA Dermatol. 2020 04 01; 156(4):411-420. Guttman-Yassky E, Blauvelt A, Eichenfield LF, Paller AS, Armstrong AW, Drew J, Gopalan R, Simpson EL. PMID: 32101256; PMCID: PMC7142380.
      View in: PubMed   Mentions: 139     Fields:    Translation:HumansCTClinical Trials
    370. Recapture Rate of Brodalumab in Patients With a Lapse in Treatment. J Drugs Dermatol. 2020 Apr 01; 19(4):384-387. Lebwohl M, Cather J, Armstrong A, Van Voorhees A, Jacobson A. PMID: 32272515.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    371. Dermatologists in social media: A study on top influencers, posts, and user engagement. J Am Acad Dermatol. 2020 11; 83(5):1452-1455. Sierro TJ, Young PM, Kassabian SK, Wu KK, Armstrong AW. PMID: 32151630.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    372. Comparison of Biologics and Oral Treatments for Plaque Psoriasis: A Meta-analysis. JAMA Dermatol. 2020 03 01; 156(3):258-269. Armstrong AW, Puig L, Joshi A, Skup M, Williams D, Li J, Betts KA, Augustin M. PMID: 32022825; PMCID: PMC7042876.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    373. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol. 2020 Jun; 82(6):1445-1486. Menter A, Gelfand JM, Connor C, Armstrong AW, Cordoro KM, Davis DMR, Elewski BE, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Prater EF, Rahimi RS, Rupani RN, Siegel M, Stoff B, Strober BE, Tapper EB, Wong EB, Wu JJ, Hariharan V, Elmets CA. PMID: 32119894.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    374. A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S). J Invest Dermatol. 2020 09; 140(9):1784-1793.e2. Gelfand JM, Shin DB, Duffin KC, Armstrong AW, Blauvelt A, Tyring SK, Menter A, Gottlieb S, Lockshin BN, Simpson EL, Kianifard F, Sarkar RP, Muscianisi E, Steadman J, Ahlman MA, Playford MP, Joshi AA, Dey AK, Werner TJ, Alavi A, Mehta NN. PMID: 32088207; PMCID: PMC7434644.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    375. Examination of Treatment Satisfaction Instruments in Psoriasis: 2017 Results from the Psoriasis Working Group of the International Dermatology Outcome Measures (IDEOM). Dermatology. 2021; 237(2):151-157. Kornmehl H, Callis Duffin K, Salame N, Perez-Chada LM, Singh S, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. PMID: 31991410.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    376. Maintenance of clinical response and consistent safety profile with up to 3 years of continuous treatment with guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials. J Am Acad Dermatol. 2020 Apr; 82(4):936-945. Reich K, Griffiths CEM, Gordon KB, Papp KA, Song M, Randazzo B, Li S, Shen YK, Han C, Kimball AB, Armstrong AW, Foley P, Blauvelt A. PMID: 31809827.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    377. Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure. Dermatol Ther (Heidelb). 2020 Feb; 10(1):133-150. Armstrong A, Paul C, Puig L, Boehncke WH, Freeman M, Torii H, Papp K, Griffiths CEM, Blauvelt A, Reich K, Gooderham M, Terui T, Renda L, Agada N, Xu W, Gallo G, Lebwohl MG. PMID: 31749092; PMCID: PMC6994584.
      View in: PubMed   Mentions: 30  
    378. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol. 2020 Jan; 82(1):161-201. Menter A, Cordoro KM, Davis DMR, Kroshinsky D, Paller AS, Armstrong AW, Connor C, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Elmets CA. PMID: 31703821.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    379. Differences in wage earnings between psoriasis patients on biologics versus those on oral therapies: a population-based study in the United States. J Dermatolog Treat. 2021 Jun; 32(4):440-445. Nguyen K, Ehsani-Chimeh N, Salame N, Armstrong AW. PMID: 31557069.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    380. Where you live matters: Regional differences in health care resource use for psoriasis in the United States. J Am Acad Dermatol. 2020 Jun; 82(6):1360-1367. Nguyen KB, Read C, Wu KK, Armstrong AW. PMID: 31606478.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    381. Achievement of the National Psoriasis Foundation treatment targets with ixekizumab: Pooled analyses from 4 clinical studies. J Am Acad Dermatol. 2021 08; 85(2):330-336. Armstrong A, Amato D, Huster W, Ojeh C, Van Voorhees AS. PMID: 31562945.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    382. Biomechanical Testing of Additive Manufactured Proximal Humerus Fracture Fixation Plates. Ann Biomed Eng. 2020 Jan; 48(1):463-476. Tilton M, Armstrong A, Sanville J, Chin M, Hast MW, Lewis GS, Manogharan GP. PMID: 31555983.
      View in: PubMed   Mentions: 9     Fields:    
    383. Does location matter? Geographic variations in healthcare resource use for atopic dermatitis in the United States. J Dermatolog Treat. 2021 May; 32(3):314-320. Wu KK, Nguyen KB, Sandhu JK, Armstrong AW. PMID: 31416361.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    384. Association between atopic dermatitis and conjunctivitis in adults: a population-based study in the United States. J Dermatolog Treat. 2021 Jun; 32(4):455-459. Wu KK, Borba AJ, Deng PH, Armstrong AW. PMID: 31437060.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    385. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population J Drugs Dermatol. 2019 Sep 01; 18(9):910-916. Han G, Armstrong AW, Desai SR, Guenin E. PMID: 31524347.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    386. Dermal suture only versus layered closure: A randomized, split wound comparative effectiveness trial. J Am Acad Dermatol. 2019 Dec; 81(6):1346-1352. Joo JS, Zhuang AR, Tchanque-Fossuo C, Tartar D, Armstrong AW, King TH, Sivamani RK, Eisen DB. PMID: 31442535.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    387. Engaging but inaccurate: A cross-sectional analysis of acne videos on social media from non-health care sources. J Am Acad Dermatol. 2020 Aug; 83(2):610-612. Borba AJ, Young PM, Read C, Armstrong AW. PMID: 31442538.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    388. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial. Lancet. 2019 09 07; 394(10201):831-839. Reich K, Armstrong AW, Langley RG, Flavin S, Randazzo B, Li S, Hsu MC, Branigan P, Blauvelt A. PMID: 31402114.
      View in: PubMed   Mentions: 160     Fields:    Translation:HumansCTClinical Trials
    389. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. J Am Acad Dermatol. 2019 Sep; 81(3):775-804. Elmets CA, Lim HW, Stoff B, Connor C, Cordoro KM, Lebwohl M, Armstrong AW, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kiselica M, Kivelevitch D, Korman NJ, Kroshinsky D, Leonardi CL, Lichten J, Mehta NN, Paller AS, Parra SL, Pathy AL, Farley Prater EA, Rupani RN, Siegel M, Strober BE, Wong EB, Wu JJ, Hariharan V, Menter A. PMID: 31351884.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    390. Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumab. J Dermatolog Treat. 2020 Sep; 31(6):617-623. Reich K, Foley P, Han C, McElligott S, Muser E, Li N, Armstrong AW. PMID: 31305186.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    391. Development of the Psoriasis Symptoms Scale (PSS) in patients with moderate-to-severe psoriasis: qualitative and quantitative analyses. J Dermatolog Treat. 2020 Aug; 31(5):452-459. Armstrong AW, Edson-Heredia E, Naegeli AN, Burge R, Poon JL, Anatchkova M, Sun L, Zhu B, Wyrwich KW. PMID: 31157576.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    392. An unusual spiculated presentation of follicular porokeratosis. Dermatol Online J. 2019 Jul 15; 25(7). Young PM, Leavens J, Gaspard S, Kim G, Armstrong AW. PMID: 31450276.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    393. Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study. J Invest Dermatol. 2019 12; 139(12):2437-2446.e1. Gordon KB, Armstrong AW, Foley P, Song M, Shen YK, Li S, Muñoz-Elías EJ, Branigan P, Liu X, Reich K. PMID: 31207232.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    394. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2. J Dermatolog Treat. 2020 Sep; 31(6):606-614. Cork MJ, Eckert L, Simpson EL, Armstrong A, Barbarot S, Puig L, Girolomoni G, de Bruin-Weller M, Wollenberg A, Kataoka Y, Remitz A, Beissert S, Mastey V, Ardeleanu M, Chen Z, Gadkari A, Chao J. PMID: 31179791.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCTClinical Trials
    395. Factors Influencing Sleep Difficulty and Sleep Quantity in the Citizen Pscientist Psoriatic Cohort. Dermatol Ther (Heidelb). 2019 Sep; 9(3):511-523. Smith MP, Ly K, Thibodeaux Q, Weerasinghe T, Beck K, Shankle L, Armstrong AW, Boas M, Bridges A, Doris F, Gelfand JM, Lafoy B, Orbai AM, Takeshita J, Truman S, Wan MT, Wu JJ, Siegel MP, Bell SJ, Bhutani T, Liao W. PMID: 31177381; PMCID: PMC6704222.
      View in: PubMed   Mentions: 13  
    396. Effects of online care on functional and psychological outcomes in patients with psoriasis: A randomized controlled trial. J Am Acad Dermatol. 2023 02; 88(2):364-370. Young PM, Chen AY, Ford AR, Cheng MY, Lane CJ, Armstrong AW. PMID: 31175908.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    397. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials. J Am Acad Dermatol. 2020 Jan; 82(1):54-61. Perez-Chada LM, Gottlieb AB, Cohen J, Mease P, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF. PMID: 31163240.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    398. Patient-reported outcomes of adalimumab, phototherapy, and placebo in the Vascular Inflammation in Psoriasis Trial: A randomized controlled study. J Am Acad Dermatol. 2019 Oct; 81(4):923-930. Noe MH, Wan MT, Shin DB, Armstrong AW, Duffin KC, Chiesa Fuxench ZC, Kalb RE, Menter A, Simpson EL, Takeshita J, Tyring SK, Van Voorhees AS, Mehta NN, Gelfand JM. PMID: 31163241; PMCID: PMC6746579.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    399. Exploring Mental Disorders in Patients With Skin Diseases. JAMA Dermatol. 2019 06 01; 155(6):660-661. Armstrong AW. PMID: 31066869.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    400. Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting. J Rheumatol Suppl. 2019 Jun; 95:11-19. Jadon DR, Chandran V, Ogdie A, Pennington SR, Stober C, Gladman DD, de Wit M, O'Sullivan D, Mease P, Armstrong AW, Callis Duffin K, Magee C, Helliwell P, Ritchlin CT, FitzGerald O. PMID: 31154399.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    401. Report of the Skin Research Workgroups from the GRAPPA 2018 Annual Meeting. J Rheumatol Suppl. 2019 Jun; 95:28-32. Perez-Chada LM, Merola JF, Armstrong AW, Gottlieb AB. PMID: 31154401.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    402. Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry. RMD Open. 2019; 5(1):e000867. Mease PJ, Etzel CJ, Huster WJ, Muram TM, Armstrong AW, Lisse JR, Rebello S, Dodge R, Murage MJ, Greenberg JD, Malatestinic WN. PMID: 31245045; PMCID: PMC6560672.
      View in: PubMed   Mentions: 16  Translation:Humans
    403. Problematic Strength of the Association Between Atopic Dermatitis and Suicidality-Reply. JAMA Dermatol. 2019 05 01; 155(5):638. Wu KK, Bui TL, Armstrong AW. PMID: 30942837.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    404. Assessing Skin Biopsy Rates for Histologic Findings Indicative of Nonpathological Cutaneous Disease. Dermatol Surg. 2019 05; 45(5):640-649. Solomon JA, Oswalt M, Nodzenski M, Glener J, Schaeffer MR, Cartee TV, Maher IA, Sobanko JF, Waldman A, Yoo SS, Lewis S, Barr M, Marous M, Sledge B, Duke JK, Armstrong AW, Poon E, Veledar E, Dellavalle RP, Alam M. PMID: 30829782.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    405. Comparison of physical and mental functioning among moderate-to-severe psoriasis patients on biologic versus oral therapy. Arch Dermatol Res. 2019 Aug; 311(6):453-460. Salame N, Ehsani-Chimeh N, Armstrong AW. PMID: 31020408.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    406. Economic burden of cutaneous infections in children and adults with atopic dermatitis. Pediatr Dermatol. 2019 May; 36(3):303-310. Sandhu JK, Salame N, Ehsani-Chimeh N, Armstrong AW. PMID: 30968453.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    407. Comparison of Running Cutaneous Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis of the Face and Neck: A Randomized Clinical Trial. JAMA Dermatol. 2019 03 01; 155(3):321-326. Sklar LR, Pourang A, Armstrong AW, Dhaliwal SK, Sivamani RK, Eisen DB. PMID: 30649154; PMCID: PMC6439934.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    408. Use of 5-0 Fast Absorbing Gut versus 6-0 Fast Absorbing Gut during cutaneous wound closure on the head and neck: A randomized evaluator-blinded split-wound comparative effectiveness trial. J Am Acad Dermatol. 2019 Jul; 81(1):213-218. Pourang A, Crispin MK, Clark AK, Armstrong AW, Sivamani RK, Eisen DB. PMID: 30797848.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    409. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019 Apr; 80(4):1029-1072. Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, Armstrong AW, Connor C, Cordoro KM, Davis DMR, Elewski BE, Gelfand JM, Gordon KB, Gottlieb AB, Kavanaugh A, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Leonardi CL, Lichten J, Lim HW, Mehta NN, Paller AS, Parra SL, Pathy AL, Rupani RN, Siegel M, Wong EB, Wu JJ, Hariharan V, Elmets CA. PMID: 30772098.
      View in: PubMed   Mentions: 342     Fields:    Translation:Humans
    410. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol. 2019 Apr; 80(4):1073-1113. Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, Armstrong AW, Connor C, Cordoro KM, Elewski BE, Gordon KB, Gottlieb AB, Kaplan DH, Kavanaugh A, Kivelevitch D, Kiselica M, Korman NJ, Kroshinsky D, Lebwohl M, Lim HW, Paller AS, Parra SL, Pathy AL, Prater EF, Rupani R, Siegel M, Stoff B, Strober BE, Wong EB, Wu JJ, Hariharan V, Menter A. PMID: 30772097.
      View in: PubMed   Mentions: 219     Fields:    Translation:Humans
    411. Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 Studies. Am J Clin Dermatol. 2019 Feb; 20(1):155-164. Armstrong AW, Reich K, Foley P, Han C, Song M, Shen YK, You Y, Papp KA. PMID: 30417277; PMCID: PMC6513809.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    412. Association Between Atopic Dermatitis and Suicidality: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019 02 01; 155(2):178-187. Sandhu JK, Wu KK, Bui TL, Armstrong AW. PMID: 30540348; PMCID: PMC6439544.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    413. Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis. PLoS One. 2019; 14(1):e0210517. Armstrong AW, Huang A, Wang L, Miao R, Patel MY, Gadkari A, Mallya UG, Chao J. PMID: 30682042; PMCID: PMC6347241.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    414. Real-world experience of calcipotriene and betamethasone dipropionate foam 0.005%/0.064% in the treatment of adults with psoriasis in the United States. J Dermatolog Treat. 2019 Aug; 30(5):454-460. Wu JJ, Veverka KA, Lu M, Armstrong AW. PMID: 30307343.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    415. Clinical Goals and Barriers to Effective Psoriasis Care. Dermatol Ther (Heidelb). 2019 Mar; 9(1):5-18. Strober BE, van der Walt JM, Armstrong AW, Bourcier M, Carvalho AVE, Chouela E, Cohen AD, de la Cruz C, Ellis CN, Finlay AY, Gottlieb AB, Gudjonsson JE, Iversen L, Kleyn CE, Leonardi CL, Lynde CW, Ryan C, Theng CT, Valenzuela F, Vender R, Wu JJ, Young HS, Kimball AB. PMID: 30578464; PMCID: PMC6380974.
      View in: PubMed   Mentions: 32  
    416. Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR). Am J Clin Dermatol. 2018 Dec; 19(6):879-886. Singh S, Kalb RE, de Jong EMGJ, Shear NH, Lebwohl M, Langholff W, Hopkins L, Srivastava B, Armstrong AW. PMID: 30267377; PMCID: PMC6267545.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    417. Online Care Versus In-Person Care for Improving Quality of Life in Psoriasis: A Randomized Controlled Equivalency Trial. J Invest Dermatol. 2019 05; 139(5):1037-1044. Armstrong AW, Ford AR, Chambers CJ, Maverakis E, Dunnick CA, Chren MM, Gelfand JM, Gibbons CM, Gibbons BM, Lane CJ. PMID: 30481495; PMCID: PMC6599714.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    418. Adverse Medical Conditions Across Treatment Options in Patients With Psoriasis: A Claims-Based Analysis J Drugs Dermatol. 2018 11 01; 17(11):1211-1218. Wu JJ, Armstrong A, Singh R, Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Arikan D, Fleischer A, Guérin A, Ganguli A. PMID: 30500143.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    419. Anti-tumor necrosis factor agents in sarcoidosis: A systematic review of efficacy and safety. Semin Arthritis Rheum. 2019 06; 48(6):1093-1104. Adler BL, Wang CJ, Bui TL, Schilperoort HM, Armstrong AW. PMID: 30446173.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    420. Effectiveness of Online vs In-Person Care for Adults With Psoriasis: A Randomized Clinical Trial. JAMA Netw Open. 2018 10 05; 1(6):e183062. Armstrong AW, Chambers CJ, Maverakis E, Cheng MY, Dunnick CA, Chren MM, Gelfand JM, Wong DJ, Gibbons BM, Gibbons CM, Torres J, Steel AC, Wang EA, Clark CM, Singh S, Kornmehl HA, Wilken R, Florek AG, Ford AR, Ma C, Ehsani-Chimeh N, Boddu S, Fujita M, Young PM, Rivas-Sanchez C, Cornejo BI, Serna LC, Carlson ER, Lane CJ. PMID: 30646223; PMCID: PMC6324453.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    421. Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials. JAMA Dermatol. 2018 10 01; 154(10):1137-1144. Callis Duffin K, Merola JF, Christensen R, Latella J, Garg A, Gottlieb AB, Armstrong AW. PMID: 29874367; PMCID: PMC6233740.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    422. Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial. J Dermatolog Treat. 2019 Feb; 30(1):27-34. Armstrong A, Puig L, Langley R, Tsai TF, Song M, Wasfi Y, Jiang J, Li S, Han C. PMID: 28797188.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    423. A provider global assessment quality measure for clinical practice for inflammatory skin disorders. J Am Acad Dermatol. 2019 03; 80(3):823-828. Gottlieb A, Salame N, Armstrong AW, Merola JF, Parra S, Takeshita J, Chen SC, Latella J, Van Beek M, International Dermatology Outcome Measures and the American Academy of Dermatology. PMID: 30244058.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    424. Access to Dermatological Care with an Innovative Online Model for Psoriasis Management: Results from a Randomized Controlled Trial. Telemed J E Health. 2019 07; 25(7):619-627. Ford AR, Gibbons CM, Torres J, Kornmehl HA, Singh S, Young PM, Chambers CJ, Maverakis E, Dunnick CA, Armstrong AW. PMID: 30222518; PMCID: PMC6417973.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    425. Oral small molecules for psoriasis. Semin Cutan Med Surg. 2018 Sep; 37(3):163-166. Singh S, Armstrong AW. PMID: 30215633.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    426. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative. Arch Dermatol Res. 2018 Nov; 310(9):701-710. Perez-Chada LM, Cohen JM, Gottlieb AB, Duffin KC, Garg A, Latella J, Armstrong AW, Ogdie A, Merola JF. PMID: 30167814.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    427. Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in Psoriasis. Dermatology. 2018; 234(5-6):157-165. Salame N, Perez-Chada LM, Singh S, Callis Duffin K, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. PMID: 30121657.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    428. Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis Foundation: A Systematic Review. JAMA Dermatol. 2018 08 01; 154(8):934-950. Ford AR, Siegel M, Bagel J, Cordoro KM, Garg A, Gottlieb A, Green LJ, Gudjonsson JE, Koo J, Lebwohl M, Liao W, Mandelin AM, Markenson JA, Mehta N, Merola JF, Prussick R, Ryan C, Schwartzman S, Siegel EL, Van Voorhees AS, Wu JJ, Armstrong AW. PMID: 29926091.
      View in: PubMed   Mentions: 71     Fields:    Translation:Humans
    429. Suicidality among psoriasis patients: a critical evidence synthesis. G Ital Dermatol Venereol. 2019 Feb; 154(1):56-63. Wu KK, Armstrong AW. PMID: 30019576.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    430. Patient-Reported Outcome Measures for Pediatric Psoriasis: A Systematic Review and Critical Appraisal from International Dermatology Outcome Measures (IDEOM). Dermatology. 2018; 234(3-4):112-119. Salame N, Torres J, Sandhu J, Callis Duffin K, Garg A, Gottlieb AB, Latella J, Merola JF, Armstrong AW. PMID: 31112972.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    431. Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization. BMC Dermatol. 2018 06 28; 18(1):4. Armstrong AW, Foster SA, Comer BS, Lin CY, Malatestinic W, Burge R, Goldblum O. PMID: 29954363; PMCID: PMC6025830.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    432. Building a Citizen Pscientist: Advancing Patient-Centered Psoriasis Research by Empowering Patients as Contributors and Analysts. Dermatol Ther (Heidelb). 2018 Sep; 8(3):405-423. Sanchez IM, Shankle L, Wan MT, Afifi L, Wu JJ, Doris F, Bridges A, Boas M, Lafoy B, Truman S, Orbai AM, Takeshita J, Gelfand JM, Armstrong AW, Siegel MP, Liao W. PMID: 29876724; PMCID: PMC6109031.
      View in: PubMed   Mentions: 2  
    433. Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial. Circ Cardiovasc Imaging. 2018 06; 11(6):e007394. Mehta NN, Shin DB, Joshi AA, Dey AK, Armstrong AW, Duffin KC, Fuxench ZC, Harrington CL, Hubbard RA, Kalb RE, Menter A, Rader DJ, Reilly MP, Simpson EL, Takeshita J, Torigian DA, Werner TJ, Troxel AB, Tyring SK, Vanderbeek SB, Van Voorhees AS, Playford MP, Ahlman MA, Alavi A, Gelfand JM. PMID: 29776990; PMCID: PMC5991103.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    434. Report of the Skin Research Working Groups from the GRAPPA 2017 Annual Meeting. J Rheumatol Suppl. 2018 Jun; 94:40-43. Gottlieb AB, Coates LC, van Mens LJJ, Armstrong AW, Merola JF. PMID: 29858353.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    435. Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting. J Rheumatol Suppl. 2018 Jun; 94:54-61. Jadon DR, Chandran V, Stober C, Ogdie A, Armstrong AW, Callis Duffin K, Gladman DD, Helliwell PS, O'Sullivan D, de Wit M, FitzGerald O, Ritchlin CT. PMID: 29858357.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    436. Comparison of mental health outcomes among adults with psoriasis on biologic versus oral therapies: a population-based study. J Dermatolog Treat. 2019 Mar; 30(2):135-140. Salame N, Ehsani-Chimeh N, Armstrong AW. PMID: 29757044.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    437. Number needed to treat and costs per responder among biologic treatments for moderate-to-severe psoriasis: a network meta-analysis. Curr Med Res Opin. 2018 07; 34(7):1325-1333. Armstrong AW, Betts KA, Signorovitch JE, Sundaram M, Li J, Ganguli AX, Wu EQ. PMID: 29619856.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    438. Treatment preferences and treatment satisfaction among psoriasis patients: a systematic review. Arch Dermatol Res. 2018 May; 310(4):271-319. Florek AG, Wang CJ, Armstrong AW. PMID: 29442137.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    439. Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2018 02; 78(2):383-394. Whitlock SM, Enos CW, Armstrong AW, Gottlieb A, Langley RG, Lebwohl M, Merola JF, Ryan C, Siegel MP, Weinberg JM, Wu JJ, Van Voorhees AS. PMID: 29332708.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    440. The Evolving Landscape of Psoriasis Treatment. Semin Cutan Med Surg. 2018 Feb; 37(2S):S39-S43. Armstrong AW, Gordon KB, Menter MA, Wu JJ. PMID: 29614136.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    441. Common and Not-So-Common Comorbidities of Psoriasis. Semin Cutan Med Surg. 2018 Feb; 37(2S):S48-S51. Menter MA, Armstrong AW, Gordon KB, Wu JJ. PMID: 29614138.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    442. Characteristics of Medical Liability Claims Against Dermatologists From 1991 Through 2015. JAMA Dermatol. 2018 02 01; 154(2):160-166. Kornmehl H, Singh S, Adler BL, Wolf AE, Bochner DA, Armstrong AW. PMID: 29214284; PMCID: PMC5839273.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    443. Practical Strategies for Optimizing Management of Psoriasis. Semin Cutan Med Surg. 2018 Feb; 37(2S):S52-S55. Wu JJ, Armstrong AW, Gordon KB, Menter MA. PMID: 29614139.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    444. Treating to Target-A Realistic Goal in Psoriasis? Semin Cutan Med Surg. 2018 Feb; 37(2S):S44-S47. Gordon KB, Armstrong AW, Menter MA, Wu JJ. PMID: 29614137.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    445. Teledermatology in the United States: An Update in a Dynamic Era. Telemed J E Health. 2018 09; 24(9):691-697. Yim KM, Florek AG, Oh DH, McKoy K, Armstrong AW. PMID: 29356616.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    446. Real-World Clinical Experience With Apremilast in a Large US Retrospective Cohort Study of Patients With Moderate to Severe Plaque Psoriasis. J Drugs Dermatol. 2017 12 01; 16(12):1240-1245. Armstrong A, Levi E. PMID: 29240859.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    447. Psoriasis and wound healing outcomes: A retrospective cohort study examining wound complications and antibiotic use. Dermatol Online J. 2017 Nov 15; 23(11). Young PM, Parsi KK, Schupp CW, Armstrong AW. PMID: 29447626.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    448. Psoriasis in solid organ transplant patients: best practice recommendations from The Medical Board of the National Psoriasis Foundation. J Dermatolog Treat. 2018 Jun; 29(4):329-333. Prussick R, Wu JJ, Armstrong AW, Siegel MP, Van Voorhees AS. PMID: 28884635.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    449. Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis. J Am Acad Dermatol. 2018 02; 78(2):395-402. Bui TL, Silva-Hirschberg C, Torres J, Armstrong AW. PMID: 29056237.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    450. Are patients comprehending? A critical assessment of online patient educational materials. J Dermatolog Treat. 2018 May; 29(3):295-299. Bui TL, Silva-Hirschberg C, Torres J, Armstrong AW. PMID: 28866954.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    451. Using qualitative methods to understand factors contributing to patient satisfaction among dermatology patients: a systematic review. J Dermatolog Treat. 2018 May; 29(3):290-294. Gibbons C, Singh S, Gibbons B, Clark C, Torres J, Cheng MY, Wang EA, Armstrong AW. PMID: 28817990.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    452. Psoriasis and suicidality: A systematic review and meta-analysis. J Am Acad Dermatol. 2017 Sep; 77(3):425-440.e2. Singh S, Taylor C, Kornmehl H, Armstrong AW. PMID: 28807109.
      View in: PubMed   Mentions: 80     Fields:    Translation:Humans
    453. Psoriasis. JAMA Dermatol. 2017 09 01; 153(9):956. Armstrong AW. PMID: 28903148.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    454. International Dermatology Outcome Measures (IDEOM) Group 2016 New York Meeting: Meeting Summary and Data from the Psoriasis Working Group. J Drugs Dermatol. 2017 Aug 01; 16(8):770-777. Perez-Chada LM, Singh S, Callis-Duffin K, Garg A, Gottlieb AB, Latella J, Armstrong AW, Merola JF. PMID: 28809992.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    455. Antibiotic Resistance in Acne Treatment. JAMA Dermatol. 2017 08 01; 153(8):810-811. Adler BL, Kornmehl H, Armstrong AW. PMID: 28636689.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    456. An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies. PLoS One. 2017; 12(7):e0181039. Singh S, Young P, Armstrong AW. PMID: 28719618; PMCID: PMC5515416.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    457. Quality of life among dermatology patients: a systematic review of investigations using qualitative methods. G Ital Dermatol Venereol. 2019 Feb; 154(1):72-78. Singh S, Ehsani-Chimeh N, Kornmehl H, Armstrong AW. PMID: 28712272.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    458. Drivers of Healthcare Costs Among the Costliest Patients With Psoriasis Over Three Years in a United States Health Plan. J Drugs Dermatol. 2017 Jul 01; 16(7):651-658. Armstrong AW, Zhao Y, Herrera V, Li Y, Bancroft T, Hull M, Altan A. PMID: 28697216.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    459. Direct-Access Online Care for the Management of Atopic Dermatitis: A Randomized Clinical Trial Examining Patient Quality of Life. Telemed J E Health. 2017 09; 23(9):726-732. Kornmehl H, Singh S, Johnson MA, Armstrong AW. PMID: 28570163.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    460. Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United States. Clin Drug Investig. 2017 May; 37(5):493-501. Armstrong AW, Koning JW, Rowse S, Tan H, Mamolo C, Kaur M. PMID: 28303523.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    461. Proceedings of the GRAPPA 2016 Retreat. J Rheumatol. 2017 05; 44(5):668-673. Jadon DR, Gladman DD, Mease PJ, FitzGerald O, Chandran V, Goel N, Rosen CF, Maksymowych WP, Ritchlin CT, Ogdie A, Coates LC, Cauli A, Soriano ER, Husni ME, Campbell W, Azevedo VF, Callis Duffin K, Armstrong AW, Gottlieb AB, Kavanaugh A, Garg A, Helliwell PS. PMID: 28461522.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    462. Benchmarking Care in Psoriatic Arthritis - The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting. J Rheumatol. 2017 05; 44(5):674-678. Favier G, Gladman DD, Merola JF, Armstrong AW, Boehncke WH, Helliwell PS. PMID: 28461523.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    463. Defining Outcome Measures for Psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting. J Rheumatol. 2017 05; 44(5):701-702. Callis Duffin K, Gottlieb AB, Merola JF, Latella J, Garg A, Armstrong AW. PMID: 28461532.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    464. Rethinking costs of psoriasis: 10% of patients account for nearly 40% of healthcare expenditures among enrollees with psoriasis in a U.S. health plan. J Dermatolog Treat. 2017 Nov; 28(7):613-622. Armstrong AW, Zhao Y, Herrera V, Li Y, Bancroft T, Hull M, Altan A. PMID: 28320213.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    465. Development and psychometric evaluation of the self-assessment of psoriasis symptoms (SAPS) - clinical trial and the SAPS - real world patient-reported outcomes. J Dermatolog Treat. 2017 Sep; 28(6):505-514. Armstrong AW, Banderas B, Foley C, Stokes J, Sundaram M, Shields AL. PMID: 28147886.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    466. The International Dermatology Outcome Measures (IDEOM) Initiative: A Review and Update. J Drugs Dermatol. 2017 Feb 01; 16(2):119-124. Elman SA, Merola JF, Armstrong AW, Duffin KC, Latella J, Garg A, Gottlieb AB. PMID: 28300853.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    467. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator-controlled VOYAGE 2 trial. J Am Acad Dermatol. 2017 Mar; 76(3):418-431. Reich K, Armstrong AW, Foley P, Song M, Wasfi Y, Randazzo B, Li S, Shen YK, Gordon KB. PMID: 28057361.
      View in: PubMed   Mentions: 262     Fields:    Translation:HumansCTClinical Trials
    468. National Psoriasis Foundation Priorities for Patient-Centered Research: Proceedings from the 2016 Conference. J Psoriasis Psoriatic Arthritis. 2017; 2(3):73-80. Afifi L, Shankle L, Armstrong AW, Boas M, Bridges A, Chiguil V, Doris F, Callis Duffin K, Fielding E, Fleischmann R, Gelfand JM, Kiselica M, Kiselica C, LaFoy B, Latella JJ, Takeshita J, Truman S, Wan MT, Wilkerson V, Wu JJ, Siegel MP, Liao W. PMID: 28825055; PMCID: PMC5562437.
      View in: PubMed   Mentions: 6  
    469. Body Region Involvement and Quality of Life in Psoriasis: Analysis of a Randomized Controlled Trial of Adalimumab. Am J Clin Dermatol. 2016 Dec; 17(6):691-699. Armstrong AW, Villanueva Quintero DG, Echeverría CM, Gu Y, Karunaratne M, Reyes Servín O. PMID: 27815915; PMCID: PMC5110581.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    470. Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data. Dermatol Ther (Heidelb). 2017 Mar; 7(1):97-109. Armstrong AW, Koning JW, Rowse S, Tan H, Mamolo C, Kaur M. PMID: 27905011; PMCID: PMC5336424.
      View in: PubMed   Mentions: 23  
    471. From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis. J Am Acad Dermatol. 2017 Feb; 76(2):290-298. Armstrong AW, Siegel MP, Bagel J, Boh EE, Buell M, Cooper KD, Callis Duffin K, Eichenfield LF, Garg A, Gelfand JM, Gottlieb AB, Koo JY, Korman NJ, Krueger GG, Lebwohl MG, Leonardi CL, Mandelin AM, Menter MA, Merola JF, Pariser DM, Prussick RB, Ryan C, Shah KN, Weinberg JM, Williams MO, Wu JJ, Yamauchi PS, Van Voorhees AS. PMID: 27908543.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    472. Effect of a Pre-Treatment Educational Video in Improving Patient Satisfaction with 5-Fluorouracil Treatment for Actinic Keratoses: A Randomized Controlled Trial. Dermatol Ther (Heidelb). 2016 Dec; 6(4):675-681. Agbai ON, Davari P, Johnson J, Armstrong A, Fazel N. PMID: 27778164; PMCID: PMC5120637.
      View in: PubMed   Mentions: 3  
    473. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study. J Drugs Dermatol. 2016 Oct 01; 15(10):1192-1196. Gottlieb A, Menter A, Armstrong A, Ocampo C, Gu Y, Teixeira HD. PMID: 27741335.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    474. Practice Guidelines for Teledermatology. Telemed J E Health. 2016 12; 22(12):981-990. McKoy K, Antoniotti NM, Armstrong A, Bashshur R, Bernard J, Bernstein D, Burdick A, Edison K, Goldyne M, Kovarik C, Krupinski EA, Kvedar J, Larkey J, Lee-Keltner I, Lipoff JB, Oh DH, Pak H, Seraly MP, Siegel D, Tejasvi T, Whited J. PMID: 27690203.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansPHPublic Health
    475. Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: A systematic review. J Am Acad Dermatol. 2016 Nov; 75(5):906-917. Hill MK, Kheirandish Pishkenari A, Braunberger TL, Armstrong AW, Dunnick CA. PMID: 27615798.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    476. Relationship between psoriasis and metabolic syndrome: a systematic review. G Ital Dermatol Venereol. 2016 Dec; 151(6):663-677. Singh S, Young P, Armstrong AW. PMID: 27589483.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    477. Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasis. J Dermatolog Treat. 2017 May; 28(3):200-205. Armstrong AW, Feldman SR, Korman NJ, Meng X, Guana A, Nyirady J, Herrera V, Zhao Y. PMID: 27541729.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    478. Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. N Engl J Med. 2016 Aug 04; 375(5):422-34. Kimball AB, Okun MM, Williams DA, Gottlieb AB, Papp KA, Zouboulis CC, Armstrong AW, Kerdel F, Gold MH, Forman SB, Korman NJ, Giamarellos-Bourboulis EJ, Crowley JJ, Lynde C, Reguiai Z, Prens EP, Alwawi E, Mostafa NM, Pinsky B, Sundaram M, Gu Y, Carlson DM, Jemec GB. PMID: 27518661.
      View in: PubMed   Mentions: 278     Fields:    Translation:HumansCTClinical Trials
    479. A Clinician's Guide to the Diagnosis and Treatment of Candidiasis in Patients with Psoriasis. Am J Clin Dermatol. 2016 Aug; 17(4):329-36. Armstrong AW, Bukhalo M, Blauvelt A. PMID: 27435194; PMCID: PMC4963441.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    480. Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naïve patients with psoriasis. J Am Acad Dermatol. 2016 Oct; 75(4):740-746. Armstrong AW, Betts KA, Sundaram M, Thomason D, Signorovitch JE. PMID: 27476973.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    481. From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2016 Oct; 75(4):798-805.e7. Choi YM, Debbaneh M, Weinberg JM, Yamauchi PS, Van Voorhees AS, Armstrong AW, Siegel M, Wu JJ. PMID: 27461230.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    482. Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial. Trials. 2016 07 22; 17(1):340. Awasthi S, Wilken R, Patel F, German JB, Mills DA, Lebrilla CB, Kim K, Freeman SL, Smilowitz JT, Armstrong AW, Maverakis E. PMID: 27449926; PMCID: PMC4957407.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    483. Perceptions of Aesthetic Outcome of Linear vs Multiple Z-Plasty Scars in a National Survey. JAMA Facial Plast Surg. 2016 Jul 01; 18(4):263-7. Ratnarathorn M, Petukhova TA, Armstrong AW, Wang AS, King TH, Eisen DB. PMID: 27054523.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    484. RAC1 activation drives pathologic interactions between the epidermis and immune cells. J Clin Invest. 2016 07 01; 126(7):2661-77. Winge MC, Ohyama B, Dey CN, Boxer LM, Li W, Ehsani-Chimeh N, Truong AK, Wu D, Armstrong AW, Makino T, Davidson M, Starcevic D, Kislat A, Nguyen NT, Hashimoto T, Homey B, Khavari PA, Bradley M, Waterman EA, Marinkovich MP. PMID: 27294528; PMCID: PMC4922704.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    485. Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical Trials. JAMA Dermatol. 2016 06 01; 152(6):661-9. Armstrong AW, Lynde CW, McBride SR, Ståhle M, Edson-Heredia E, Zhu B, Amato D, Nikaï E, Yang FE, Gordon KB. PMID: 26953848.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    486. Secukinumab in the Treatment of Palmoplantar, Nail, Scalp, and Pustular Psoriasis. J Clin Aesthet Dermatol. 2016 Jun; 9(6 Suppl 1):S12-S16. Armstrong AW, Vender R, Kircik L. PMID: 28439342; PMCID: PMC5395240.
      View in: PubMed   Mentions: 13  
    487. Secukinumab: Review of Clinical Evidence from the Pivotal Studies ERASURE, FIXTURE, and CLEAR. J Clin Aesthet Dermatol. 2016 Jun; 9(6 Suppl 1):S7-S12. Armstrong AW, Papp K, Kircik L. PMID: 28439341; PMCID: PMC5395241.
      View in: PubMed   Mentions: 3  
    488. The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis. J Clin Aesthet Dermatol. 2016 Jun; 9(6 Suppl 1):S3-S6. Zeichner JA, Armstrong A. PMID: 28439340; PMCID: PMC5395242.
      View in: PubMed   Mentions: 15  
    489. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatol Int. 2017 Jan; 37(1):97-105. Yim KM, Armstrong AW. PMID: 27221457.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    490. International Dermatology Outcome Measures Initiative as Applied to Psoriatic Disease Outcomes: An Update. J Rheumatol. 2016 05; 43(5):959-60. Merola JF, Armstrong AW, Saraiya A, Latella J, Garg A, Callis Duffin K, Gottlieb AB. PMID: 27134269.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    491. Screening Recommendations for Hepatitis B Virus Infection. JAMA Dermatol. 2016 05 01; 152(5):565-6. Do D, Armstrong AW. PMID: 27049505.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    492. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis. Arthritis Rheumatol. 2016 05; 68(5):1060-71. Coates LC, Kavanaugh A, Mease PJ, Soriano ER, Laura Acosta-Felquer M, Armstrong AW, Bautista-Molano W, Boehncke WH, Campbell W, Cauli A, Espinoza LR, FitzGerald O, Gladman DD, Gottlieb A, Helliwell PS, Husni ME, Love TJ, Lubrano E, McHugh N, Nash P, Ogdie A, Orbai AM, Parkinson A, O'Sullivan D, Rosen CF, Schwartzman S, Siegel EL, Toloza S, Tuong W, Ritchlin CT. PMID: 26749174.
      View in: PubMed   Mentions: 357     Fields:    Translation:Humans
    493. Who are the Pioneers? A Critical Analysis of Innovation and Expertise in Cutaneous Noninvasive and Minimally Invasive Cosmetic and Surgical Procedures. Dermatol Surg. 2016 Mar; 42(3):335-51. Bangash HK, Eisen DB, Armstrong AW, Nelson AA, Jalian HR, Alam M, Avram MM, Ibrahimi OA. PMID: 26918969.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    494. US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Am J Clin Dermatol. 2016 Feb; 17(1):87-97. Lebwohl MG, Kavanaugh A, Armstrong AW, Van Voorhees AS. PMID: 26718712; PMCID: PMC4733141.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    495. Adalimumab Efficacy in Patients with Psoriasis Who Received or Did Not Respond to Prior Systemic Therapy: A Pooled Post Hoc Analysis of Results from Three Double-Blind, Placebo-Controlled Clinical Trials. Am J Clin Dermatol. 2016 Feb; 17(1):79-86. Papp KA, Armstrong AW, Reich K, Karunaratne M, Valdecantos W. PMID: 26547918; PMCID: PMC4733136.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    496. Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners. J Cutan Med Surg. 2016 May; 20(3):196-206. Armstrong AW, Aldredge L, Yamauchi PS. PMID: 26712930; PMCID: PMC4834511.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    497. A case of Kaposi sarcoma in an immunocompetent, heterosexual Irish man: a discussion of etiology and viral transmission. Dermatol Online J. 2015 Oct 16; 21(10). Florek AG, Eilers D, Armstrong AW. PMID: 26632797.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    498. Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. N Engl J Med. 2015 Oct; 373(14):1318-28. Lebwohl M, Strober B, Menter A, Gordon K, Weglowska J, Puig L, Papp K, Spelman L, Toth D, Kerdel F, Armstrong AW, Stingl G, Kimball AB, Bachelez H, Wu JJ, Crowley J, Langley RG, Blicharski T, Paul C, Lacour JP, Tyring S, Kircik L, Chimenti S, Callis Duffin K, Bagel J, Koo J, Aras G, Li J, Song W, Milmont CE, Shi Y, Erondu N, Klekotka P, Kotzin B, Nirula A. PMID: 26422722.
      View in: PubMed   Mentions: 301     Fields:    Translation:HumansCTClinical Trials
    499. Response to: "is tonsillectomy a therapeutic option for plaque-type psoriasis?". J Am Acad Dermatol. 2015 Oct; 73(4):e155. Armstrong AW, Florek AG. PMID: 26369861.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    500. The Role of Biologic Therapies in Dermatology. Med Clin North Am. 2015 Nov; 99(6):1183-94. Fathi R, Armstrong AW. PMID: 26476247.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    501. Screening Recommendations for Chlamydia and Gonorrhea. JAMA Dermatol. 2015 Sep; 151(9):1014-6. Sharon VR, Armstrong AW. PMID: 26177006.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    502. Effect of Automated Online Counseling on Clinical Outcomes and Quality of Life Among Adolescents With Acne Vulgaris: A Randomized Clinical Trial. JAMA Dermatol. 2015 Sep; 151(9):970-5. Tuong W, Wang AS, Armstrong AW. PMID: 26017816; PMCID: PMC4985004.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    503. Simple Elbow Dislocation. Hand Clin. 2015 Nov; 31(4):521-31. Armstrong A. PMID: 26498542.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    504. Essential Truths for the Care and Management of Moderate-to-Severe Psoriasis. J Drugs Dermatol. 2015 Aug; 14(8):805-12. Blauvelt A, Armstrong AW, Krueger GG. PMID: 26267724.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    505. Effect of Adhesive Strips and Dermal Sutures vs Dermal Sutures Only on Wound Closure: A Randomized Clinical Trial. JAMA Dermatol. 2015 Aug; 151(8):862-7. Custis T, Armstrong AW, King TH, Sharon VR, Eisen DB. PMID: 25875131; PMCID: PMC4982140.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    506. Successful treatment of psoriasis with ustekinumab in patients with multiple sclerosis. Dermatol Online J. 2015 Jul 15; 21(7). Chang S, Chambers CJ, Liu FT, Armstrong AW. PMID: 26436967.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    507. Does class attendance matter? Results from a second-year medical school dermatology cohort study. Int J Dermatol. 2015 Jul; 54(7):807-16. Eisen DB, Schupp CW, Isseroff RR, Ibrahimi OA, Ledo L, Armstrong AW. PMID: 26108264.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    508. Comparing cutaneous research funded by the US National Institutes of Health (NIH) with the US skin disease burden. J Am Acad Dermatol. 2015 Sep; 73(3):383-91.e1. Hagstrom EL, Patel S, Karimkhani C, Boyers LN, Williams HC, Hay RJ, Weinstock MA, Armstrong AW, Dunnick CA, Margolis DJ, Dellavalle RP. PMID: 26051697.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    509. Economic Burden of Psoriasis in the United States: A Systematic Review. JAMA Dermatol. 2015 Jun; 151(6):651-8. Brezinski EA, Dhillon JS, Armstrong AW. PMID: 25565304.
      View in: PubMed   Mentions: 104     Fields:    Translation:Humans
    510. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation. JAMA Dermatol. 2015 Apr; 151(4):432-8. Armstrong AW, Bagel J, Van Voorhees AS, Robertson AD, Yamauchi PS. PMID: 25517130.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    511. Effectiveness of a novel interactive health care education tool on clinical outcomes and quality of life in acne patients: A randomized controlled pilot study. J Dermatolog Treat. 2015 Oct; 26(5):435-9. Wang AS, Wu J, Tuong W, Schupp C, Armstrong AW. PMID: 25790848.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    512. Psoriasis and risk of diabetes-associated microvascular and macrovascular complications. J Am Acad Dermatol. 2015 Jun; 72(6):968-77.e2. Armstrong AW, Guérin A, Sundaram M, Wu EQ, Faust ES, Ionescu-Ittu R, Mulani P. PMID: 25791800.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    513. Purse-string suture vs second intention healing: results of a randomized, blind clinical trial. JAMA Dermatol. 2015 Mar; 151(3):265-70. Joo J, Custis T, Armstrong AW, King TH, Omlin K, Kappel ST, Eisen DB. PMID: 25372450.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    514. Participant satisfaction with appearance-based versus health-based educational videos promoting sunscreen use: a randomized controlled trial. Dermatol Online J. 2015 Feb 16; 21(2). Tuong W, Armstrong AW. PMID: 25756492.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    515. Patient-centered, direct-access online care for management of atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2015 Feb; 151(2):154-60. Armstrong AW, Johnson MA, Lin S, Maverakis E, Fazel N, Liu FT. PMID: 25338198.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    516. Comparing the effectiveness of automated online counseling to standard web-based education on improving acne knowledge: a randomized controlled trial. Am J Clin Dermatol. 2015 Feb; 16(1):55-60. Tuong W, Wang AS, Armstrong AW. PMID: 25502610; PMCID: PMC4591056.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    517. An evidence-based review of the mechanism of action, efficacy, and safety of biologic therapies in the treatment of psoriasis and psoriatic arthritis. Curr Med Chem. 2015; 22(16):1930-42. Brezinski EA, Armstrong AW. PMID: 25921645.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    518. The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatology. J Am Acad Dermatol. 2015 Feb; 72(2):345-8. Gottlieb AB, Levin AA, Armstrong AW, Abernethy A, Duffin KC, Bhushan R, Garg A, Merola JF, Maccarone M, Christensen R. PMID: 25486914.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    519. Comparative prevalence of complementary and alternative medicine use among outpatients in dermatology and primary care clinics. JAMA Dermatol. 2014 Dec; 150(12):1363-5. Sivamani RK, Morley JE, Rehal B, Armstrong AW. PMID: 25251705.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    520. Efficacy of photodynamic therapy vs other interventions in randomized clinical trials for the treatment of actinic keratoses: a systematic review and meta-analysis. JAMA Dermatol. 2014 Dec; 150(12):1281-8. Patel G, Armstrong AW, Eisen DB. PMID: 25162181.
      View in: PubMed   Mentions: 18     Fields:    
    521. Effect of tonsillectomy on psoriasis: a systematic review. J Am Acad Dermatol. 2015 Feb; 72(2):261-75. Rachakonda TD, Dhillon JS, Florek AG, Armstrong AW. PMID: 25455609.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    522. Pre-bisection of a single skin biopsy does not produce technically inadequate specimens for direct immunofluorescence: a review of 3450 specimens. J Cutan Pathol. 2014 Nov; 41(11):890-2. Loh E, Armstrong AW, Fung MA. PMID: 25262568.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    523. Treatments for nail psoriasis: a systematic review by the GRAPPA Nail Psoriasis Work Group. J Rheumatol. 2014 Nov; 41(11):2306-14. Armstrong AW, Tuong W, Love TJ, Carneiro S, Grynszpan R, Lee SS, Kavanaugh A. PMID: 25362716.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    524. Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis. F1000Res. 2014; 3:248. Armstrong AW, Wu J, Johnson MA, Grapov D, Azizi B, Dhillon J, Fiehn O. PMID: 25580230; PMCID: PMC4288418.
      View in: PubMed   Mentions: 47     Fields:    
    525. Effective management of psoriasis and psoriatic arthritis: insights on current and emerging therapies and enhanced professional collaboration. Semin Arthritis Rheum. 2014 Dec; 44(3):e7-8. Mease PJ, Armstrong AW. PMID: 25476667.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    526. Psoriasis provoked or exacerbated by medications: identifying culprit drugs. JAMA Dermatol. 2014 Sep; 150(9):963. Armstrong AW. PMID: 24989499.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    527. Public perception of dermatologists and comparison with other medical specialties: results from a national survey. J Am Acad Dermatol. 2014 Nov; 71(5):875-81. Brezinski EA, Harskamp CT, Ledo L, Armstrong AW. PMID: 25175709.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    528. Set-back versus buried vertical mattress suturing: results of a randomized blinded trial. J Am Acad Dermatol. 2015 Apr; 72(4):674-80. Wang AS, Kleinerman R, Armstrong AW, Fitzmaurice S, Pascucci A, Awasthi S, Ratnarathorn M, Sivamani R, King TH, Eisen DB. PMID: 25129615.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    529. Metabolomic analysis using porcine skin: a pilot study of analytical techniques. Dermatol Online J. 2014 Jun 15; 20(6). Wu J, Fiehn O, Armstrong AW. PMID: 24945638.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    530. The International Dermatology Outcome Measures initiative as applied to psoriatic disease outcomes: a report from the GRAPPA 2013 meeting. J Rheumatol. 2014 Jun; 41(6):1227-9. Gottlieb AB, Armstrong AW, Christensen R, Garg A, Duffin KC, Boehncke WH, Merola JF, Gladman DD, Mease PJ, Swerlick RA, Rosen CF, Abernethy A. PMID: 24882858.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    531. Outcomes research in psoriasis and psoriatic arthritis using large databases and research networks: a report from the GRAPPA 2013 Annual Meeting. J Rheumatol. 2014 Jun; 41(6):1233-6. Armstrong AW, Gelfand JM, Garg A. PMID: 24882860.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    532. Psoriasis and psoriatic arthritis educational initiatives: an update from the 2013 GRAPPA Annual Meeting. J Rheumatol. 2014 Jun; 41(6):1240-3. Duffin KC, Garg A, Armstrong AW, Helliwell P, Mease PJ. PMID: 24882862.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    533. Who do you prefer? A study of public preferences for health care provider type in performing cutaneous surgery and cosmetic procedures in the United States. Dermatol Surg. 2014 Jun; 40(6):671-8. Bangash HK, Ibrahimi OA, Green LJ, Alam M, Eisen DB, Armstrong AW. PMID: 24852472.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    534. Strategies to maximize treatment success in moderate to severe psoriasis: establishing treatment goals and tailoring of biologic therapies. Semin Cutan Med Surg. 2014 Jun; 33(2):91-7. Brezinski EA, Armstrong AW. PMID: 25085668.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    535. JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis. J Immunol Res. 2014; 2014:283617. Hsu L, Armstrong AW. PMID: 24883332; PMCID: PMC4027021.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    536. Evaluation and management of adult shoulder pain: a focus on rotator cuff disorders, acromioclavicular joint arthritis, and glenohumeral arthritis. Med Clin North Am. 2014 Jul; 98(4):755-75, xii. Armstrong A. PMID: 24994050.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    537. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs. 2014 Mar; 74(4):423-41. Mease PJ, Armstrong AW. PMID: 24566842; PMCID: PMC3958815.
      View in: PubMed   Mentions: 100     Fields:    Translation:Humans
    538. Effect of appearance-based education compared with health-based education on sunscreen use and knowledge: a randomized controlled trial. J Am Acad Dermatol. 2014 Apr; 70(4):665-669. Tuong W, Armstrong AW. PMID: 24508292.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic Health
    539. Surgeon error and slide quality during Mohs micrographic surgery: is there a relationship with tumor recurrence? J Am Acad Dermatol. 2014 Feb; 70(2):386-7. Campbell T, Armstrong AW, Schupp CW, Barr K, Eisen DB. PMID: 24438960.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    540. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014 Mar; 70(3):512-6. Rachakonda TD, Schupp CW, Armstrong AW. PMID: 24388724.
      View in: PubMed   Mentions: 286     Fields:    Translation:Humans
    541. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review. Curr Pharm Des. 2014; 20(4):500-12. Armstrong AW, Brezinski EA, Follansbee MR, Armstrong EJ. PMID: 23565631.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    542. Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review. Curr Pharm Des. 2014; 20(4):513-28. Brezinski EA, Follansbee MR, Armstrong EJ, Armstrong AW. PMID: 23565632.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimals
    543. Psoriasis, electrocardiographic characteristics, and incidence of atrial fibrillation. Arch Dermatol Res. 2013 Dec; 305(10):891-7. Armstrong AW, Azizi S, Wu J, Harskamp CT, Farrow J, Johnson MA, Klem K, Anderson D, Armstrong EJ. PMID: 24166719.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    544. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA Dermatol. 2013 Oct; 149(10):1180-5. Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG. PMID: 23945732.
      View in: PubMed   Mentions: 139     Fields:    Translation:Humans
    545. Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response. Expert Rev Clin Immunol. 2013 Oct; 9(10):949-58. Hsu L, Armstrong AW. PMID: 24128157.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimals
    546. Tumor necrosis factor inhibitors and myocardial infarction in psoriasis--reply. JAMA. 2013 Sep 11; 310(10):1076. Armstrong AW. PMID: 24026612.
      View in: PubMed   Mentions:    Fields:    
    547. Immunology of atopic dermatitis: novel insights into mechanisms and immunomodulatory therapies. Semin Cutan Med Surg. 2013 Sep; 32(3):132-9. Harskamp CT, Armstrong AW. PMID: 24175400.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    548. Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting. J Rheumatol. 2013 Aug; 40(8):1438-41. Armstrong AW, Coates LC, Espinoza LR, Ogdie AR, Rich P, Soriano ER. PMID: 23908541.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    549. Psoriasis outcome measures: a report from the GRAPPA 2012 annual meeting. J Rheumatol. 2013 Aug; 40(8):1428-33. Gottlieb AB, Armstrong AW. PMID: 23908539.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    550. Psoriasis and psoriatic arthritis video project: an update from the 2012 GRAPPA annual meeting. J Rheumatol. 2013 Aug; 40(8):1455-6. Callis Duffin K, Armstrong AW, Mease PJ. PMID: 23908546.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    551. Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting. J Rheumatol. 2013 Aug; 40(8):1434-7. Armstrong AW, Gelfand JM, Boehncke WH, Armstrong EJ. PMID: 23908540.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    552. Severe adverse events from the treatment of advanced melanoma: a systematic review of severe side effects associated with ipilimumab, vemurafenib, interferon alfa-2b, dacarbazine and interleukin-2. J Dermatolog Treat. 2014 Oct; 25(5):401-8. Ma C, Armstrong AW. PMID: 23763243.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    553. Evaluation criteria for mobile teledermatology applications and comparison of major mobile teledermatology applications. Telemed J E Health. 2013 Sep; 19(9):678-82. Ho B, Lee M, Armstrong AW. PMID: 23808886.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    554. Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg. 2013 Sep; 206(3):410-7. Wang AS, Armstrong EJ, Armstrong AW. PMID: 23759697.
      View in: PubMed   Mentions: 136     Fields:    Translation:HumansAnimals
    555. Access to health care in patients with psoriasis and psoriatic arthritis: data from National Psoriasis Foundation survey panels. JAMA Dermatol. 2013 Jun; 149(6):717-21. Bhutani T, Wong JW, Bebo BF, Armstrong AW. PMID: 23783152.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    556. Reply: To PMID 22459360. J Am Acad Dermatol. 2013 Jun; 68(6):1042-3. Armstrong AW, Wu J. PMID: 23680198.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    557. Psoriasis and Sexual Behavior in Men: examination of the National Health and Nutrition Examination Survey (NHANES) in the United States. J Sex Med. 2014 Feb; 11(2):394-400. Armstrong AW, Harskamp CT, Schupp CW. PMID: 23679217.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    558. Do TNF inhibitors reduce the risk of myocardial infarction in psoriasis patients? JAMA. 2013 May 15; 309(19):2043-4. Armstrong AW. PMID: 23677316.
      View in: PubMed   Mentions: 10     Fields:    
    559. Prevalence of pilomatricoma in Turner syndrome: findings from a multicenter study. JAMA Dermatol. 2013 May; 149(5):559-64. Handler MZ, Derrick KM, Lutz RE, Morrell DS, Davenport ML, Armstrong AW. PMID: 23426075.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    560. Standardizing training for psoriasis measures: effectiveness of an online training video on Psoriasis Area and Severity Index assessment by physician and patient raters. JAMA Dermatol. 2013 May; 149(5):577-82. Armstrong AW, Parsi K, Schupp CW, Mease PJ, Duffin KC. PMID: 23426158.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    561. Surgeon error and slide quality during Mohs micrographic surgery: is there a relationship with tumor recurrence? J Am Acad Dermatol. 2013 Jul; 69(1):105-11. Campbell T, Armstrong AW, Schupp CW, Barr K, Eisen DB. PMID: 23582570.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    562. Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc. 2013 Apr 04; 2(2):e000062. Armstrong EJ, Harskamp CT, Armstrong AW. PMID: 23557749; PMCID: PMC3647278.
      View in: PubMed   Mentions: 165     Fields:    Translation:Humans
    563. Improving patient education with an eczema action plan: a randomized controlled trial. JAMA Dermatol. 2013 Apr; 149(4):481-3. Shi VY, Nanda S, Lee K, Armstrong AW, Lio PA. PMID: 23553035.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    564. Clinical and histologic diagnostic guidelines for psoriasis: a critical review. Clin Rev Allergy Immunol. 2013 Apr; 44(2):166-72. Johnson MA, Armstrong AW. PMID: 22278173.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    565. Effect of nutrient supplementation on atopic dermatitis in children: a systematic review of probiotics, prebiotics, formula, and fatty acids. JAMA Dermatol. 2013 Mar; 149(3):350-5. Foolad N, Brezinski EA, Chase EP, Armstrong AW. PMID: 23682371.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    566. The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2013 Mar; 31(3):433-42; discussion 442-3. Armstrong AW, Harskamp CT, Armstrong EJ. PMID: 23249828.
      View in: PubMed   Mentions: 97     Fields:    Translation:Humans
    567. Postoperative preferences in cutaneous surgery: a patient-centered investigation from an academic dermatologic surgery practice. Dermatol Surg. 2013 May; 39(5):773-8. Sharon VR, Armstrong AW, Jim-On S, Ibrahimi OA, Eisen DB. PMID: 23432932.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    568. Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United States. Pediatr Dermatol. 2013 Jul-Aug; 30(4):424-8. Mercy K, Kwasny M, Cordoro KM, Menter A, Tom WL, Korman N, Belazarian L, Armstrong AW, Levy ML, Paller AS. PMID: 23360462; PMCID: PMC3641153.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    569. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013 Apr; 68(4):654-662. Armstrong AW, Harskamp CT, Armstrong EJ. PMID: 23360868.
      View in: PubMed   Mentions: 167     Fields:    Translation:Humans
    570. Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis. JAMA Dermatol. 2013 Jan; 149(1):84-91. Armstrong AW, Harskamp CT, Armstrong EJ. PMID: 23407990.
      View in: PubMed   Mentions: 131     Fields:    Translation:Humans
    571. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011. PLoS One. 2012; 7(12):e52935. Armstrong AW, Schupp C, Wu J, Bebo B. PMID: 23285231; PMCID: PMC3532407.
      View in: PubMed   Mentions: 93     Fields:    Translation:Humans
    572. Separate- versus same-day preoperative consultation in dermatologic surgery: a patient-centered investigation in an academic practice. Dermatol Surg. 2013 Feb; 39(2):240-7. Sharon VR, Armstrong AW, Jim On SC, Ibrahimi OA, Eisen DB. PMID: 23279092.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    573. Harnessing the power of crowds: crowdsourcing as a novel research method for evaluation of acne treatments. Am J Clin Dermatol. 2012 Dec 01; 13(6):405-16. Armstrong AW, Cheeney S, Wu J, Harskamp CT, Schupp CW. PMID: 23039257.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    574. Videos to influence: a systematic review of effectiveness of video-based education in modifying health behaviors. J Behav Med. 2014 Apr; 37(2):218-33. Tuong W, Larsen ER, Armstrong AW. PMID: 23188480.
      View in: PubMed   Mentions: 144     Fields:    Translation:Humans
    575. Psoriasis and sexual behavior in U.S. women: an epidemiologic analysis using the National Health and Nutrition Examination Survey (NHANES). J Sex Med. 2013 Feb; 10(2):326-32. Armstrong AW, Follansbee MR, Harskamp CT, Schupp CW. PMID: 23171046.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    576. Psoriasis and psoriatic arthritis video project: an update from the GRAPPA 2011 annual meeting. J Rheumatol. 2012 Nov; 39(11):2198-200. Callis Duffin K, Armstrong AW, Mease PJ. PMID: 23118287.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    577. Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting. J Rheumatol. 2012 Nov; 39(11):2204-10. Armstrong AW, Callis Duffin K, Garg A, Gelfand JM, Gottlieb AB, Krueger GG, Qureshi AA, Rosen CF. PMID: 23118289.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    578. Psoriasis and autoimmune disorders: a review of the literature. J Am Acad Dermatol. 2012 Nov; 67(5):1076-9. Hsu LN, Armstrong AW. PMID: 23062896.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    579. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology. 2012; 225(2):121-6. Armstrong AW, Schupp C, Bebo B. PMID: 23108113.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    580. Congenital self-healing reticulohistiocytosis: concern for a poor prognosis. Dermatol Online J. 2012 Oct 15; 18(10):2. Larsen L, Merin MR, Konia T, Armstrong AW. PMID: 23122009.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    581. Crowdsourcing in eczema research: a novel method of data collection. J Drugs Dermatol. 2012 Oct; 11(10):1153-5. Armstrong AW, Harskamp CT, Cheeney S, Schupp CW. PMID: 23285714.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    582. Perceptions of expertise in cutaneous surgery and cosmetic procedures: what primary care physicians think. Dermatol Surg. 2012 Oct; 38(10):1645-51. Ibrahimi OA, Bangash H, Green L, Alam M, Armstrong AW, Eisen DB. PMID: 22958115.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    583. Crowdsourcing for data collection: a pilot study comparing patient-reported experiences and clinical trial data for the treatment of seborrheic dermatitis. Skin Res Technol. 2013 Feb; 19(1):55-7. Armstrong AW, Wu J, Harskamp CT, Cheeney S, Schupp CW. PMID: 22891700.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    584. Teledermatology operational considerations, challenges, and benefits: the referring providers' perspective. Telemed J E Health. 2012 Oct; 18(8):580-4. Armstrong AW, Kwong MW, Chase EP, Ledo L, Nesbitt TS, Shewry SL. PMID: 22881579.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    585. Power of crowdsourcing: novel methods of data collection in psoriasis and psoriatic arthritis. J Am Acad Dermatol. 2012 Dec; 67(6):1273-1281.e9. Armstrong AW, Harskamp CT, Cheeney S, Wu J, Schupp CW. PMID: 22818792.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    586. Novel approach to utilizing electronic health records for dermatologic research: developing a multi-institutional federated data network for clinical and translational research in psoriasis and psoriatic arthritis. Dermatol Online J. 2012 May 15; 18(5):2. Armstrong AW, Reddy SB, Garg A. PMID: 22630572.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    587. Why some dermatologists do not practice store-and-forward teledermatology. Arch Dermatol. 2012 May; 148(5):649-50. Armstrong AW, Kwong MW, Chase EP, Ledo L, Nesbitt TS, Shewry SL. PMID: 22782162.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    588. Do automated text messages increase adherence to acne therapy? Results of a randomized, controlled trial. J Am Acad Dermatol. 2012 Dec; 67(6):1136-42. Boker A, Feetham HJ, Armstrong A, Purcell P, Jacobe H. PMID: 22521201.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    589. Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy. PLoS One. 2012; 7(4):e33486. Brezinski EA, Armstrong AW. PMID: 22509259; PMCID: PMC3324468.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    590. Survey of demographic and educational factors among dermatology chairs and chiefs. Cutis. 2012 Apr; 89(4):195-8. Alikhan A, Ghods M, Armstrong AW. PMID: 22611750.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    591. State of teledermatology programs in the United States. J Am Acad Dermatol. 2012 Nov; 67(5):939-44. Armstrong AW, Wu J, Kovarik CL, Goldyne ME, Oh DH, McKoy KC, Shippy AM, Pak HS. PMID: 22459360.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    592. Crowdsourcing for research data collection in rosacea. Dermatol Online J. 2012 Mar 15; 18(3):15. Armstrong AW, Harskamp CT, Cheeney S, Schupp CW. PMID: 22483526.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    593. Advances in management of atopic dermatitis: new therapies and novel uses of existing treatments. Semin Cutan Med Surg. 2012 Mar; 31(1):17-24. Chase EP, Armstrong AW. PMID: 22361285.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    594. The effect of academic "misrepresentation" on residency match outcomes. Dermatol Online J. 2012 Jan 15; 18(1):1. Maverakis E, Li CS, Alikhan A, Lin TC, Idriss N, Armstrong AW. PMID: 22301038.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    595. Application of mobile teledermatology for skin cancer screening. J Am Acad Dermatol. 2012 Oct; 67(4):576-81. Lamel SA, Haldeman KM, Ely H, Kovarik CL, Pak H, Armstrong AW. PMID: 22243769.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    596. Coronary artery disease in patients with psoriasis referred for coronary angiography. Am J Cardiol. 2012 Apr 01; 109(7):976-80. Armstrong AW, Harskamp CT, Ledo L, Rogers JH, Armstrong EJ. PMID: 22221950.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    597. Impact of live interactive teledermatology on diagnosis, disease management, and clinical outcomes. Arch Dermatol. 2012 Jan; 148(1):61-5. Lamel S, Chambers CJ, Ratnarathorn M, Armstrong AW. PMID: 22250233.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    598. Health outcomes in atopic dermatitis. Dermatol Clin. 2012 Jan; 30(1):73-86, viii. Rehal B, Armstrong AW. PMID: 22117869.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    599. Combination treatments for psoriasis: a systematic review and meta-analysis. Arch Dermatol. 2012 Apr; 148(4):511-22. Bailey EE, Ference EH, Alikhan A, Hession MT, Armstrong AW. PMID: 22184718.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    600. Practice models and challenges in teledermatology: a study of collective experiences from teledermatologists. PLoS One. 2011; 6(12):e28687. Armstrong AW, Kwong MW, Ledo L, Nesbitt TS, Shewry SL. PMID: 22194887; PMCID: PMC3237480.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    601. Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists. J Am Acad Dermatol. 2012 Sep; 67(3):357-62. Parsi KK, Brezinski EA, Lin TC, Li CS, Armstrong AW. PMID: 22079041.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansPHPublic Health
    602. Nonmelanoma skin cancer. Dermatol Clin. 2012 Jan; 30(1):125-39, ix. Kim RH, Armstrong AW. PMID: 22117874.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    603. A review of health outcomes in patients with psoriasis. Dermatol Clin. 2012 Jan; 30(1):61-72, viii. Li K, Armstrong AW. PMID: 22117868.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    604. Melanoma: epidemiology, diagnosis, treatment, and outcomes. Dermatol Clin. 2012 Jan; 30(1):113-24, ix. Tuong W, Cheng LS, Armstrong AW. PMID: 22117873.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    605. Patient-centered online management of psoriasis: a randomized controlled equivalency trial. J Am Acad Dermatol. 2012 Jun; 66(6):948-53. Chambers CJ, Parsi KK, Schupp C, Armstrong AW. PMID: 21890236; PMCID: PMC3233643.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    606. Cost-effectiveness analysis of a patient-centered care model for management of psoriasis. J Am Acad Dermatol. 2012 Apr; 66(4):563-70. Parsi K, Chambers CJ, Armstrong AW. PMID: 21835497.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    607. A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis. Exp Dermatol. 2011 Jul; 20(7):544-9. Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge JC. PMID: 21692858.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    608. Umbilicated erythematous papules in an immunocompromised patient. Lancet Infect Dis. 2011 Jun; 11(6):488. Tuerk M, Cheng LS, Konia T, Armstrong AW. PMID: 21616459.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    609. Angiogenesis and oxidative stress: common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci. 2011 Jul; 63(1):1-9. Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge JC. PMID: 21600738.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    610. Health-care delivery methods in teledermatology: consultative, triage and direct-care models. J Telemed Telecare. 2011; 17(4):214-6. Pathipati AS, Lee L, Armstrong AW. PMID: 21508078.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    611. Elephantiasic thyroid dermopathy. Am J Med. 2011 Sep; 124(9):e1-2. Li K, Lin S, Armstrong AW. PMID: 21497784.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    612. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010. PLoS One. 2011 Apr 13; 6(4):e17520. Rehal B, Armstrong AW, Armstrong A. PMID: 21533286; PMCID: PMC3076368.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    613. Psoriasis and hypertension severity: results from a case-control study. PLoS One. 2011 Mar 29; 6(3):e18227. Armstrong AW, Lin SW, Chambers CJ, Sockolov ME, Chin DL. PMID: 21479272; PMCID: PMC3066207.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    614. Current state of acne treatment: highlighting lasers, photodynamic therapy, and chemical peels. Dermatol Online J. 2011 Mar 15; 17(3):2. Kim RH, Armstrong AW. PMID: 21426868.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    615. Online video improves clinical outcomes in adults with atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol. 2011 Mar; 64(3):502-7. Armstrong AW, Kim RH, Idriss NZ, Larsen LN, Lio PA. PMID: 21236514.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    616. Failure to maximize patient adherence strategies in clinical practice. Arch Dermatol. 2010 Dec; 146(12):1430-1. Armstrong AW. PMID: 21173331.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    617. A pale version. Am J Med. 2010 Sep; 123(9):802-4. Cheng LS, Mulgrew K, Lin S, Idriss N, Eisen DB, Fung MA, Armstrong AW. PMID: 20800147.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    618. Combination systemic therapies in psoriatic arthritis. J Dermatolog Treat. 2011 Oct; 22(5):276-84. Daly M, Alikhan A, Armstrong AW. PMID: 20666676.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    619. Effects of video-based, online education on behavioral and knowledge outcomes in sunscreen use: a randomized controlled trial. Patient Educ Couns. 2011 May; 83(2):273-7. Armstrong AW, Idriss NZ, Kim RH. PMID: 20570081.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    620. Evaluation and comparison of store-and-forward teledermatology applications. Telemed J E Health. 2010 May; 16(4):424-38. Armstrong AW, Sanders C, Farbstein AD, Wu GZ, Lin SW, Liu FT, Nesbitt TS. PMID: 20438384.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    621. Erythema induratum of Bazin. Dermatol Online J. 2010 Apr 15; 16(4):1. Sharon V, Goodarzi H, Chambers CJ, Fung MA, Armstrong AW. PMID: 20409408.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    622. Online, video-based patient education improves melanoma awareness: a randomized controlled trial. Telemed J E Health. 2009 Dec; 15(10):992-7. Idriss NZ, Alikhan A, Baba K, Armstrong AW. PMID: 20028190.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    623. Text-message reminders to improve sunscreen use: a randomized, controlled trial using electronic monitoring. Arch Dermatol. 2009 11; 145(11):1230-6. Armstrong AW, Watson AJ, Makredes M, Frangos JE, Kimball AB, Kvedar JC. PMID: 19917951.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansPHPublic Health
    624. A national survey to determine an optimal fourth year curriculum for dermatology candidates. Dermatol Online J. 2009 Oct 15; 15(10):2. Alikhan A, Ledo L, Armstrong AW. PMID: 19951620.
      View in: PubMed   Mentions:    Fields:    
    625. Physician workforce for acne care in the United States, 2003 through 2005. Arch Dermatol. 2009 Oct; 145(10):1195-6. Armstrong AW, Idriss N, Bergman H. PMID: 19841414.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    626. Digital imaging in dermatology: attitudes, behaviors, and innovations. Skin Res Technol. 2009 Aug; 15(3):376-7. Idriss SZ, Armstrong AW, Kvedar JC, Lio PA. PMID: 19624436.
      View in: PubMed   Mentions:    Fields:    
    627. Follicular eruption on arms and legs. Phrynoderma. Arch Dermatol. 2008 Nov; 144(11):1509-14. Armstrong AW, Setyadi HG, Liu V, Strasswimmer J. PMID: 19015431.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    628. Images in HIV/AIDS. Sweet syndrome and syphilis in an HIV-infected person. AIDS Read. 2008 Mar; 18(3):134-5. Johnson LE, Armstrong AW, Dezube BJ, Tahan SR, Gold HS. PMID: 18398981.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    629. Fate of manuscripts declined by the Journal of the American Academy of Dermatology. J Am Acad Dermatol. 2008 Apr; 58(4):632-5. Armstrong AW, Idriss SZ, Kimball AB, Bernhard JD. PMID: 18249470.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    630. Chronically unreduced elbow dislocations. Hand Clin. 2008 Feb; 24(1):91-103. Lyons RP, Armstrong A. PMID: 18299023.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    631. Economic evaluation of interactive teledermatology compared with conventional care. Telemed J E Health. 2007 Apr; 13(2):91-9. Armstrong AW, Dorer DJ, Lugn NE, Kvedar JC. PMID: 17489695.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    632. Ultrasound evaluation and clinical correlation of subscapularis repair after total shoulder arthroplasty. J Shoulder Elbow Surg. 2006 Sep-Oct; 15(5):541-8. Armstrong A, Lashgari C, Teefey S, Menendez J, Yamaguchi K, Galatz LM. PMID: 16979047.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    633. The efficacy of ultrasound in the diagnosis of long head of the biceps tendon pathology. J Shoulder Elbow Surg. 2006 Jan-Feb; 15(1):7-11. Armstrong A, Teefey SA, Wu T, Clark AM, Middleton WD, Yamaguchi K, Galatz LM. PMID: 16414462.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    634. Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme. J Cutan Pathol. 2004 May; 31(5):393-7. Armstrong AW, Fazeli A, Yeh SW, Mackool BT, Liu V. PMID: 15059226.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    635. Arthroscopic versus open treatment of anterior shoulder instability. Instr Course Lect. 2004; 53:559-63. Armstrong A, Boyer D, Ditsios K, Yamaguchi K. PMID: 15116644.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    April's Networks
    Concepts (900)
    Derived automatically from this person's publications.
    _
    Co-Authors (51)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _